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Abstract 
Voltage-gated sodium channels are the primary molecules responsible for the rising phase 
of action potentials in electrically excitable cells. There are 10 distinct sodium channel 
isoforms Nav 1.1-1.8 (SCNIA-SCN5A and SCN8A-SCNIIA) and the majority of these 
undergo tissue and developmentally regulated alternative splicing. Two such examples are 
those of the SCN8A (Nav 1.6) and SCN9A (Nav 1.7) genes. SCN8A gene contains two 
mutually exclusive exons, 18N and 18A. Transcripts with exon 18N have a conserved in-
frame stop codon that predicts the synthesis of a truncated, non functional sodium channel. 
This protein is expressed in fetal brain and non-neuronal tissues. Once the exon 18A is 
included, the resulted protein will be a functional channel, that is expressed in adult 
neurons ofCNS and PNS. The SCN9A exon 5N is preferentially expressed in the PNS and 
CNS of adult tissues and significant usage of exon 5A was found only in DRG. These two 
isoforms differ in one amino acid in the S3 domain I (exons 5A and 5N). This change of 
one amino acid induced a small shift of activation to more hyperpolarized potentials for 
exon SA compared with exon SN. Analysis of SeNSA pre-mRNA splicing supports a 
model in which exon 18A exclusion in non-neuronal tissue is regulated primarily by the 
presence in the cell types of several hnRNPs proteins that function through an exonic 
splicing silencer (ESS) found in this exon together with the absence of neuron specific 
Fox-I protein. In neuronal cells the absence of these hnRNPs together with the presence of 
neuron specific Fox-l cause the exon to be included. The SeNSA exon 18N is included in 
non neuronal cells due to the SR proteins that function through an exonic splicing enhancer 
(ESE) found in this exon. In neuronal cells the lower levels of these SR proteins cause the 
exon 18N to be skipped. This type of control of mutually exclusive splicing through the 
proteome make-up of a cell type would appear to be influential in the temporal and tissue 
specific splicing of SeN8A, another member of the voltage gated sodium channels and 
may indeed represent a more general mechanism. 
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1. Introduction 
1.1 An overview of Pre-mRNA splicing. 
The initial primary transcript, precursor RNA (pre-mRNA) is synthetisized by RNA 
polymerase II (Pol II) and is extensively processed before functional mRNA exits the 
nucleus to be translated into protein in the cytoplasm. Before this final step can occur the 
pre-mRNA undergoes several modifications that can occur both co and post 
transcriptionally. Among these, are steps such as the addition of a 7-methyl guanosine cap 
at the 5' end, splicing of introns, and 3' end formation by cleavage and polyadenylation 
(de Almeida and Carmo-Fonseca 2008). Splicing and other RNA processing events occur 
while RNA polymerase II actively transcribes pre-mRNA (Maniatis and Reed 2002). 
Pre-mRNA splicing is the reaction where introns (non coding intervening sequences 
present in pre-mRNA) are removed and exons (protein coding regions that will be included 
in the mature mRNA) are joined together (Gilbert 1978). 
To dictate splicing, each intron is marked by a GU dinucleotide at the 5' end and a AG 
dinucleotide at the 3' end, although exceptions exist (Kreivi and Lamond 1996). These 
nearly 100% conserved dinucleotides at either end of the intron, in reality, form part of 
more loosely defined sequences known respectively as the 5' and 3' splices sites. The 5' 
splice site is a degenerate 8-nucleotide motif with a consensus motif MAG/GTRAGT 
(where M is A or C and R is A or G) and the holo-3'splice site which is even more loosely 
defined being composed of three elements: the 3' splice site that has a consensus CAG 
among which again only dinucleotides AG are universally conserved, a branch point (BP) 
consensus in which an A nucleotide is universally conserved, and a polypyrimidine tract 
which are usually spread across the last 40 nucleotides of the intron but they can take up 
considerably more space (Fig. 1) (Gooding, Clark et at. 2006; Venables 2007). 
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5' splice site Branch Poly Y site tract 3' splice site 
~--==_L.:G::-U .RAGU ---- YNCURAC Y(n) YAGC:=;;:== 
, 
Figure 1. Schematic representation of exon-intron boundaries and consensus sequences for 
5' and 3' splice sites and branch point. The two exons and the intron are indicated. Poly 
(Y) tract means region rich in pyrimidines. The universally conserved nucleotides are the 
dinucleotide cores of the 5' and 3' splice sites GV and AG respectively together with the 
branch point (A). 
Intron removal is carried out by the spliceosome, a dynamic multi subunit particle 
containing five small ribonuclear proteins snRNPs, VI , V2, V4, V5 and V6 that function 
in conjunction with over 200 distinct non-snRNP auxiliary proteins (Hartmuth, Urlaub et 
a1. 2002; Jurica, Licklider et a1. 2002; Nilsen 2003; de Almeida and Carmo-Fonseca 2008). 
Each V snRNP consists of an snRNA (or two in the case of V4IU6), a common set of 
seven Sm proteins (BIB', 03, 02, 01, E, F, and G) and a variable number of particle-
specific proteins (Fig. 2). The most probable secondary structures of the human 
spliceosomal VI, V2, U4IU6, and V5 snRNAs are shown in Figure 2. 
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Figure 2. Protein composition and snRNA secondary structures of the human spliceosomal 
snRNPs. All seven Sm proteins (BIB', D3, D2, Dl, E, F, and G) or LSm proteins (LSm2-
8) are indicated by "Sm" or "LSm" at the top of the boxes showing the proteins associated 
with each snRNP. The U41U6.U5 tri-snRNP contains two sets of Sm proteins and one set 
ofLSm proteins (Figure from (Will and Luhrmann). 
Initial recognition of exonlintron junction is based on direct interactions between VI 
snRNP with the 5' splice site, the V2 auxiliary factor (U2AF65/35) with the 
polypyrimidine tract, and V2 snRNP with the branch point sequence (Fig. 3). The 
interactions between the pre-mRNA and snRNPs are based on their sequence specificity, 
thus the splice sites are classified by their complementarity to VI snRNA 5' splice site and 
the extent of the polypyrimidine tract. Greater complementarity with V I snRNA and 
longer polypyrimidine tracts translate into higher afftnity binding sites for these 
spliceosome components and consequently more efficient exon recognition (Hertel 2008). 
The possibility of ascribing a strength to the 5' and 3' splice site has being the focus of 
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many studies principally based on position weight matrices that are calculated from 
collections of splice sites (Shapiro and Senapathy 1987; Senapathy, Shapiro et a1. 1990). 
To date we are still unable given a stretch of DNA if a 8 nucleotide stretch will function as 
a 5' splice sites or not, nor indeed if a 3' splice site confinning to consensus will do so. 
5' ss 
Figure 3. Schematic representation of the direct interactions between VI snRNP with the 
5' splice site, the U2 auxiliary factor, V2AF65 and U2AF35, with the polypyrimidine tract 
and the 3' splice site respectively, and V2 snRNP with the branch point sequence. 
1.1.1 Spliceosome complex formation. 
The assembly of the spliceosome has been characterized principally using in vitro systems 
where several distinct intermediates in an assembly pathway can be observed (Query, 
Strobel et al. 1995). The first complex to be formed is a nonspecific, H complex, and 
consists of heterogeneous nuclear ribonucleoproteins, hnRNPs, binding with pre-mRNA 
(Konarska, Grabowski et al. 1985). H complex formation does not require splice sites or 
ATP and occurs in vitro even at 4°C. As mentioned previously, the 5' splice site of an 
intron is recognized by the snRNP VI, through complementary pairing of the RNA bases. 
The 3' splice site, with its upstream polypyrimidine tract, is bound by the protein V2 
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auxiliary factor U2AF, which is a heterodimer that includes U2AF65, a protein containing 
tandem RNA recognition motifs that binds tightly to the polypyrimidine tract, and U2AF35 
which binds the real 3' splice site (Brow 2002). These factors, together with additional 
proteins, form a first discrete functional spliceosome complex called the E or commitment 
complex, which bridges the intron and brings the splice sites that are to be cleaved 
together. E complex formation requires incubation in vitro at 30°C and assembles more 
efficiently on pre-mRNAs containing both a 5' splice site and the polypyrimidine tract at 
the 3' splice site. However, there are also complexes related to the E complex, so called 
E5' and E3' complexes, that assemble in half-substrate RNAs containing only a 5' or a 3' 
splice site, respectively (Michaud and Reed 1993). U2AF recruits the U2 snRNP, and an 
A TP dependent step allows the RNA portion of the U2 snRNP to base pair with a 
branchpoint, upstream of the 3' splice site. This base pairing of the U2 with the branch 
point completes the A complex. Recently, Kotlajich et aI, carried out a series of kinetic 
trap experiments using pre-mRNAs that undergo alternative 5' splice site selection or 
alternative exon inclusion and, in both cases, they showed that commitment to splice site 
pairing occurs in the A complex (Kotlajich, Crabb et al. 2009). Subsequent, ATP-
dependent steps lead to the binding of the U4-U5-U6 tri-snRNP and the formation of the B 
complex. Different rearrangements that follow, with the subsequent formation of the 
catalytic spliceosome C complex, in which two transesterification reactions on the splice 
sites occurs (Fig. 4). 
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Figure 4. Spliceosome assembly. In the earliest E spliceosomal complex, the VI snRNP is 
recruited to the 5'ss. In a subsequent step, the V2 snRNP stably associates with the BP, 
fonning the A complex. The V41U6.V5 tri-snRNP is then recruited, generating the pre-
catalytic B complex. Major rearrangements in RNA- RNA and RNA- protein interactions, 
leading to the destabilization of the VI and V4 snRNPs, give rise to the activated 
spliceosome (the B-act complex). Subsequent catalytic activation by the DEAR-box RNA 
helicase Prp2, generates the B catalytically activated complex, which catalyzes the first of 
the two steps of splicing. This yields the C complex, which in turn catalyzes the second 
step. The spliceosome then dissociates and, after additional remodeling, the released 
snRNPs take part in additional rounds of splicing (Figure from (Will and Luhrmann). 
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During the first step of transesterification, an adenosine residue generally located within 
100 nucleotides of the 3' end of the intron, in a sequence element known as the branch 
point sequence (BP), carries out a nucleophilic attack on the 5' splice site. This reaction 
generates the splicing intermediates (free exon 1 and lariat-exon 2). During step 2, exon 1 
attacks at the 3' splice site to generate splicing products (spliced exon and lariat intron) 
(Fig. 5). 
5'SS BP 3'SS + 
~~~ -----A--pc=CC= ~ L--,;;........IPC== 
Step 1 Step 2 
Figure s. Schematic representation of sequential transesterification during splicing. In the 
first reaction, an adenosine residue of the 3' end of the intron, in a sequence element 
known as the branch point sequence (BP), carries out a nucleophilic attack on the 5' splice 
site. This reaction generates the splicing intermediates (free exon I and lariat-exon 2). 
During step 2, exon I attacks at the 3' splice site of exon 2 to generate splicing products 
(spliced exon and lariat intron) (Figure from (Will and Luhrmann). 
Spliceosome assembly in cells however is likely to differ from what is happening on 
simple single-intron RNAs in vitro. Before the spliceosome complex forms across the 
intron, the splice sites are usually defined through interactions between splice-site-bound 
components across the exons. The assembly of these "exon definition" complexes CEDes) 
is stimulated by proteins that bind to special sequences in the exon itself. In particular, E, 
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A and B complexes have primarily been analyzed and defined in studies using simple two 
exonlsingle intron constructs, such that the spliceosome components can only assemble 
across the intron (Fig. 6). However, a number of latter [mdings have shown that at least VI 
and V2AF subunits of the spliceoosme E complex can interact across the single exon as 
part of an EDC that is essential for high fidelity splice site recognition. Therefore, it is 
possible for the VI and V2 snRNPs to first interact across a single exon before pairing 
with spliceosome components on a flanking exon, indicating that VI and V2 containing 
(that is, A-like) EDC may be able to form on natural substrates as part of the spliceosome 
assembly pathway (Berget 1995; Reed 2000); (House and Lynch 2006). 
Figure 6. A network of protein-protein interactions across the exon and intron. Before the 
spliceosome complex forms across the intron (double-headed green arrow), the splice sites 
are usually defmed through interactions between splice-site-bound components across the 
exons (double-headed pink arrow). The assembly of these "exon definition" complexes 
(EDCs) is stimulated by proteins that bind to special sequences in the exon itself. 
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1.2 Alternative splicing: where a common precursor pre-mRNA 
molecule can generate multiple mRNAs. 
As previously explained, the splicing reaction occurs in two transesterification steps within 
a large spliceosome complex containing more than 100 proteins assembled stepwise onto 
pre-mRNA introns (Zhou, Licklider et al. 2002). During alternative splicing, the 
spliceosome assembly is altered so that a splice site is optionally used depending on the 
cell type, developmental stage or sex, resulting in the inclusion or exclusion of alternative 
exon sequences in the mature mRNA. Alternative splicing is therefore a process by which 
the exons of the RNA produced by transcription are reconnected in multiple different ways 
increasing greatly protein diversity. 
Estimates of how commonly alternative splicing occurs in human protein coding genes 
have increased over the years, from an initial 5 % to more than 95 % (Calarco, Zhen et al.; 
Sharp 1994). Recent studies have suggested that alternative splicing is nearly ubiquitous in 
human transcripts and is frequently controlled in a tissue specific manner (Pan, Shai et al. 
2004; Wang, Sandberg et al. 2008). In particular, extensive tissue specific alternative 
splicing has been observed in the mammalian nervous system and is thought to contribute 
to both its molecular and cellular complexity (Lipscombe 2005). In some cases a single 
pre-mRNA can generate a large number of protein isoforms, for example, transcripts of the 
Dscam, Neurexin and Sio genes (Saito, Nelson et al. 1997; Graveley 2001; Xie 2008). The 
consequences of alternative splicing include altered mRNA stability or subcellular 
localization and the addition or deletion of specific protein coding sequences. Functional 
differences among protein isoforms range from subtle modulations to on/off switches or 
even antagonistic effects (Shipston 2001; Revil, Shkreta et al. 2006». These mechanisms 
of alternative splicing are so tightly controlled that even subtle defects in alternative 
splicing factors or aberrant inclusion of alternative exon can result in genetic diseases 
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(Hammes, Guo et a1. 2001; Faustino and Cooper 2003; Kashima and Manley 2003; 
Licatalosi and Darnell 2006). 
Studies with tissue or sex-specific exons identified both cis-acting pre-mRNA elements 
and trans acting factors that control alternative splicing (Black 2003). Furthennore, pre-
mRNA structures are also important for alternative splicing regulation (Grover, Houlden et 
a1. 1999; Xing and Lee 2006). In addition to cell type, developmental stage and sex-
specific regulation, alternative splicing can also be dynamically regulated in response to 
extracellular stimuli such as cytokines, honnones or neurotransmitters, adding a further 
dimension to the control of the flow of genetic infonnation (Xie and McCobb 1998; 
Stamm 2002; Lee, Yu et a1. 2007). However, it is not clear in most cases how alternative 
splicing is controlled by external stimuli and intracellular signaling pathways (Rafuse and 
Landmesser 1996; Hepp, Dupont et a1. 2001; Rozic-Kotliroff and Zisapel 2007). 
1.2.1 Types of alternative splicing. 
Transcripts from a gene can undergo many different patterns of alternative splicing. 
Typical types of alternative splicing are inclusion or skipping of one or more exons 
(cassette exons), shortening or lengthening of an exon by alternative 5' and 3' splice site 
usages, mutual exclusion of two or more exons, and retained introns. Different promoters 
and different polyadenylation sites may specify alternative 5' and 3' tenninal exons, 
respectively. More complex alternative splicing patterns can be fonned by combinations of 
different basic types (Fig. 7). 
Many alternatively spliced genes contain entire exons that are individually included or 
excluded from the mature mRNA. When such an exon is retained, the splicing pattern 
resembles that for a constitutive gene in which all potential coding sequences are 
incorporated into the mature mRNA. When it is removed, it is presumably carried on a 
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long intron that also contains its flanking noncoding sequences. Such alternatively spliced 
exons represent discrete cassettes of genetic information encoding peptide subsegments 
that are differentially incorporated into the mature gene product. 
Cassette exons are delimited by splice sites that lie at the boundaries between mRNA-
coding and noncoding sequence. While the exon itself mayor may not be incorporated, its 
immediate flanking introns are invariably excluded in the splicing process. There are 
numbers of genes with internal alternative splice sites which, in contrast, actually lie 
entirely within potential coding sequence. Splicing at such a site results in the exclusion of 
some fraction of an otherwise intact exon. Through the use of alternative 5' or 3' splice 
sites, exons can be extended or shortened in length. 
Several other genes incorporate intron sequence into mRNA by failing to splice both 
members of a donor/acceptor pair altogether. The retained intron necessarily maintains an 
intact translational reading frame and, in effect, creates a longer fusion exon. 
A very special case of paired cassette exons show mutually exclusive splicing. Here, one 
exon or the other of the mutually exclusive ex on pair is invariably spliced into a given 
mRNA, but the exclusion or inclusion of both simultaneously does not occur. 
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Figure 7. Modes of alternative splicing. Typical types of alternative splicing are inclusion 
or skipping of one or more exons (cassette exons), mutual exclusion of two or more exons, 
retained introns and shortening or lengthening of an exon by alternative 5' and 3' splice 
site. Different promoters (P) and different polyadenylation sites may specify alternative 5' 
and 3' terminal exons, respectively. [n these graphics, exons are represented by boxes and 
introns by lines. Exon regions included in the messages by alternative splicing are colored 
while constitutive exons are shown in gray. Promoters are indicated with arrows and 
polyadenylation sites with AAAA. 
1.2.2 Mutually exclusive splicing "when two is already a 
crowd". 
Mutually exclusive splicing (ME) is a process in which only one of a set of two or more 
exons in a pre-mRNA is included in the fmal transcript. This form of splicing plays an 
important role in gene evolution, since it provides the potential to modulate protein 
functions simply by swapping the mutually exclusive exons without disrupting protein size 
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or structure (Letunic, Copley et al. 2002). Furthennore, ME splicing can provide a 
multitude of distinct protein isofonns. An impressive example of ME alternative splicing 
has been reported for the Drosophila homolog of the human Down-syndrome adhesion 
molecule (Dscam) gene. The Dscam gene has liS exons, 95 of which are alternatively 
spliced. Alternative exons are organized in four clusters with 12 alternative versions of 
exon 4, 48 versions of exon 6, 33 versions of exon 9, and 2 versions of exon 17. Only one 
version of a particular ex on is chosen, with the exclusion of others, so that by the 
combinatorial use of alternative exons, the Dscam pre-mRNA can potentially encode 
38,016 different isofonns. It has been demonstrated that conserved sequence elements in 
introns that fonns RNA secondary structures play a functional role in the mutually 
exclusive splicing in Dscam gene (May, Olson et a1.; Graveley 2005). 
For genes with mutually exclusive exon pairs, no cellular mRNAs have yet been detected 
that incorporate both exons in vivo, despite the fact that the introns between them contain 
functional 5' and 3' splice sites (Mullen, Smith et a1. 1991). Therefore the intriguing 
question is what are the mechanisms involved that prevents ME exons from being spliced 
to each other? To date different mechanisms have been investigated (Fig. 8). The first is 
sterie interference between splice sites (Smith and Nadal-Ginard 1989). Minimal spacing 
requirements, around 50 nucleotides for mammalian introns, are necessary between the 5' 
splice site and the branch point. Below this threshold the distance between, VI and V2 
snRNPs is such that they cannot bind productively to the 5' splite site and the branch point 
respectively. Thus, the two exons remain free to become spliced to the flanking 
constitutive exons but not to their mutually exclusive partner. Examples include the a-
tropomyosin and a-actinin genes (Smith and Nadal-Ginard 1989; Southby, Gooding et a1. 
1999). Another mechanism is that pairs of ME exons are flanked by splice sites of 
incompatible types. In addition to the major spliceosome, cells have a minor spliceosome 
in which the small nuclear ribonucleoproteins (snRNPs) VI and V2 are replaced by VII 
and V12. "V1IV2" and "VIIIVI2" splice sites have distinct consensus sequences and are 
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incompatible, so an intron with a VI 5' splice site and a Vl2 3' splice site cannot be 
spliced. An example of this type of control is the mutually exclusive splicing of exons 6 
and 7 of the human stress-activated protein kinase (iNKJ) gene that have VllU2 introns on 
the upstream side and VillU12 introns on the downstream side (Kreivi and Lamond 1996; 
Letunic, Copley et al. 2002). Spliceosomal incompatibility prevents not only splicing 
together of the ME exons but also exon skipping of both. 
However, the majority of ME exon pairs do not have a mechanism that absolutely prohibits 
their splicing together and in these cases, regulated selection of the individual exons may 
be sufficiently coordinated to minimize inappropriate splicing without the need for an 
absolute physical impediment to double-exon inclusion (Grabowski and Black 2001). In 
these cases trans acting factors, acting through splicing regulatory cis-acting elements, 
functions as repressors of one ME exon and activators of its partner, allow the functional 
versatility to promote the required coordinated regulation. However, the appearance of 
strict ME splicing may occur even when the splicing machinery does not achieve the 
required degree of fidelity. If the two exons are not both a multiple of 3 nucleotides, the 
alteration in reading frame and consequent introduction of stop codon can lead to disposal 
by nonsense mediated decay (NMD) of products containing both ME exons and the 
degradation of a transcript. Close to 60% of predicted ME exons would produce 
frameshifts upon double inclusion so NMD play an important role in alternative ME 
splicing regulation (Jones, Carstens et al. 2001). 
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Figure 8. Mechanisms of Mutually Exclusive Splicing. 
(A) Steric interference occurs when the branch point (white circle) of the downstream ME 
exon is too close to the upstream 5' splice site. Mutually exclusive exons are shown in red 
and green, constitutive exons in blue. (B) A model of spliceosomal incompatibility. The 
splice sites used by the "VIIV2" and "V ll/u12" snRNP containing spliceosomes have 
distinct consensus sequences and are incompatible. For example, an intron with a VI 5' 
splice site and a V12 3' splice site cannot be spliced. In panels (A) and (B), impossible 
splice pathways are shown by the double-headed red arrows. (C) Mutually exclusive 
splicing can have tightly coordinated regulation by trans acting factors, indicated by the 
orange and yellow ellipses, some of which can act as both repressors and activators of ME 
exon pairs. In some cases, nonsense mediated decay (NMD) can dispose of mRNAs 
containing both ME exons if a premature termination codon is introduced (indicated by 
stop sign). Figure from (Smith 2005). 
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1.3 Splicing regulatory elements and associated factors. 
As I previously mentioned the cis-acting elements which the splicesome recognizes (5' and 
3' splice site) are highly degenerate resulting in the paradox that such an important and 
precise process as splicing with the added complexity of alternative splicing is dictated by 
redundant sequences. Today it is clear that although necessary, these consensus elements 
are by no means sufficient to define exoniintron borders. A myriad of auxiliary splicing 
cis-acting regulatory elements exist that can either enhance splicing and are termed exon 
splicing enhancers or intronic splicing enhancers depending on their location or repress 
exon inclusion and are called exon or intron splicing silencers, again depending on where 
they are found. 
1.3.1 Exonic splicing enhancers and the SR protein family. 
Studies on alternative splicing have identified exonic cis-acting elements, referred to as 
exonic splicing enhancers (ESEs), that facilitate the process of exon definition, thus 
helping exon inclusion in the mRNA (Mardon, Sebastio et al. 1987; Lam and Hertel 2002). 
Although originally discovered in regulated exons, ESEs are today also known to be 
components of constitutively spliced exons (Mayeda, Screaton et al. 1999; Schaal and 
Maniatis 1999). 
ESEs assist early spliceosomal complex formation by interacting with components of the 
splicing machinery that make up the previously described E complex (Reed 1996). This is 
done generally through the serine/arginine-rich proteins, SRs, and SR related proteins that 
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generally assemble on ESEs elements to promote both regulated and constitutive splicing 
by forming networks of interaction with each other (Fig. 9) (Blencowe 2000). 
ESE 
Figure 9. Mechanistic model connecting ESE and SRs. Splicing enhancer sequences 
within the exon (ESE) recruit proteins of the SR protein family, which establish a network 
of protein-protein interactions across the exon that stabilize the exon defined complex. 
The SR proteins are nuclear phosphoproteins that are concentrated, together with most 
other splicing factors, in nuclear subregions termed speckels, which are believed to be sites 
of storage or assembly of splicing factors. It has been proposed that SR proteins and other 
splicing factors are recruited from the speckles to the sites of active transcription. Thus, 
certain SR proteins shuttle continuously between the nucleus and cytoplasm (Caceres, 
Screaton et al. 1998). The SR proteins have a common domain structure of one or two 
RNA binding domains followed by an RS domain containing repeated arginine/serine 
dipeptides, which can be highly phosphorylated. This phosphorylation modulates protein-
protein interaction, that serves as a bridge between the 5' and 3' splice sites across the 
introns and across the exons and/or between enhancers and adjacent splice site, within the 
spliceosome (Caceres, Screaton et al. 1998; Black 2003; Ram and Ast 2007). Much of 
initial understanding of ESEs derives from the regulation of inclusion of exon 4 in the 
doublesex (dsx) gene in Drosophila. The doublesex repeat element (dsxRE) , in this exon, is 
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one of the first best characterized ESE element consisting of six repeats of a I3-nucleotide 
consensus sequence and a purine-rich element located between repeat 5 and 6. A 
muItisubunit complex, containing SR-related proteins, alternative splicing factors 
Transformer (Tra), Transformer 2 (Tra2) and additional SR proteins assembles on dsx ESE 
element and once fully assembled, the dsxRE complex activates the recognition of a weak, 
sex specific 3' splice site, thereby promoting exon 4 inclusion and the female 
differentiation pathway (Ryner and Baker 1991; Tian and Maniatis 1992). Similarly, 
mammalian ESEs were identified initially as a purine rich sequences that associate with SR 
familiy proteins and promotes the utilization of adjacent splice site (Mardon, Sebastio et al. 
1987; Lavigueur, La Branche et al. 1993). Some of the mammalian SR family includes the 
proteins: SRp20, SRp30c, 9G8, SRp40, SRp55, SRp70, SC35 and ASF/SF2. SR-related 
family of proteins have RS domain but serve different role. These include, for example, 
V2AF, VI-70K, SRmI60/300, Tra2 and numerous others (Table 1). 
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Table 1. SR and SR-related proteins with their respective binding sites. 
Name* Domains Binding sequence 
Canonical SR proteins 
SRp20 (SFRS3) RRMondRS GCUCCUCUUC 
SC35 (SFRS2) RRMondRS UGCUGUU 
ASF/SF2 (SFRSl) RRM,RRMH RGAAGAAC 
ondRS 
SRp40 (SFRS5) RRM,RRMH 
andRS 
AGGAGAAGGGA 
SRp55 (SFRS6) RRM,RRMH 
andRS 
GGCAGCACCUG 
SRp75 (SFRS4) RRM,RRMH 
andRS 
GAAGGA 
9G8(SFRS7) RRM, zinc finger (GAC)n 
andRS 
SRp30c (SFRS9) RRM,RRMH CUGGAUU 
andRS 
SRp38 (FUSIP1) RRMondRS AAAGACAAA 
Other SR proteins 
SRp54 RRMondRS NO 
SRp46 (SFRS2B) RRMondRS NO 
RNPSl RRMond NO 
Ser-rich 
SRrp35 RRMondRS NO 
SRrp86 (SRrp508 RRMond RS NO 
ondSFRS12) 
TRA2a RRMondtwo GAAARGARR 
Arg-rich 
TRA2~ RRM ond two RS (GAA)n 
RBMS RRMond RS NO 
CAPER (RBM39) RRMond RS NO 
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Different members of SR proteins are generally interchangeable in their ability to fulfill a 
wide range of activities in the splicing reaction. SR proteins seem to be also important in 
splicing regulation being able to modulate selection of alternative splice sites in a 
concentration dependent manner (Tacke and Manley 1999). 
Protein-protein interaction screens have indicated, that through their RS domains, SR-
family proteins, such as SC35 and ASF/SF2 can interact with each other, with VI-70K SR 
related protein, and with small V2AF35 subunit of the heterodimeric V2AF35/65 auxiliary 
splicing factor, which contains a short RS domain (Fu 1995). These interaction studies led 
to the proposal that SR family and SR related proteins facilitate splicing by forming 
interactions across the exons and introns. However, it was proposed that, in naturally 
occurring enhancers, SR proteins apparently may bind as a component of a multiprotein 
complex, whose components are not yet identified but may include known splicing factors 
as the large RS domain proteins SRm160/300, Tra2, VI snRNP and heterogeneous 
ribonucleoproteins, such as hnRNPs Al and hnRNP H. The SRm160/300 subunits are new 
SR-related proteins that lack RNA binding domain. SRm160/300 in particular is thought to 
be required for a typical purine rich mammalian ESE (consisting of six GAA repeats) to 
promote splicing of a pre-mRNA. The stable association of SRml60/300 with this pre-
mRNA required the ESE, the VI snRNP binding at the 5' splice site and the hTra2~ 
binding to (GAA)n sequence element. Thus, SRm160/300 promotes critical interaction 
between SR proteins, SR related proteins and hTra2~ bound to ESE, and snRNP 
components of the spliceosome complex (Blencowe, Bauren et al. 2000). The binding sites 
for a SR protein members can be fairly degenerate (Black 2003). 
Due to the importance of these ESEs in pre mRNA splicing a lot of work has gone into the 
possibility of predicting the presence of these enhancers. Several ESE prediction programs 
are presently available (Fairbrother, Yeh et al. 2002; Zhang and Chasin 2004). The 
majority of these are developed on either functional consensus motifs for SR proteins 
identified through a functional SELEX (systemic evolution of ligands by exponential 
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enrichment) method, on the statistical analysis of differences in hexamer frequencies 
between exons and introns and between exons with weak and strong splice sites based on 
the presumption that the ESE will be more common in exons rather than introns and again 
more common in exons with weak splices sites or on consensus sequences derived from 
known ESE and corresponding trans acting factors. Although extremely useful as a starting 
point in investigation of splicing mechanism, the presence of a high score motif in a 
sequence does not necessarily identify that sequence as an exonic splicing enhancer in its 
native context (Goren, Ram et a1. 2006). 
1.3.2 Exonic splicing silencer and hnRNP proteins. 
While the positive regulation of splicing is thought to occur as a result of protein-protein 
interaction strengthening the recognition of the splice site, negative regulation of splice site 
choice often result from the prevention of the splice site to be recognized. These negative 
regulatory sequences, within an exon, are called exonic splicing silencer, ESSs, and in the 
majority of cases are bound by particular hnRNP family proteins. 
The hnRNP proteins are large group of molecules identified by their association with pre-
mRNA or hnRNAs (heterogeneous nuclear RNAs). At least 20 hnRNPs have been 
identified, and are designated from hnRNP Al to hnRNP U (Table 2) (Dreyfuss, Kim et a1. 
2002). hnRNP proteins contain one or more of RNA binding motifs. The most common is 
the RNP motif (RBD, also called RNA recognition motif, RRM), KH domains and RGG 
(Arg-Gly-Gly) boxes (Burd and Dreyfuss 1994). 
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Table 2. hnRNPs involved in pre-mRNA splicing with respective binding sequences. 
Name Other names Domains· Binding sequences 
hnRNPA1 NA RRM. RGG and G UAGGGAIU 
hnRNPA2 NA RRM. RGG and G (UUAGGG)n 
hnRNP 61 
hnRNPCl AUFl RRM Urich 
hnRNPC2 
hnRNPF NA RRM. RGG and GY GGGA and G rich 
hnRNPG NA RRMandSRGY CC(NO and MGU 
hnRNPH DSEFl RRM. RGG. GYR and GY GGGA and G rich 
hnRNPH' 
hnRNPI PTa RRM UCUU and CUCUCU 
hnRNPl NA RRM CandArich 
hnRNPlL SRRF RRM CandArich 
hnRNPM NA RRMandGY NO 
hnRNPO NA RRM and RGG NO 
The structure of hnRNPs is modular, apart from the RNA binding domain, each hnRNP 
protein also contains the protein-protein interaction domain that mediates the localization 
of the protein. hnRNP proteins participate in various nuclear events, such as transcriptional 
regulation (Tomonaga and Levens 1995; Michelotti, Michelotti et al. 1996; Miau, Chang et 
al. 1998), telomere length maintenance (Eversole and Maizels 2000; Fiset and Chabot 
2001), immunoglobulin gene recombination (Dempsey, Sun et al. 1999), splicing (Ashiya 
and Grabowski 1997; Chan and Black 1997; Chou, Rooke et al. 1999; Del Gatto-Konczak, 
Olive et al. 1999; Tange, Damgaard et al. 2001; Chen and Manley 2009), pre-ribosomal-
RNA (Russell and Tollervey 1992), and 3' end processing (Kessler, Henry et a1. 1997). 
These proteins are also important in nucleo-cytoplasmic transport of mRNA (Lee, Henry et 
al. 1996), in mRNA localization (Hoek, Kidd et al. 1998; Mouland, Xu et at. 2001), 
translation (Habelhah, Shah et al. 2001) and stability (Xu, Chen et al. 2001). Like SRs 
proteins also hnRNPs continuously shuttle between nucleus and cytoplasm. 
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Although a role as a negative regulator for splicing can be found in the literature for the 
majority of hnRNPs, some major players involved in pre-mRNA splicing regulation 
emerge. The most abundant hnRNPs belong to the NB type. This family consists of a 
number of isoforms (AI, A21B1, B2 and A3) showing extensive post transcriptional and 
translational modifications and sharing common RNA binding motif (Pozzoli and Sironi 
2005). hnRNP AI, the most studied, contains two RNA binding domains and a glycine rich 
auxiliary domain. Using model substrates containing competing 5' splice sites, hnRNP Al 
was shown to induce a shift toward the use of distal 5' splice site (Mayeda, Munroe et al. 
1994). hnRNP Al has been shown to also affect the use of the 3' splice site, as in the case 
of K-SAM exon in FGFR2 receptor mRNA, resulting in skipping of this exon (Del Gatto, 
Gesnel et al. 1996). The application of the SELEX approach has identified UAGGGAIU as 
the highest "winner" sequence for hnRNP Al (Burd and Dreyfuss 1994). hnRNP A 1 can 
interact with itself and with other hnRNPs, as well as with U2 and U4 snRNPs (Buvoli, 
Cobianchi et al. 1992; Cartegni, Maconi et al. 1996). 
hnRNP proteins belonging to the H group (hnRNPs F, H, H' and 2H9) are encoded by 
different genes but share common binding site (GGGA) and similar structure. hnRNP H 
has been shown to act both as a activator and repressor of splicing. For example, hnRNP H 
acts as a powerful repressor in the rat p-tropomyosin gene by binding to the UGUGGG 
motif and causing ex on 7 skipping in non muscle cells (Chen, Kobayashi et al. 1999; 
Chou, Rooke et al. 1999). It was also demonstrated that insertion of a UGUGGG motif in 
CFTR exon 9 results in lower inclusion of this exon (Pagani, Stuani et al. 2003; Buratti, 
Baralle et al. 2004). 
hnRNP G proteins, in humans, are encoded by two genes RBMY and RBMX located on 
chromosome Y and X respectively. The product of RBMX has been implicated in splicing 
regulation of two mutually exclusive exons in the a-tropomyosin gene, in particular 
hnRNP G was shown to promote skipping of the skeletal muscle specific exon (SK) and to 
enhance the inclusion of the non muscle specific exon (NM) (Elliott, Oghene et al. 1998). 
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HnRNP DL (hnRNPD-like) JKTBP protein it is closely related to hnRNPD/AUF family. 
There at least two isofonns of JKTBPI and 2 in HeLa cells. The major isofonn JKTBP1, 
although it is primarily nuclear, shuttles between the nucleus and cytoplasm in HeLa cells 
(Akagi, Kamei et a1. 2000). Little is known about the RNA binding properties of JKTBP. 
The consensus sequence for JKTBP2 is the 7 nt sequence ACUAGCIT (Kamei and 
Yamada 2002). A UAG present in these consensus splice sites is also found in the JKTBP 
high-affinity binding sites, thus JKTBP may playa role in alternative splice site switching 
(Akagi, Kamei et a1. 2000). 
Other hnRNP proteins, such as hnRNP L, K, El and E2, have traditionally been thought to 
regulate cytoplasmic export, stability and translation of specific mRNA (Liu and Mertz 
1995; Makeyev, Eastmond et a1. 2002; Perrotti and Calabretta 2002). However, each of 
these proteins was found also in the nucleus and may be involved in splicing reactions 
(Pinol-Roma 1999). Rothrock et a1. showed that hnRNP Land hnRNP El are the primary 
ESS binding proteins found in nuclear extracts from a T-derived cell line, and that a 
hnRNP L is the key regulatory protein responsible for ESS depending exon 4 silencing of 
the CD45 gene (Rothrock, House et a1. 2005). 
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1.3.3 Intronic splicing silencers and enhancers. 
Cis-acting regulatory elements in the intronic sequences have being studied to a lesser 
extent than those present in exons. Like exonic regulation, there are both positive and 
negative cis-acting sequences in the intron, so called intronic splicing enhancer (ISE) and 
intronic splicing silencer (ISS). 
Some of the best characterized ISSs include binding sites for previously described hnRNP 
Al protein (Hui and Bindereif 2005; Matlin, Clark et al. 2005; Wagner, Baraniak et al. 
2005; Kashima, Rao et al. 2007). hnRNP Al has been shown to interact with a novel 
intronic silencer element (ISS), important for the splicing of the second HIV-l tat intron. 
The removal of the second tat intron is regulated by a combination of a suboptimal 3' 
splice site and cis-acting splicing enhancers and silencers. The positional overlap between 
the ISS element and the branch point -26, as well as the anchoring sites for U2 snRNP at 
the branch point -26, suggested that hnRNP A 1 binding physically blocks the association 
of branch point binding factors, such as SFI and U2 snRNP. Consistent with this view, 
Tange et aI., observed that hnRNP Al blocked U2 snRNP binding to the branch point, in 
the ISS dependent manner, of the second tat intron (Tange, Damgaard et al. 2001). 
hnRNP I, also called PTB and PTBPI is another major player in splicing control. PTB has 
strong RNA binding activity, and its preferred binding site is UCUU, often flanked by 
pyrimidines (Perez, Lin et al. 1997). Initially it was hypothesized that PTB is a positive 
splicing regulator, but later studies revealed that PTB is rather a splicing repressor (Garcia-
Blanco, Jamison et al. 1989; Valcarcel and Gebauer 1997). Early models of PTB 
repression suggested that it may compete with U2AF65 for polypyrimidine tract, however 
regulation by PTB often requires additional PTB binding elements. In the case of exon Nl 
of the c-src gene, for example, cooperative binding sites on both exon sides are reqiured 
for its repression in non neuronal cells (Chou, Underwood et al. 2000). The presence of a 
tissue restricted counterpart of the ubiquitously expressed PTB was initially detected in rat 
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brain extracts based on its different electrophoretic mobility but similar RNA binding 
activity to PTB. Two independent studies latter identified and cloned nPTB (also known as 
PTBP2 and brPTB), confirming that is tissue restricted paralog of PTB. Subsequently, 
nPTB has been identified as a key regulator of exon NI splicing of the c-src gene and as a 
protein that interacts with Nova-I12, a neuron specific protein. Data from in vitro analysis 
showed that nPTB can act either neutrally or as a weaker repressor than PTB in preventing 
ex on NI inclusion of c-src gene (Ashiya and Grabowski 1997; Markovtsov, Nikolic et al. 
2000; Polydorides, Okano et al. 2000). Additional focused and genome-wide analyses of 
PTB and nPTB have shed light on the mechanism by which these factors regulate 
alternative splicing. Both proteins display mutually exclusive expression patterns in the 
brain, with PTB being expressed in glial and non-neuronal cells, and nPTB in neurons. 
When PTB is present at sufficient levels, it represses splicing of exon lOin nPTB 
transcripts, producing an isoform containing a stop codon that is degraded by NMD 
pathway. PTB also appears to further inhibit nPTB expression or turnover at the protein 
level independent of its effect on splicing of exon 10. Thus, down-regulation of PTB 
should lead to the expression of functional nPTB. In neurons, the silencing of PTB 
expression is achieved by the neuron-specific micro-RNA miR-124, which effectively 
dcrepresses nPTB exon 10 splicing, although efficient inclusion of this exon in neurons 
also requires positive-acting splicing regulators, such as neural specific SR-related protein 
of 100 kDa, nSRlOO protein (also known as SRRM4), which promotes exon 10 inclusion 
of nPTB. This mutually exclusive expression pattern appears to be established after cells 
have committed to a neuronal fate, because neural progenitor cells appear to express both 
PTB and nPTB (Boutz, Chawla et al. 2007; Makeyev, Zhang et al. 2007; Spellman, Llorian 
et al. 2007; Calarco, Superina et al. 2009). 
There are several elements known to act as intronic splicing enhancers, ISE's, but the 
proteins that mediate their effects are less well characterized than for ESE's. One well 
characterized ISE element is the triplet (GGG) which often occurs in clusters and can 
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enhance recognition of adjacent 5' or 3' splice sites (McCullough and Berget 1997). 
Intronic (CA) repeats in several cases can enhance splicing of upstream exons, probably 
through binding ofhnRNP L protein (Hui and Bindereif2005; Hung, Heiner et a1. 2008). 
TIA-I is an important ISE protein that binds pyrimidine-rich sequences that binds 
downstream of exon 9, of the CFTR (cystic fibrosis transmembrane conductance regulator) 
gene (Zuccato, Buratti et at. 2004; Venables 2007). Another example in which TIA-I 
regulates splicing via ISE elements is Fas exon 6 that can be included or skipped to 
generate mRNA encoding a membrane bound fonn of the receptor that promotes apoptosis 
or a soluble isofonn that prevents programmed cell death respectively. TIA-I protein 
promotes VI snRNP binding to the 5' splice site of intron 6, by binding to the ISE element 
in the +6 to +20 position downstream of Fas exon 6, which in tum facilitate exon inclusion 
(Izquierdo, Majos et at. 2005). 
Two RNA-binding proteins with family members expressed specifically in nervous system 
andlor muscle tissues are the muscleblind-like (MBNL) and CVGBP/ETR-like (CELF; 
also known as Bruno-like) factors (Barreau, Paillard et a1. 2006; Pascual, Vicente et a1. 
2006). These factors have been implicated in neurological disorders and in CVG 
trinucleotide expansion diseases such as myotonic dystrophy (Gallo and Spickett; Cooper 
2009). These factors are also involved in several aspects of mRNA metabolism, including 
alternative splicing (Ladd, Charlet et a1. 2001; Ho, Charlet et at. 2004). Several studies 
using model pre-mRNA substrates have demonstrated that MBNL and CELF bind intronic 
CVG-repeat and VG-rich elements respectively. At least some members of this family 
activate splicing through intronic enhancer elements (Charlet, Logan et a1. 2002; Ho, 
Charlet et a1. 2004). 
Another common ISE element is the hexanucletide (U)GCAVG motif that represents 
highly specific recognition element for the Fox family proteins. This element strongly 
enhances the splicing and since is an important subject of this thesis it will be discussed in 
more detail below. 
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1.3.4 (U)GCAUG element as a cell type specific splicing signal. 
(U)GCAUG element has the peculiarity of functioning both as an enhancer or silencer 
(Kuroyanagi 2009). As previously mentioned computational target prediction for the 
binding of specific splicing factors is often very difficult, largely due to the small size and 
degeneracy of splicing factor binding motif. An exception to this degeneracy is the 
hexanucleotide (U)GCAUG motif, which is an important intronic element regulating the 
splicing of several exons (Huh and Hynes 1994; Modafferi and Black 1997; Lim and Sharp 
1998). Computational analysis further showed that the (U)GCAUG elements were 
preferentially localized to the proximal downstream intron with greatest enrichment of 
sites in the first 100 nucleotides downstream, however it has being shown to function at a 
distances of up to 1 kb from the regulated exon. Further evidence for the importance of this 
regulatory element comes from the fact that it is evolutionarily conserved near the 
orthologous alternative exons from fish to humans (Minovitsky, Gee et al. 2005). 
The hexamer (U)GCAUG is the functional motif shared among many brain enriched 
exons, but also an enhancer of alternative exons with different tissue specific regulation. 
Thus, (U)GCAUG is a marker specifically of regulated alternative splicing, but not a 
general marker for all alternative exons (Jin, Suzuki et al. 2003; Nakahata and Kawamoto 
2005; Underwood, Boutz et al. 2005). The majority of brain-enriched exons possess at 
least one copy of (U)GCAUG in the flanking intron, and the remaining few generally have 
closely related GCAUG pentameric motif(s) in the proximal intron (Brudno, Gelfand et al. 
200 I). As these hexamer elements can act from within different sequence contexts, 
specific RNA secondary structures are probably not critical for hexamer function. 
Therefore, it is likely that the (U)GCAUG motif comprises the essential cis-active element. 
Repeated (U)GCAUG sequences are capable of functioning in a cell type dependent 
fashion in a heterologous context, a finding that has not been established for many of the 
other potential vertebrate elements (Huh and Hynes 1994). 
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The patterns of alternative polyadenylation were strongly correlated with those of 
alternative splicing across tissues, and (U)GCAUG(U) heptamer was highly enriched in 
the extension region of tandem 3' untranslated regions (UTRs) (Wang, Sandberg et al. 
2008). 
1.3.5 The Fox protein family: evolutionarily conserved 
regulators of tissue-specific alternative splicing in metazoans. 
(U)GCAUG represents a highly specific recognition element for the Fox family of 
proteins. The Fox-l (feminizing locus on X) gene was originally identified in C. eiegans, 
where it acts as a numerator element in counting the number of X chromosomes relative to 
ploidity, and determining male or hermaphrodite development (Auweter, Fasan et a1. 
2006). There are several homologues of C.elegans Fox-l in mouse and human genomes. In 
addition to human Fox-l (Ataxin-2 binding protein, A2BPI gene), there are other 
paralogous genes in the mammalian genomes. One of them is Fox-2 (RNA binding motif 
9, RBM9 gene) and the other is Fox-3 (hexaribonucleotide binding protein 3, HRNbp3, 
NeuN gene) (Shibata, Huynh et al. 2000; Lieberman, Friedlich et a1. 2001; McKee, Minet 
et al. 2005; Kim, Adelstein et al. 2009). 
Fox-l expression has being observed to be high in brain, heart and skeletal muscle, while 
Fox-2 protein shows much broader tissue expression as well as higher expression levels in 
the embryo relative to the adult than Fox-I. Fox-3 protein expression has only been 
observed in neurons (Kuroyanagi 2009). Recently, it has been reported that Fox-3 gene 
product is NeuN, neuron specific protein, whose expression has been used widely as a 
reliable tool to detect most postmitotic neuronal cell type in neuroscience, developmental 
biology and stem cell research fields as well as diagnostic histopathology (Kim, Adelstein 
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et al. 2009). Alignments of the cDNA, EST and genomic databases indicate that both the 
A2BP! (Fox-!) and RBM9 (Fox-2) genes have multiple promoters and multiple internal 
casette exons that are variably included in the mRNA (Fig. 10). 
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Figure 10. Schematic structure and major splicing patterns of the mouse Fox-II A2bp 1 and 
Fox-2/Rbm9 genes. Boxes indicate exons and horizontal lines indicate introns. Use of 
these exons is supported by cDNA and/or EST sequences in GenBanklEMBLIDDBJ 
databases. Coding regions are coloured; RRM domains in orange, brain-specific region in 
green, muscle-specific region in magenta, other isoform-specific regions in blue, and 
common regions in yellow. The size of the exons is not proportional to that of the introns 
(Figure from (Kuroyanagi 2009). 
Both gene transcripts are found to undergo tissue specific alternative splicing. In both 
cases, brain and striated muscles express unique splice variants generated by mutually 
exclusive splicing of exons B40 and M43, respectively, which provide different coding 
sequences in the middle of the C-terminal region. A2BP} gene (Fox-I) contains an 
additional cassette type alternative exon A53, consisting of 53 nucleotides. Inclusion or 
exclusion of exon A53 results in two different amino acid sequences at the C-terminal 
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region (Nakahata and Kawamoto 2005; Baraniak, Chen et a1. 2006; Fukumura, Kato et a1. 
2007). 
In the case of the A2BPl gene, moreover, it appears that brain and striated muscle utilize 
alternative promoters, resulting in different amino acid sequences at the N terminus. The 5' 
RACE of skeletal muscle mRNAs yielded essentially a single species of sequence with 29 
unique N-terminal amino acids. The 5' RACE, using brain mRNAs, however, yielded 
multiple products with multiple deduced amino acid sequences, all of which differ from 
the muscle amino acid sequence at the very N-terminus (Nakahata and Kawamoto 2005). 
Exon/intron organization of RBM9 and A2BPl genes shows remarkable similarities at the 
RNA binding domain (RBD), encoded in four exons. Of note is that the significant 
amounts of RBM9 and A2BPI mRNAs from skeletal muscles are missing a part of the 
RBD by exon skipping. Specifically, they lack the 93 nt exon that encodes RNPI, one of 
the two most critical motifs of the RBD (Burd and Dreyfuss 1994). This isoform is missing 
crucial residues for RNA binding, and thus, will not mediate splicing enhancement or 
repression through the (U)GCAUG element. Instead, the intact N- and C-terminal domains 
of this isoform can counteract the effect of full length Fox proteins in enhancing a Fox 
dependent exoo. Thus, rather than the autoregulated splicing reducing the overall level of 
the protein, the new isoform directly antagonizes Fox activity (DamianoY and Black). 
1.3.6 Fox family proteins targets and implications. 
The Fox-l family of proteins for the first time was identified in C.eiegans, while the Fox-l 
protein in humans was originally identified as an interactor with ataxin-2 and both Fox-l 
and Fox-2 interact with ataxin-l, which are mutated in spinal cerebellar ataxia (Shibata, 
Huynh et a1. 2000; Lam, Bowman et a1. 2006). Indeed, genes with Fox dependent 
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alternative splicing events have being frequently associated with diseases, including 
several neurological, heart, and muscular disorders. Furthermore, mutations in the Fox-I 
gene itself or alteration of its expression are associated with neurological disorders and 
heart disease (Kaynak, von Heydebreck et al. 2003; Bhalla, Phillips et al. 2004; Szatmari, 
Paterson et al. 2007). Two recent alternative splicing profiling studies have also found a 
connection between the Fox family of splicing regulators and breast and ovarian cancer. 
These studies implicate the altered regulation of Fox-dependent splicing networks in 
various cancers, and analysis of these networks should uncover how these isoforms 
contribute to the development and progression of the cancer disease (Lapuk, Marr et al.; 
Venables, Klinck et al. 2009). 
Fox-2 CLIP (ultaviolet cross-linking and immunoprecipitation assay) tag clusters in human 
embryonic stem cell (hESCs) revealed an enrichment of RNA-binding proteins, nuclear 
mRNA splicing factors, and serine/threonine kinases. Among these Fox-2 target genes 
were heterogeneous ribonucleoproteins (hnRNPs) such as A2/BI, HI, H2, and PTB, 
alternative splicing regulators including Fox-I, oPTB, SRp20, SRp40, SRp55, and Tra2a, 
and other RNA-binding proteins important for stem cell biology (Yeo, Coufal et al. 2009). 
1.3.7 Mechanisms of alternative splicing regulation by the Fox 
family. 
Experimental validation of many predicted target genes for the Fox family confirmed a 
previously demonstrated trend with respect to exon inclusion or skipping, depending on the 
location of the (U)GCAUG element. The alternative exon is included when the Fox-l 
family binds to the (U)GCAUG element in the downstream intronic region, while the exon 
is skipped when the Fox family binds to the (U)GCAUG element in the upstream intronic 
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region (Fig. 11) (LIorian, Schwartz et al.; Racca, Gardiol et al.; Licatalosi, Mele et al. 
2008; Zhang, Zhang et al. 2008; Yeo, Coufal et al. 2009). 
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Figure 11. Schematic illustration of alternative splicing regulation by the Fox-l family. 
(A) The Fox-l family represses exon inclusion by binding to (U)GCAUG element(s) in the 
upstream intronic flanking (UIF) region. (B) The Fox-l family enhances exon inclusion by 
binding to the (U)GCAUG element(s) in the downstream intronic flanking (OIF) region. 
Boxes indicate exons and horizontal lines indicate introns. Blue horizontal lines indicate 
the UIF and DIF regions. Orange boxes indicate (U)GCAUG elements. Figure from 
(Kuroyanagi 2009). 
However, to date very little is known about the molecular mechanisms through which Fox-
1 and Fox-2 proteins regulate alternative splicing. It is of interest to note that the solution 
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structure of the Fox-l RNA binding domain (RBD) in complex with (U)GCAUG(!l) 
heptamer showed that the last three nucleotides, UG(!D, are recognized in a canonical way 
by the four stranded J3 sheet of the RBD. In contrast, the first four nucleotides, (U)GCA, 
are bound by two loops of the protein in an unprecedented manner. Nucleotides Ul, G2 
and C3 are wrapped around a single phenylalanine in the Fox protein, while G2 and A4 
form a base pair. This novel RNA binding site is independent from the p sheet binding 
interface. These results demonstrate the unusual molecular mechanism of sequence 
specific RNA recognition by Fox-I, which is exceptional in its high affinity for a defined 
but short sequence element. The structure of Fox-l in complex with (U)GCAUG(U) is 
particularly interesting for understanding the function of the protein. Fox-l induces 
curvature in the RNA upon binding. Therefore, the binding of Fox-l to its RNA targets 
might lead to a conformational changes in the RNA that in tum many influence splicing 
regulation (Auweter, Fasan et al. 2006). 
Studies performed on specific genes have focused on mechanism of Fox-llFox-2 
mediating repression while little is known about how the Fox-l proteins promote inclusion 
of an exon via binding to (U)GCAUG element(s) in the downstream intronic region. For 
example, exon 9 of the human mitochondrial ATP synthase y subunit (Fly) gene is one of 
the model systems of Fox-l mediated exon skipping. Fox-l repressed Fly exon 9 by 
inhibiting splicing of the downstream intron 9 via GCAUG elements in the upstream 
intronic region without affecting efficiency of splicing of intron 8 where the GCAUO 
elements reside (Fukumura, Kato et al. 2007). Unexpectedly, Ul snRNP components were 
specifically absent from prespliceosomal E complex on the intron 9 formed, and Fox-l 
prevented formation of the E complex in the in vitro splicing reaction with HeLa nuclear 
extract. Mutations in the 5' splice site of intron 9 conferred Ul dependency and 
concomitantly impaired Fox-l mediated regulation, indicating that Ul independent 
splicing of hFly intron 9 is indispensable for induction of exon 9 skipping by Fox-l 
(Fukumura and Inoue 2009). Still, it is not known whether Fox-l mediated repression of 
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alternative exons in other target genes IS generally accompanied by VI independent 
splicing (Fukumura and Inoue 2009). 
Calcitonin-specific exon 4 is regulated by a balance between competing effects of the Fox-
I family proteins binding to (V)GCAUG elements at positions -34 in the UlF region and + 
45 in ex on 4, and of Tra2b and SRp55 protein binding to exonic splicing enhancers (ESEs) 
(Tran, Coleman et al. 2003; Zhou, Baraniak et al. 2007). Furthermore, Zhou et al. 
demonstrated that the Fox-l family proteins bound to the -34 (V)GCAUG silencer element 
to prevent SFI from binding to the branch point without affecting VI snRNP binding to 
the pre-mRNA, and that the -34 (U)GCAUG element repressed formation of 
prespliceosome E' complex, a pre-spliceosome complex formed in U2AF-depleted HeLa 
nuclear extracts prior to early (E) complex formation. They also demonstrated that the 
Fox-I family of proteins interfered with binding ofTra2~ and SRp55 to the ESEs via the + 
45 (V)GCAUG element and that the + 45 (U)GCAUG element blocked recruitment of 
V2AF65 and formation of the pre-spliceosome E complex. These results raised a fail-safe 
two step model of repression of calcitonin-specific exon 4 by the Fox-l family and two 
(U)GCAUG elements (Fig. 12) (Zhou, Baraniak et al. 2007). 
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Figure 12. A model for repression of prespliceosome complex formation by the Fox-l 
family. The repression of calcitonin specific exon 4 of calcitoninlCGRP pre-mRNA in 
neuronal cells by the Fox-l family involves two distinct regulatory events. First, the -34 
element in the UIF region prevents E' complex formation through repressing SF! binding 
to the branch point (BP). Second, the + 45 exonic element blocks transition to E complex 
via inhibiting U2AF65 binding to polypyrimidine tract (PY). Figure from (Kuroyanagi 
2009). 
Expression of Fox-l promoted inclusion of EIIIB exon in the ratfibronectin gene via 
highly repeated and evolutionarily conserved UGCAUG motifs in the downstream intronic 
region. Expression of Fox-lor Fox-2 enhanced inclusion of a short neuron-specific exon, 
Nt, of the c-src gene through UGCAUG element in the DIF region in non-neuronal HeLa 
cells. Fox-2 positively regulated inclusion of exon 16 of protein 4.1R pre-mRNA via 
conserved three copies of UGCAUG motifs in the downstream intronic region in late 
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erythroleukemia cell differentiation as well as in heterologous HeLa cells (Kuroyanagi 
2009). 
A clue to elucidating the promotion mechanism, may come from the interaction between 
Fox protein and a VI snRNP specific protein VI-C in a yeast two-hybrid system, which is 
also the case ofTIA-1 recruiting VI snRNP to the 5' splice site (Forch, Puig et al. 2002; 
Ohkura, Takahashi et al. 2005). Furthermore, Fox-I activity on model substrates indicate 
that the protein can activate splicing from a multimerized (V)GCAUG element. This 
activation is independent of other binding elements. Thus, Fox-I can apparently activate 
splicing and not just release an exon from repression by other proteins (Auweter, Fasan et 
al. 2006). 
1.4 Alternative splicing in sodium channel genes. 
Sodium channels are large integral membrane proteins, encoded by at least ten genes in 
mammals. Selective permeation of sodium ions through voltage dependent sodium 
channels is fundamental to the generation of action potentials in excitable cells. The 
different sodium channels have remarkably similar functional properties, but small albeit 
relevant changes in sodium channel function and/or different sodium channel isoforms, 
generated by alternative splicing, are biologically important as underscored by mutations 
that cause several sodium channel human diseases, or channelopathies. 
1.4.1 Sodium channel isoforms. 
Voltage gated sodium channels are responsible for the generation of action potential and 
thereby play an important role in propagation of electrical impulses in muscle, nerve and 
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heart tissues (Hodgkin and Huxley 1952). Sodium channels are integral membrane proteins 
that form ion channel, conducting sodium ions through a plasma membrane. Influx of 
sodium ions depolarizes the membrane further and initiates the rising phase of the action 
potential. Sodium channels are classified according to the trigger that opens the channel for 
such ions, either a voltage-change (voltage-gated sodium channels) or binding of a 
substance (a ligand) to the channel (ligand-gated sodium channels). The channel is 
composed of pore forming (l subunit of - 260 kDa associated with one or two P subunits, 
PI (SCNIB, 36 kDa), localized in brain, skeletal and cardiac muscle, and P2 (SCN2B, 33 
kDa), localized in central nervous system and cardiac muscle (Catterall and Epstein 1992). 
Additionally, two other members of the p subunit have been described, PIA, a splice 
variant of the SCNB I gene, and p3 (SCN3B) localized primarily in neuronal tissue 
(Kazen-Gillespie, Ragsdale et al. 2000). The (l subunit gene family consist of nine genes 
that are highly conserved across species. The gene names are referred to as SCNlA 
through SCNllA (the SCN617A gene is part of the Nax sub-family and has uncertain 
function). The proteins of these channels are named Nayl.l through Nayl.9 (Table 3). The 
channels are characterized by differential sensitivities to the sodium channel blocker 
tctrodoxin and inactivation kinetics. Highly tetrodoxin sensitive channels are encoded by 
SCNIA, SCN2A, SCN3A, SCN4A, SCN8A and SCN9A genes, and all of them have 
faster inactivation kinetics compared to the sodium channel genes SCN5A, SCNIOA and 
SCNIIA, that are also less sensitive to tetrodoxin. SCN9A, SCNIOA and SCNllA are 
expressed in peripheral nervous system (PNS). SCNIA, SCN2A, SCN3A and SCN8A are 
also expressed in PNS, but are more abundant in the central nervous system (CNS). 
SCN4A and SCN5A are highly expressed in skeletal muscle and heart, respectively. 
SCN 6NSCN7 A is expressed in different tissues, but still is debated whether this gene 
encodes a functional sodium channel (Table 3) (Isom, De Jongh et al. 1992; Yoshida 1994; 
Goldin, Barchi et al. 2000; Goldin 2001). 
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Table 3. The voltage gated sodium channel gene family and tissue specificity, 
modified from (Koopmann, Bezzina et al. 2006). 
Primary tissues wbere channels 
Channel Gene Location are expressed 
Nayl.l SCNIA 2q24 eNS; brain 
Nayl.2 SCN2A 2q23-q24.3 eNS; brain 
Nayl.3 SCl\lJA 2q24 eNS; brain 
Nayl.4 SCN4A 17q23.1-q25.3 adult skeletal muscle 
Na.,l.5 SCNSA 3p21 heart muscle; skell."tal muscle 
Na,. SCN6AlSCN7A 2q21-q23 PNS; bean muscle: skelL"tal 
muscle: uterus 
Na.,l.6 SCN8A 12q13 eNS; brain 
Na.,1.7 SCN9A 2q24 PNS; 
Na.,1.8 SCl\rIOA 3p24.2-p22 PNS 
Na.,1.9 SCNIIA 3p24-p21 PNS 
Na.,f1.1 SCNIB 19q13.1 brain; bean muscle: skeletal 
muscle 
Na.,f1.4 SCN4B llq23 brain: PNS: bean muscle; 
skeletal muscle 
1.4.2 Structure of voltage gated sodium channel family. 
Sodium channels can often be isolated from cells as a complex of two types of protein 
subunits, a and p. An a subunit fonns the core of the channel. The a-subunit has four 
repeat domains, labeled I through IV, each containing six membrane-spanning regions, 
labeled Sl through S6 (Fig. 13). The highly conserved S4 region acts as the channel's 
voltage sensor, which is due to positive amino acids located at every third position. When 
stimulated by a change in transmembrane voltage, this region moves toward the 
extracellular side of the cell membrane, allowing the channel to become penneable to ions 
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(Yang and Hom 1995). The ions are conducted through a pore, which can be broken into 
two regions. The more external portion of the pore is fonned by the "P-Ioops" (the region 
between S5 and S6) of the four domains. This region is the most narrow part of the pore 
and is responsible for its ion selectivity. The inner portion (more cytoplasmic) of the pore 
is fonned by the combined S5 and S6 regions of the four domains. The region linking 
domains III and IV plugs the channel after prolonged activation, inactivating it, thus this 
region is important for channel function (Kellenberger, Scheuer et al. 1996). The p subunit 
consist of one transmembrane segment, an intracellular domain and a glycosylated 
extracellular domain. The function of the p subunit is to control channel gating, regulate 
the level of expression of the a subunit at the plasma membrane, and are most likely 
involved in cell adhesion through interaction with the cytoskeleton, extracellular matrix, 
and some other adhesion molecules, important for cell migration and aggregation (Goldin 
1993; Isom and Catterall 1996; Isom 2001). When the a subunit protein is expressed by a 
cell, it is able to fonn channels which conduct sodium ions, even if p subunits are not 
expressed, but when p subunits assemble with a subunits the resulting complex can display 
altered voltage dependence and cellular localization (lsom, De Jongh et al. 1992). 
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Figure 13. The primary structures of the subunits of the voltage-gated ion channels are 
illustrated as transmembrane folding diagrams. Cylinders represent a-helical segments (S 1-
S6). Bold lines represent the polypeptide chains of each subunit with length approximately 
proportional to the number of amino acid residues in the brain sodium channel subtypes. 
The extracellular domains of the PI and P2 subunits are shown as immunoglobulin-like 
folds . \fI, sites of probable N-linked glycosylation; P in red circles, sites of demonstrated 
protein phosphorylation by PKA (circles) and PKC (diamonds); green, pore-lining 
segments; white circles, the amino residues that form the ion selectivity filter and the 
tetrodotoxin binding site; yellow, S4 voltage sensors; h in blue circle, inactivation particle 
in the inactivation gate loop; blue circles, sites implicated in forming the inactivation gate 
receptor. Sites of binding of a and P scorpion toxins (a-ScTx and P-ScTx) and a site of 
interaction between a and PI subunits are also shown (modified from (Yu and Catterall 
2003). 
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1.4.3 Expression profiles of sodium channels during 
development and subcellular localizations. 
Mammalian sodium channels, in addition to the differences in cellular and tissue 
expression, also have different expression profiles during development, and different 
subcellular localizations, consistent with a distinct role of each of these in mammalian 
physiolgy. As mentioned previously, Nav 1.3 is highly expressed in fetal nervous system, 
whereas Nay 1.1, Nay 1.2 and Nay 1.6 are abundant in the adult CNS. Nav 1.1 and Nav 1.2 
are localized to the soma of the neuron, where they can control neuronal excitability 
through interaction of synaptic impulses to set the threshold for action potential initiation 
and propagation to the dendritic and axonal parts of the neuron. Nay 1.6, during 
development has been shown to replace Nay 1.2 in maturing nodes of Ranvier, the gaps in 
myelin sheaths of myelinated axons where action potential conduction takes place (Boiko, 
Rasband et a1. 2001; Kaplan, Cho et a1. 2001; Craner, Hains et a1. 2004). The most 
abundant sodium channels, expressed in PNS are Nay 1.7, Nay 1.8 and Nay 1.9. Nav 1.7 
appears to be localized to the axons, where it may function in initiating and conducting the 
action potential in PNS neurons. More restricted expression patterns are observed for Nay 
1.8 and Nay 1.9 sodium channel, expressed in small sensory neurons of dorsal root 
ganglion and trigeminal ganglia, where they. together with Nay 1.7 have an important role 
in perception of pain (Akopian, Souslova et a1. 1999; Black, Fjell et a1. 1999). 
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1.4.4 Developmentally regulated alternative splicing of sodium 
channel genes. 
For each particular sodium channel gene, subtle differences in channel properties can be 
attributed to alternative splicing, post-translational modifications, changes in the 
expression of ancillary p-subunits, and mutations. Importantly, alternative splicing of 
transcripts derived from a common gene has been shown to generate biochemical and 
phannacologically distinct sodium channel isofonns (Goldin 2001). Minor changes in the 
properties of specific isofonns result in human diseases of muscle, heart, and the nervous 
system (Onkal and Djamgoz 2008). 
Alternative RNA splicing has been described for several sodium channel genes (Table 4), 
for example SCNIA with extended exon 11, SCN3A has three different variants of exon 
12, SCN5A can alternative splice resulting in a difference in one amino acid in exon 18, 
SCN9A undergoes alternative splicing resulting in an extended exon 11, and SCNIIA can 
result in an alternative spliced isofonn lacking exon 16 (Schaller, Krzemien et at. 1992; 
Makielski, Ye et al. 2003; Raymond, Castle et al. 2004; Thimmapaya, Neelands et al. 
2005). Additionally, developmentally regulated and tissue specific splice variants of 
SCN2A, SCN3A, SCN8A and SCN9A, exon 5N and 5A, are expressed predominantly 
neonatally (N) or in adults (A), have been described (Lu and Brown 1998; Heron, 
Crossland et at. 2002). Two such alternative splicing events, in particular ME splicing are 
of central importance to this PhD thesis and concern the SCN8A and SCN9A sodium 
channel genes. 
Previous research has shown developmentally regulated alternative splicing of SCN8A 
coding exon 18. Exons, 18N (neonatal) and 18A (adult), encodes transmembrane segments 
S3 and S4 in domain III. Prior studies of SCN8A variants demonstrated that fetal neurons 
and non-neuronal cells produce two variant transcripts, one containing the alternative exon 
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18N and one that skips exon 18. Because SeN8A exon 18N includes a stop codon, the 
prediction was that fetal neurons and non-neuronal cells would express a truncated, non 
functional variant of Nav1.6 sodium channel (Plummer, McBurney et al. 1997). The 
proportion of transcripts containing exon 18N is highest in mouse fetal brain between 
EI2.S and Pl.S, while at later stages the predominant transcripts contain exon 18A 
(Plummer, McBurney et al. 1997). In a recent paper it was suggested that macrophages can 
express a full-length variant ofNav1.6 through deletion of exon 18N in SCN8A transcripts. 
From a functional standpoint, these Nav1.6 channels are required for macrophage 
podosome formation, melanoma invadopodia formation and cellular invasion (Carrithers, 
Chatterjee et al. 2009). In adult brain and spinal cord, the major transcript contains exon 
18A. In addition, four alternatively spliced noncoding exons in the 5' UTR region of 
SCN8A gene have been reported (Drews, Lieberman et al. 2005). Regarding SCN9A 
sodium channel gene, previous research has identified exons SN and SA of the gene that 
undergo mutually exclusive alternative RNA splicing to produce mRNAs coding either for 
an isoform predominant in dorsal root ganglion (5A) or a different isoform (SN) 
preferentially expressed in the PNS and CNS neurons of adult tissues. These exons are 92 
bp in length and encode amino acids which correspond to part of the S3 and most of S4 
transmembrane segments within domain I and the extracellular loop between them. 
Despite 22 nucleotide differences between the exons, only a single amino acid is altered, 
specifying either aspartic acid (in exon 5A) or serine (in exon SN). 
It is still debated what the functional consequences of this amino acid change might be, but 
the outcome may be significant. First, because the alternative splicing to generate (5N) and 
(5A) isoforms is developmentally regulated, thus representing an investment by the 
organism in maintaining this differential expression (Sarao, Gupta et al. 1991). Thus, a 
channel with a neutral charged residue may be advantageous in the neonate when cells are 
migrating and differentiating whereas channels with a negatively charged residue are 
preferable in the mature cells of the adult (Auld, Goldin et al. 1990). The fmding that 
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virtually the same alternative splicing module, (exons SN and SA), has been preserved in 
distinct sodium channel genes provides further support to the idea that the single amino 
acid difference has substantial functional significance (Onkal and Djamgoz 2008). The 
electrophysiological differences have been observed between the 'adult' and 'neonatal' 
isoforms, that could have a number of physiological (developmental) and 
pathophysiological consequences. Compared to the 'adult', for example the 'neonatal' 
channel was associated with a larger charge of sodium ions entry into the cell during each 
opening of the channel. The additional sodium ions influx may be important for 
intracellular pH regulation (Levi, Dalton et al. 1997; Cooper, Schell et al. 1998; Blaustein 
and Lederer 1999; Karmazyn, Gan et al. 1999; Bers, Barry et a1. 2003). It has been shown, 
in particular, that alternatively spliced variants of the human Nav 1.7 channel (SN and SA) 
can have different functional properties. The change of one amino acid in the S3 domain I 
(exons SA and SN) induced a small shift of activation to more hyperpolarized potentials 
for exon SA compared with exon SN. Thus, channels with exon SA inactivate more slowly 
than channels with exon SN, causing a delay in inactivation for SA variants compared with 
SN during a slow depolarization ramp protocol. As a consequence, fewer channels are 
inactivated at the potential range where the inward current is present. This increase in 
channel availability will therefore induce larger inward current amplitudes that might 
increase cell excitability (Chatelier, Dahllund et a1. 2008). 
Alternative splicing have been described also for the p subunits; SCNIBa and SCNIBb 
differ beyond the immunoglobulin region (Ig)-loop region, resulting in a distinct C-
terminal domain and longer SCNB 1 b transcript (Kazen-Gillespie, Ragsdale et a1. 2000). 
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Table 4. Different splice variants of voltage-gated sodium channels 
modified from (Koopmann, Bezzina et al. 2006). 
Gene name Splice variants GenBank accession number Ccmmentl 
SCNIA variant I AB093548 variant I contains extended exon II 
variant 2 NM_OO6920 
SCN2A neonatal isoform exon 5N 
adult isoform exon 5A 
SCN3A neonatal isoform AF035685 exon 5N 
adult isoform AF035686 exon 5A 
splice variant NM_OO6922 this variant contains extended exon 
12 
SCNSA variant I NM_198056 variant I contains I extra amino 
variant 2 NM_OOO335 acid in exm 18 
SCNSA neonatal isoCorm AY682082 exon 5N 
adult isoCorm AY682081 exon 5A 
neonatal isoform AF050730 exon 18N 
adult isoform AF050730 exonl8A 
splice variant AY682083 this variant contains extended exon 
12 
SCN9A neonatal isoform AY682085 exon 5N 
adult isoCorm AY682084 exm 5A 
splice variant AY682086 this variant contains extended exon 
11 
SCNllA spl ice variant AY686224 A exon 16 
SCNIB variant a NALOOI037 variant b encodes longer transcript 
variant b NM_199037 
N-neonataDYi A-adult; NO-not determined. 
1.4.5 Chanelopathies: the role of sodium channels in disease. 
Mutations in SCNIA and SCN2A cause different epilepsy syndromes (Escayg, 
MacDonald et at. 2000; Sugawara, Mazaki-Miyazaki et al. 2001», whereas mutations in 
SCN4A have been linked to myotonia conditions (Mitrovic, George et at. 1994). Mutations 
in SCN5A are linked to Brugada syndrome and long QT syndrome (Bennett, Yazawa et al. 
1995; Veldkamp, Wilders et al. 2003; Antzelevitch 2005). Mutations in the mouse ortholog 
of SCN8A gene cause ataxia and other movement disorders (Meisler, Plummer et al. 
2004). So far, only one protein truncation mutation in SCN8A sodium channel gene has 
been described in humans, associated with a case of cerebellar atrophy, ataxia, and mental 
retardation (Trudeau, Dalton et al. 2006). A single nucleotide polymorphism in SCN8A 
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gene may contribute to the risk for suicide attempts, possibly through alterations in 
neuronal conduction which hypothetically could lead to disturbed analysis of incoming 
information in periods of emotional and physical stress (Wasserman, Geijer et a1. 2005). 
Dysfunction of the Nav1.6 sodium channel alters sleep architecture, reduces diurnal 
corticosterone levels, and enhances spatial memory (Papale, Paul et a1.). There is strong 
evidence indicating that Nav1.6 is the predominant sodium channel located in the nodes of 
Ranvier in both PNS and CNS myelinated neurons, and transgenic mice in which Nav 1.6 
has been made non-functional typically die around postnatal day 15, a time at which 
myelination is rapidly progressing (Garcia, Sprunger et al. 1998; Caldwell, Schaller et a1. 
2000). Recent studies have identified changes in the expression pattern of Nav 1.6 sodium 
channel, as an important contributor to remission and progression in multiple sclerosis 
(MS). The disease process in MS attacks myelinated axons, denuding them of myelin, or 
causing them to degenerate. Following the loss of the myelin, remyelination does not 
always occur. Recovery of clinical function in cases such as this requires the restoration of 
secure action potenitial conduction along demyelinated axons. After demyelination, some 
of the axon membrane can develop higher than normal densities of Nav 1.6 sodium 
channel, restoring in this way proper action potential conduction. The available evidence 
suggests that Nav 1.6 sodium channels are important participant in axonal degeneration in 
MS, caused by sustained influx of sodium ions, which drives reverse operation of the 
sodium-calcium exchanger, an antiport molecule that can import damaging level of 
calcium into axon. Thus, Nav 1.6 are being investigated as a potential therapeutical target 
in MS. Although, subtype specific sodium channel blocker are not yet available, some of 
the nonspecific blockers, such as phenytoin and flecainide have been shown to be 
protective in mouse and rat model of MS, EAE (experimental allergic encephalomyelitis). 
However, in a recent publications it has been observed a clinical worsening following 
withdrawal of phenytoin in mouse model of MS, after prolonged exposure to this sodium 
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channel inhibitor (Caldwell, Schaller et a1. 2000; Craner, Newcombe et a1. 2004; Stys 
2004; Waxman 2006; Smith 2007; Waxman 2008). 
SCN9A (Nav 1.7), SCNIOA (Nav 1.8) and SCNIIA(Nav 1.9) sodium channels have been 
implicated in different pain conditions, but only SCN9A (Nav 1.7) channelopathies have 
been described so far. Nav l.7 plays a crucial role in our ability to perceive pain sensations. 
Cox et a1. studied several families from Northern Pakistan that contained members with an 
inability to experience pain «Cox, Reimann et a1. 2006). Neurological examinations 
indicated that while these individuals apparently had never experienced any pain 
sensations, otherwise they appeared normal. The only noted exceptions to this, were 
deficits in olfaction in some patients (Weiss, Pyrski et a!.; Goldberg, MacFarlane et a1. 
2007). It was determined that the pain insensitivity was congenital and could be mapped as 
an autosomal recessive trait linked to a region of chromosome 2. Goldberg et a1. identified 
Nav l.7 truncating mutations in patients with congenital indifference to pain, demonstrating 
that a loss-of-function of Nav l.7 can result in an insensitivity to pain (Goldberg, 
MacFarlane et a1. 2007). As individuals that lack functional Nav l.7 channels can appear 
normal except for their complete insensitivity to pain, it was proposed that drugs that 
selectively target Nayl.7 might be ideal analgesics (Cox, Reimann et a1. 2006; Ahmad, 
Dahllund et a1. 2007). It is important to note that while humans lacking functional Nav 1.7 
were generally deemed to be healthy except for the apparently complete lack of ability to 
experience pain, mice that have a global deficit in Nay1.7 die just after birth (Nassar, 
Stirling et a1. 2004), suggesting the role(s) of Nayl. 7 could be different in mice and 
humans. 
At least nine distinct point mutations in SCN9A sodium channel gene that alter the amino 
acid sequence of this channel have been identified in patients with erythromelalgia, another 
SCN9A-linked disease (Yang, Wang et a1. 2004; Dib-Hajj, Rush et a1. 2005). These 
mutations, which are thought to underlie the severe chronic burning pain sensations in the 
hands and feet that is the primary symptom associated with erythromelalgia, all cause 
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significant hyperpolarizing shifts in the voltage-dependence of activation (Cummins, Dib-
Hajj et al. 2004; Dib-Hajj, Rush et al. 2005; Choi, Dib-Hajj et al. 2006) Indeed, several 
studies on Nav1.7 mutations in erythermalgia have correlated a larger ramp current 
amplitude with an increase in dorsal root ganglion excitability (Lee, Yu et al. 2007). There 
is also an evidence that Nav 1.7 channels containing exon SA displayed a larger ramp 
current than those containing exon 5N, as mentioned previously. Mutations involved in 
erythennalgia that increase the ramp current might thus be more hannful in the presence of 
exon 5A. Interestingly, symptoms of primary erythermalgia arise in childhood or 
adolescence and may progress and become constant with age. The increased symptoms of 
erythennalgia with age might be related to an increase in the proportion of exon 5A. 
Similarly, changes in the proportions of exons 5N and 5A with age might also be related to 
differences in pain sensitivity (Chatelier, Dahllund et al. 2008). 
Other Nav l.7 point mutations underlie a second autosomal dominant chronic pain disorder, 
paroxysmal extreme pain disorder (PEPD), characterized by severe burning rectal, ocular, 
and submandibular pain sensations (Fertleman, Baker et al. 2006). 
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2. Aim of the project 
Our knowledge of the various cis- and trans-acting factors playing a role on both normal 
and aberrant splicing pathways has been greatly enhanced in the last years. However, the 
resulting information explosion has also uncovered the fact that many splicing systems are 
not easy to model. In fact due to the unexpectedly complex network of interactions 
involved in pre-mRNA splicing we are still in part ignorant of the exact molecular 
mechanism involved and this is more so the case in mutually exclusive alternative splicing. 
The Aim of this thesis is to gain insights into the molecular mechanisms involved behind 
the control of ME splicing by studying this process in selective genes of the voltage gated 
sodium channel family whose many members undergo tissue and developmentally 
regulated ME splicing. In particular I have chosen to start with two ME splicing events in 
two of the family members SCN8A exons 18N and 18A and exons SN and SA in the 
SCN9A gene. The choice behind these two specific ME splicing events stems from the 
possible implications as therapeutic targets these ME events represents. 
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3. Results 
3.1 Analysis of seN8A exon 18N and 18A mutually exclusive 
splicing regulation in a heterologous mini gene context. 
In order to create a tool with which to start to investigate the control mechanisms behind 
the tissue and developmentally regulated mutually exclusive splicing observed for SeN8A 
exon 18N and exon 18A I initially cloned these exons individually, together with a limited 
amount of respective flanking intronic sequence in the pTB minigene system, which is a 
modified version of the a-globin-fibronectin-EDB minigene (Muro, laconcig et al. 1998) 
(Fig. 14). 
Nde I Poly (A) signal 
Figure 14. Schematic representation of pTB minigene. White and black boxes represents 
the a-globin and fibronectin exons respectively. The minigene contains a functionall 
polyadenylation site at the 3' end and at the 5' end an a-globin gene promoter and SV40 
enhancer sequences to allow polymerase II transcription in the transfected cell lines. An 
Nde I restriction site in the intron between the two a-globinlfibronection hybrid exons is 
present, allowing for quick insertion of the exon and flanking intronic sequence one would 
wish to study. Black arrows in the two a-globinlfibronection hybrid exons indicate the 
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position of primers, used in RT-PCR reaction when analyzing the mRNA produced by the 
minigene. 
The rationale behind the use of the pTB minigene as a backbone was to isolate a relatively 
small DNA fragment containing the SCN8A exons under study, that would however allow 
this exon to behave as observed in vivo. This region of DNA could then be more easily 
manipulated and used as a starting point with which to investigate the cis-acting elements 
controlling the inclusion or exclusion of SCN8A exon 18N or 18A. 
3.1.1 Splicing of the pTB minigene carrying either SeN8A exon 
18N or 18A follow the observed splicing pattern observed for 
non-neuronal tissue. 
The pTB SCN8A exon 18N and pTB SCN8A exon 18A were made by standard methods 
described in material and methods section 6.17.1. Briefly, I initially subcloned the 
individual exons, SCN8A E18N and SCN8A EI8A, together with 150 bp of upstream and 
120 bp of downstream intronic sequence in the case of the fonner and 150 bp of upstream 
and 120 bp of downstream intronic sequence in the case of the later in the pUCI9 vector. 
This vector was used primarily for the purpose of sequencing of the minigene, and after the 
exact sequence was conftnned, both DNA fragments were sub-cloned into the pTB 
minigene, using Nde I restriction enzyme site present between the two a-globinlftbronectin 
hybrid exons (Fig. 14). 
The mRNA processing of these minigenes was analyzed following expression of the 
constructs in HeLa cells, through RT-PCR using oligonucleotides speciftc for the minigene 
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ALF A and BRA. As can be seen in Fig. IS, in the case of pTB mini gene carrying SeN8A 
exon 18N with its flanking intronic sequences, a unique peR product of 311 bp is 
obtained, identified as a normal inclusion of exon 18N in the mature transcript (Fig. 15, 
Lane I). On the other hand with the mini gene carrying SeN8A exon 18A, together with its 
flanking intronic sequence, a peR product of 239 bp is observed, corresponding to 
skipping of the exon 18A from the mature transcript (Fig. 15, Lane 2). These experiments 
showed that the recognition of the SeN8A exons 18N and 18A have different requirements 
even in an heterologous context and that the HeLa cells reflected the in vivo specificity of 
the expression. 
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Figure 15. Analysis of the minigene splicing assay perfonned with pTB SeN8A exon 18N 
and pTB SeN8A exon l8A minigenes. In the upper panel a schematic representation of the 
pTB SeN8A E 18N and pTB SeN8A E 18A minigenes. Lower panel: Analysis of 
expression of the constructs in HeLa cells. The mRNA produced by the minigenes was 
analyzed through RT -peR using oligonucleotides specific for the minigene ALF A and 
BRA (black arrows) and agarose gel electrophoresis. In the case ofpTB minigene carrying 
exon l8N with its flanking intronic sequences (PTB seN8A E 18N) a unique peR product 
is observed corresponding to the inclusion of exon l8N in the mature transcript (Lane l). 
On the other hand with the minigene carrying ex on l8A together with its flanking intronic 
sequence (PTB SeN8A EI8A) peR product corresponding to the skipping of the exon 
l8A from the mature transcript is observed (Lane 2). 
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3.1.2 The respective Inclusion and Exclusion of the SeN8A exon 
18N and 18A in the mRNA produced from the pTB minigene in 
Hela cells appears to be primarily dependent on exonic cis-
acting elements. 
A genomic analysis of SCN8A from human, mouse and fish had previously highlighted an 
unusually high sequence identity of 70% in the human and mouse intron between SCN8A 
ME exons 18N and 18A (counting insertions and deletions as single changes) (Plummer, 
McBurney et al. 1997). Three-way sequence comparison identified one highly conserved 
element (CEl) adjacent to a eukaryotic branchpoint consensus site located upstream of the 
3' splice site of exon l8A. The observed evolutionary conservation strongly suggested that 
this element may have a functional role that has been maintained by selection. I therefore 
decided to start the investigation of splicing regulatory elements that may be involved in 
the SCN8A mutually exclusive splicing by eliminating this 24 bp long CE I element 
through site directed deletion, in the pTB SCN8A El8A minigene, creating the pTB 
SCN8A E18A ~CEI minigene. After transfection in HeLa cells and RT-PCR analysis, 
using pTB SCN8A El8A and pTB SCN8A El8A ~CEI minigenes, a unique PCR product 
of 239 bp is observed, corresponding to a skipping of exon 18A (Fig. 16A, Lanes 1 and 2). 
Thus, at least in this context, this element does not appear to playa role in the exclusion of 
the SCN8A exon 18A in Hela cells. 
The cis-acting elements, aside the classical core elements that define an exon, controlling 
the inclusion of the SCN8A exon 18N and exclusion of the SCN8A exon 18A in the pTB 
minigene, when transfected in HeLa cells, may be present either in the exonic or intronic 
portion of the DNA used to construct the mini genes, or indeed both, as outlined in the 
introduction section 1.3. To obtain an indication whether cis-acting elements controlling 
exon inclusion or exclusion, of the two SCN8A ME exon 18N and 18A, lie in the intronic 
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or exonic segment of the gene, I made a series of different constructs composed of SCN8A 
exons I8N or 18A, where I replaced the intronic sequence upstream or downstream of 
either SCN8A exon with those of the other as well as both sides of flanking intronic 
sequence (Fig. 16B, minigenes 3-6). The substitution of the upstream intron of exon 18A 
with the upstream intron of exon 18N, resulted in two products, as can be seen on agarose 
gel. A major band of 239 bp band representing a PCR product lacking exon 18A and the 
362 bp band representing a PCR product including exon 18A (Fig. 16B, Lane 3). 
Curiously, skipping of SeN8A exon 18A was restored after transfection with minigene 
containing the intronic sequence flanking the SCN8A exon 18N upstream and downstream 
of SCN8A exon I8A (Fig. 16B, Lane 4). On the other hand the SCN8A exon 18N, 
independently of the intron context, always a unique PCR product of 311 bp corresponding 
to inclusion of exon 18N was observed (Fig. 16B, Lane 5 and 6). These results indicate 
that the intronic region immediately upstream of exon 18N may have some enhancing 
capacity on the inclusion of exon 18A, but the principal elements responsible for the 
inclusion or exclusion of exons 18N and 18A principally lie in the exonic portions of the 
DNA placed into the minigenes. 
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Figure 16. The respective inclusion and exclusion of the SeN8A exon I8N and I8A in the 
mRNA produced from the pTB minigene in Hela cells appear to be primarily dependent on 
the exonic cis-acting elements. (A) In the upper panel a schematic representation of the 
pTB SCN8A exon 18A ACEI minigene. Lower panel: analysis of expression of the 
constructs pTB SCN8A El8A and pTB SCN8A El8A ACEI in HeLa cells. The mRNA 
produced by the minigenes was analyzed through RT-PCR using oligonucleotides specific 
for the minigene ALFA and BRA (black arrows) and agarose gel electrophoresis. A unique 
PCR product of 239 bp is observed, corresponding to a skipping of exon 18A in both cases 
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and is depicted on the right hand side of the gel (Lanes I and 2). (B) In the upper panel 
schematic representations of a series of minigene constructs composed of SCN8A exons 
18N or 18A, with different combinations of intronic sequence upstream and downstream of 
the two ME exon. Lower panel: Results of the RT-PCR analysis of these mini genes in 
agarose gel electrophoresis. On the right hand side of the gel is a illustration indicating 
what each amplification corresponds to. 
3.2 Identification of an exonic splicing silencer element (ESS) in 
SeNSA ex on ISA. 
I initially decided to set out to identify the regulatory cis-acting elements that may 
modulate the mutually exclusive splicing of SCN8A exon 18A by trying to identify the 
reason as to why this exon was excluded from the pTB mRNA when transfected in Hela 
cells. The previous experiments carried out in section 3.1.2 indicated that it was highly 
likely that these lie in the exonic portion of the SCN8A sequence used in the minigene 
pTB SCN8A E18A. 
An initial approach to identify possible exon silencer elements was perfonned through 
scans of SCN8A exon 18A for sequence elements with similarity to known exon silencer 
elements, predicted by bioinformatic programs, that matches the functional silencers found 
10 the FAS-hex3 or PESS ESS databases; http://genes.mit.eduifas-ess/, 
http://cubweb.biology.columbia.edulpesx respectively (Wang, Rolish et al. 2004; Zhang 
and Chasin 2004). These analysis highlighted several important regions that may be 
involved (Fig. 17 A). In particular putative silencer elements were predicted in the 5' 
region of SCN8A exon 18A. In order to test the functional consequence of these 
predictions, using the pTB SCN8A E 18A minigene as a backbone, I made a series of 
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sequential deletions of this area. In particular derivatives of pTB SCN8A E 18A minigene 
(6-27~ 27-43~ and 43-69~) were made (Fig. 17B). These minigenes were tranfected in 
HeLa cells, RNA was extracted and subjected to RT-PCR analysis. As can be seen after 
electrophoresis the 6-27 ~ minigene gave almost complete inclusion of exon 18A while 27-
43~ and 43-69~ mini genes had no consequences on the inclusion of exon 18A (Fig. 17B). 
It therefore appears that the segment between nucleotides 6-27 of the exon, that I will refer 
to as the ESS element, of the SCN8A exon 18A, contains an ESS element, responsible for 
repressing 18A exon splicing in HeLa cells. 
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Figure 17. Identification of an exonic splicing silencer element (ESS) in SCN8A exon 
18A (A) Analysis of SCN8A exon 18A for sequence elements with similarity to known 
exon silencer elements, using a bioinformatic programs, F AS-hex3 and PESS ESS 
databases; http://genes.mit.edU/fas-ess/, http://cubweb.biology.columbia.edulpesx. 
Underlined and bold nucleotides indicate areas identified by the programs as possible ESS. 
(B) Upper panel: Schematic representation of the wt pTB SeN8A exon 18A mini gene 
carrying deletion of the nucleotides 6-27~ 27-43A and 43-69A. Lower paneL Splicing 
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analysis of the exon 18A showed that only the 6-27 ~ minigene gave complete inclusion of 
exon 18A, while 27-43~ and 43-69~ minigene had no consequences on exon 18A 
inclusion as illustrated on the right hand side of the gel. 
3.2.1 The ESS identified in the SeN8A ex on 18A inhibits the 
assembly of multiple proteins during spliceosome formation. 
The ability of an ESS to exert repression on its upstream 3' splice site is a common feature 
for the ESSs identified in mammals (Carstens, Wagner et al. 2000). If the SCN8A exon 
18A regulatory element has a dominant ESS, spliceosome assembly should be inhibited at 
an early step. The spliceosome assembly occurs stepwise and is characterized by the 
interaction of mUltiple proteins and ribonuc1ear proteins with the nascent transcript (Sharp 
1994). Although already discussed in the introduction (section 1.1.1), it is important to 
remember that these RNA and protein complexes are in order of formation as follows: H, 
E, A, Band C. H is a nonspecific complex formed by interaction of the pre-mRNA with 
multiple hnRNPs (Jamison, Crow et at. 1992). The composition of this complex can vary 
greatly between different RNAs but will include splicing regulatory proteins involved in 
the formation of the catalytically component spliceosome. Its formation occurs even at O°C 
and does not require ATP. Incubation of the pre-mRNA at 30°C leads to formation of 
complex E (House and Lynch 2006). In addition to splicing regulatory elements, such as 
SR proteins and hnRNPs, complex E contains Ul snRNP and the U2AF splicing factors at 
the 5' and 3' splice sites of the intron, respectively. Complex A forms following the 
addition of ATP and involves binding of the splicing factor U2 snRNP to the branch point 
in the intron. Incorporation of the U41U51U6 tri-snRNP leads to formation of B complex. 
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Subsequently, after maSSIve structural rearrangements, the catalytically activated 
spliceosome, complex C forms, and the first transeserifIcation step of splicing occurs (Fig. 
18A) (Fukumura and Inoue 2009). 
To further investigate the mechanism of SCN8A exon 18A repression by the ESS 
identified, I wanted to determine if this indeed was causing a block in the spliceosome 
formation and if so at what step in spliceosome assembly this was occurring. The most 
commonly used method for resolving the H, A, Band C complexes is electrophoresis on a 
vertical, 4% nondenaturating polyacrilamide gel (Konarska, Grabowski et al. 1985). The 
buffer containing Tris-glycine and heparin is usually added to the splicing reaction to 
dissociate nonspecific interactions. However, under these conditions, the E complex 
coimigrates with the H complex (Michaud and Reed 1993). 
I analyzed the assembly of spliceosome complexes formation on single exon substrates 
composed of Ex.18A WT and Ex.18A AESS RNAs, carrying the upstream 3' splice site, 
the polypyrimidine/predicted branch point (BP) sequences and the downstream 5' splice 
site of which schematic representations can be seen in Figure 18B. 
At time point 0, only complexes Hand E, that under these experimental conditions co-
migrates, formed on both the substrates (Fig. 18C, lanes I and 4). After 5 minutes of 
incubation of the splicing substrates with HeLa nuclear extract at 30°C with ATP, 
complex A was detected in both substrates but was much less abundant in the Ex.18A WT 
substrate compared with the Ex.1SA AESS substrate where the ESS was missing (Fig. 
18C, lanes 2 and 5). After 30 minutes of incubation at 30°C, complex A was observed to 
be much more abundant and stable during time on the substrate without the ESS element 
(Ex.lSA AESS) as can be seen by comparison with the Ex.lSA WT substrate (Fig. ISC, 
lanes 3 and 6). Gel analysis further showed that the complex A was not detected in both 
substrates in the absence of ATP (Fig. 180, Lane 1-6). These results further confirm the 
presence of the ESS element in SCN8A exon 18A identified in section 3.2 and suggest that 
the ESS inhibits the assembly of multiple proteins during spliceosome formation. The 
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reduction in complex A formation may be caused by a repressive effect on the exon 18A 
ESS on the strength of binding of U2 or other splicing factors during the formation of 
complex A. 
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Figure 18. The ESS identified in the SCN8A exon 18A inhibits the assembly of multiple 
proteins during spliceosome formation. (A) Schematic representation of spliceosome 
assembly that occurs stepwise and is characterized by the interaction of multiple proteins 
and ribonuclear proteins with the nascent transcript. These RNA and protein complexes are 
formed in a stepwise manner with names letters designated certain stages: H - E - A - B -
C. (B) Cartoon illustrating the two different 32P-labeled in vitro splicing substrates were 
used. (Y) indicates polypyrimindine tract, BP indicates predicted branch point sequences. 
(C) Autoradiography of acrylamide gel electrophoresis of the splicesome complexes of the 
two substrates at 0, 5 and 30 minutes. The regions corresponding to complexes H and A 
are indicated on the right hand side of the auto radiograph. (D) Autoradiography of 
acrylamide gel electrophoresis of the splicesome complexes of the two substrates at 0, 5 
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and 30 minutes without ATP. The region corresponding to complex H is indicated on the 
right hand side of the autoradiograph. 
3.3 Identification of trans-acting factors binding to the ESS 
identified in the SeNSA exon lSA. 
The vast majority of splicing enhancer and silencing sequences characterized to date 
function as binding sites for splicing regulatory proteins that in tum alter the mRNA 
processing by mechanisms previously described in the introduction (section 1.3). To 
identify the trans-acting factors binding to the ESS identified in SCN8A exon 18A, I 
performed a pull down analysis as previously described (Buratti, Baralle et a1. 2004). The 
effect observed when the 6-27 A region was eliminated in the pTB SCN8A E 18 minigene 
and the inhibition of splicesome assembly in the presence of this region indicate that the 6-
27 A region indeed contains an ESS element. It was therefore of interest to try and identify 
the trans-acting factors through which this splicing cis-acting regulatory element acts. 
Briefly, pTB SCN8A EI8A (with the ESS identified present) and pTB SCN8A EI8A 
AESS minigenes (without the ESS element) were used as a template for the amplification 
with the primer that added a T7 promoter at the start of the sequences (Fig. 19A). 
These RNA's were then covalently linked to adipic acidic beads, incubated with nuclear 
extract prepared from HeLa cells, precipitated and washed. RNA-associated proteins were 
then eluted with SDS sample buffer, separated by SDS-PAGE and visualized by 
Coomassie blue staining (Fig. 19B) and eventually proteins were identified by mass 
spectrometry and western blot. As can be seen from the coomassie gel (Fig. 19C) both 
RNAs (with and without ESS element) were observed to bind multiple proteins. However, 
comparison of the proteins bound to RNA with ESS versus RNA without ESS, revealed 
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several bands that associate specifically with RNA that contained ESS, indicating possible 
candidate proteins specific for the ESS element (Fig. 19C *). Each of the ESS-specific 
bands was excised from the gel and analyzed by mass spectrometry by the Protein 
Networks Group at ICGEB (Dr. Michael P. Meyers ICGEB), as well as a band that was 
common to both the RNA with and without ESS element (Fig. 19C #). The mass 
spectrometry analysis identified protein band common to both RNA substrates as hnRNP 
DAZAPI and the three protein bands unique to the RNA substrate with the ESS element; 
as hnRNP JKTBP, hnRNP Bl and hnRNP Al protein. With the exception ofhnRNP Bl, 
for which I did not find in literature strong evidence regarding the potential involvement in 
the repression of the splicing, the other two proteins have been strongly implicated in 
splicing regulation. 
Consistent with the identification of the ligands binding to the ESS are the presence of 
binding sites for these in the ESS. For example hnRNPAl, a "winner" sequence identified 
by SELEX, UAGGGAIU is present in the ESS region, as is the 7 nt sequence ACUAGC/T 
for hnRNP JKTBP (Fig. 190). While searching for the binding site of these proteins in the 
region of the ESS we also noted that there was a binding site for the PTB/nPTB protein 
which is UCUU (Perez, Lin et al. 1997). As PTB/nPTB would be an extremely interesting 
candidate for the binding to ESS identified in the SCN8A exon 18A, I decided to test if 
this protein was also differentially being pulled down with the two in vitro transcribed 
RNAs. Even if the differential binding of these proteins with the two in vitro transcribed 
RNAs was not observed in the coomassie gel (Fig. 1 9C) it could be the case that this would 
be masked by other proteins running in the gel in the same area as the MW of PTB/nPTB. 
This was performed by using a specific antibody against this protein in western blots 
performed on the pulled down proteins (Fig. 19E). As further confirmation of the mass 
spectrometry results, hnRNP Al and hnRNP JKTBP were also tested using specific 
antibodies against these proteins in western blot analysis. The antibody against the hnRNP 
DAZAPI protein was used in western blot analysis as a loading control. As expected, I 
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observed a very strong signal on the RNA substrate with the ESS element for hnRNP 
JKTBP and hnRNP A 1. Interestingly, this was also the case for PTB/nPTB protein (Fig. 
19E, Lane 2). 
Thus, although I cannot fully rule out the presence or importance of other proteins which 
may be involved, RNA-affinity purification clearly identifies the hnRNP family members, 
hnRNP AI, PTB/nPTB and hnRNP JKTBP as the primary proteins associated with the 
ESS regulated exonic silencer. 
78 
A 
T1 
"'"', F .. 
IfGTCTC' ... _ .... _ .. _ ..• _ .....••.•.. .... . .. ,to:"CCl'QJOCTAC'TC'OCio\ACTAGCTOCCATAAAGrC'CC'TTAOGACCCT MOAGCTTTGAGACC'CTTAAO 
B 
_ ... ,;-
::- ~ 
o 
E 
.. 
HcLa 
u Icar 
extract 
c 
# IYIRNP 
DAZAPI 
SC IIA 
HISA 
SCNRA 
EISA 4HSS 
--
.. 
PTBlnPTB 
-_ ... - --- hnRNPJKTBP 
~===========! 
hnRNPAI 
----
~--------------~ hnRNP DAZAPI 
2 3 
83 
62 
47.5 
32.5 
79 
Figure 19. Identification of trans-acting factors binding to the exonic splicing silencer 
identified in SeN8A exon I8A. (A) DNA sequence used for the ill vitro transcription of 
WT RNA and mutant .:1ESS RNA. (B) Schematic representation of the pull down 
procedure analysis. The steps are indicated on the right hand side of the figure. Following 
separation of the proteins in SDS PAGE acrylamide gel the protein bands can be visualized 
by commassie staining or recognized by western blot analysis through incubation with 
specific antibodies. (e) eoomassie blue staining of a pull down assay using WT RNA and 
mutant ~ESS RNA. Arrows indicate the proteins sequenced and identified through mass 
spectrophotometry analysis. (D) Schematic representation of the binding sites identified in 
the region of the ESS for the proteins (PTB/nPTB (dotted line), hnRNP Al (bold line) and 
JKTBP (plain lines». (E) Western blot analysis for PTB/nPTB, JKTBP hnRNP Al and 
hnRNP DAZAPI performed on a pull down of the WT RNA and mutant .:1ESS RNA. 
3.3.1. Knockdown of hnRNPs AI, PTB/nPTB and JKTBP 
protein decreases the effect of ESS identified in the exon I8A. 
To establish if hnRNPs identified to bind specifically the ESS element in SeN8A exon 
I8A (section 3.2.2.) have a functional role in the repression of seN8A exon I8A I 
performed a si-RNA experiment (SI), in which I depleted hnRNPAI, PTB/nPTB and 
hnRNP JKTBP individually as well as in different combinations from Hela cells. As no 
strong evidence was found in the literature regarding the potential involvement of hnRNP 
B I in the repression of the splicing I decided for the time being not to test this candidate as 
a potential splicing regulator of SeN8A exon I8A inclusion. 
All si-RNA treatments were effective at reducing the protein levels of the target protein as 
can be observed from their reduction in western blot analysis on protein cells extracts of 
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the treated cells (Fig. 20A, Lanes 3-6). The effect the knock down of these proteins had on 
the mRNA processing of SCN8A exon l8A was analysed by transfecting the pTB SCN8A 
E l8A mini gene in a background where these proteins had being knocked down singularly 
or in different combinations. Whereas the individual knock down of the proteins did not 
have any effect as the exon l8A was still skipped, exon l8A inclusion was observed to 
some extent when all four hnRNP proteins were eliminated (Fig. 20B, Lane 4). These 
results indicate that there is a considerable redundancy of the hnRNPs in the interactions 
with the ESS in order to maintain the exclusion of SCN8A exon l8A in HeLa cells and 
presumablly "neonatal tissues". This type of redundancy is similarly to what has being 
documented for SR proteins (Tacke and Manley 1999). 
How these hnRNPs participates in the regulation of tissue and developmental specific 
alternative splicing regulation of these ME exons remains to be understood. Tissue specific 
changes in the expression level of hnRNPs may be involved, or another possibility is that 
additional tissue specific factors are involved that function together with these hnRNPs in 
regulation of this alternative splicing. Furthermore, neuronal cells may possess different 
isoforms and amounts of hnRNPs, or another possibility is tissue-specific phosphorilation. 
Indeed, phosphorilation has been shown to affect binding of hnRNP C to pre-mRNA 
(Auboeuf, Batsche et al. 2007). 
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Figure 20. Analysis by si-RNA of the functional role played by PTB/nPTB, JKTBP and 
bnRNP Al in exon 18A exclusion from mRNA. (A) The western blot analysis of si-RNA 
experiments, depleting the hnRNP's PTB/nPTB, JKTBP and hnRNP Al individually and 
in different combinations. All si-RNA treatments were effective at reducing the protein 
levels of the target protein as can be observed comparing the western blot signals and those 
of actin used as a control. (B) Agarose gel electrophoresis analysis of the RT-PCRs 
analyzing the effect of the knockdown experiments on the inclusion of SCN8A exon 18A 
in the mRNA using the minigene pTB SCN8A E 18A. On the right hand side of the gel is a 
illustration indicating what each amplification corresponds to. 
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3.4 Deletion of the ESS, identified in the SeN8A exon 18A, in a 
mini gene composed of a larger homologous context, is 
insufficient to cause inclusion of exon 18A in the mRNA. 
Over the last few years it has emerged that pre-mRNA is embedded with splicing 
regulatory elements. The practical consequence of this is that the correct control of splicing 
often depends on multiple signals who's cumulative effect result to give the splicing 
outcome desired (Buratti, Baralle et al. 2004). Till this moment the analysis of the ESS 
silencer element, on the inclusion of SCN8A exon 18A, was performed in a reductive 
mini gene in respect to the homologous sequence context that could not provide any 
information on what effect the deletion of the ESS would have in a more homologous 
environment, or any subsequent effect may have on SCN8A exon 18N. 
I therefore constructed a SCN8A WT mini gene, spanning SCN8A exons 17 to 19, 
encompassing both the 18N and 18A exons (Fig. 21A). Transfection into HeLa cells, 
followed by RT-RCR analysis and agarose gel electrophoresis allowed me to analyze the 
RNA processing of the two SCN8A ME exon 18N and 18A in this minigene. A major 
amplicon of 620 bp, and a very minor amplicon of 549 bp were obtained (Fig. 21A). 
Sequencing of the gel-purified cDNA fragments showed that the 620 bp product contains 
exon 17, 18N and 19. This transcript, as outlined in the introduction (section 1.4.4) 
contains an in-frame stop codon that would generate a truncated protein of 1034 amino 
acids, 60% of the full-length channel protein (Plummer, McBurney et al. 1997). The 549 
bp fragment is derived from an mRNA product spliced directly from exon 17 to exon 19, 
excluding both SCN8A ME exons 18N and 18A from the mRNA. This transcript 
maintains an open reading frame but lacks sequences encoding S3 and S4 segments of 
domain III as explained in the introduction (section 1.4.4). These results indicate that the 
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SCN8A WT minigene splicing behaves in a manner observed of SCN8A splicing in non-
neuronal tissues (Plummer, McBurney et al. 1997). 
To test if ESS, identified in the SCN8A exon 18A, had the same effect in the homologous 
minigene context as it did in the pTB mini gene, I deleted this silencer element in the 
SCN8A WT mini gene, creating the mini gene SCN8A! ~SS E 18A. Furthennore as a 
number of exon sequences which repress splicing have been described, capable of 
repressing splicing of heterologous exon, suggesting that they can function independently 
in a relatively simply way by recruitment of a protein, I decided to test whether the ESS 
identified could function autonomously and represents a phenomenon of more general 
interest. This was done by introducing this sequence element into the SCN8A exon 18N, in 
the context of SCN8A WT minigene, which is nonnally included in HeLa cells, at an 
analogous location as to that in which it is found in exon 18A exon (Fig. 21 C), creating the 
mini gene SCN8A!+ESS EI8N. 
RT-PCR analysis of SCN8A!~SS EI8A (Fig. 21B) resulted in partial inclusion of 
SCN8A exon 18A. The mRNA including exon 18A also contained ME exon 18N, 
indicating that the deletion of the ESS element was not sufficient to cause the switch in 
ME of the two exons. Curiously, the inclusion of SCN8A exon 18A occurred to a much 
lesser extent than that previously observed when the same region was deleted from the 
exon in the pTB minigene context (Fig. 17B). This fact could indicate that other cis-acting 
elements may acting in the larger context, necessary to aid the inclusion of this exon or 
repress it. However, the fonner seems to be the likely if we consider the result observed 
when we created the ESS element in SCN8A exon 18N as in this scenario the exon I8N 
carrying the ESS element, identified in exon 18A, was skipped showing that this sequence 
can act in a different context repressing splicing of exon which is nonnally included (Fig. 
21C). 
Taken together these results would indicate that the ESS thus far identified is extremely 
active, as it can function out of context, and more interestingly that there are indeed other 
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cis-acting elements, present in the larger homologous context spanrung SCN8A exons 17-
19 that also playa role in recognition of the SCN8A exon 18A. 
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Figure 21. Analysis of the alternative splicing of SCN8A exon I8N and 18A in a 
homologous minigene system. (A) Schematic representation of the minigene SCN8A WT 
that spans SeN8A exons 17 through to 19. II indicates SCN8A endogenous intronic region 
not included in the minigene construct. Transfection in HeLa cells followed by RT-RCR 
resulted in two products. T7 and SP6 primers are present in the 5' and 3' region, 
respectively, of the translated region in the plasmid. The major band corresponds to exon 
17, 18N and 19 whereas the lower band was composed of exons 17 and 19. (B) Left, 
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schematic representation of the minigene SCN8A1aESS E18A. Right, analysis of the 
mRNA processing of this mini gene after transfection in HeLa cells. Two bands can be 
observed on the agarose gel, the upper band corresponds to exons 17-18N-18A-19 and the 
lower band to exons 17 -18N -19 (C) Left, schematic representation of the mini gene 
SCN8A1+ ESS E18N. Right, analysis of the mRNA processing of this minigene after 
transfection in HeLa cells where the effect of the introduction of the ESS result in 
exclusion of the exon 18N. 
3.5 Changing the 5' splice site of SCN8A exon 18A towards 
consensus aids in the inclusion of the exon in mRNA. 
The previous results have shown that deletion of the ESS element in the SCN8A 
homologous minigene context was insufficient to cause complete inclusion of the SCN8A 
exon 18A in the mRNA when a larger homologous context was included in the minigene 
as opposed to what was observed when SCNSA exon 18A together with a limited amount 
of intronic sequence was placed in a heterlogous context. This fact could indicate that other 
cis-acting elements may be needed to aid in the inclusion of this exon and whose trans-
acting factors are missing from Hela cells or that the larger context carries elements that 
repress the seN8A exon 18A inclusion. These possibility's was further accented by the 
fact that I observed that the 5' splice site of the SCN8A exon 18A differs from the 
consensus (canonical sequence of a mammalian 5' ss is MAG/GTRAGT in which / 
indicates the exon-intronjunction at two positions). The differences between the consensus 
5' splice site of SCN8A exon 18A suggest that the 5' splice site of exon 18A might be 
inherently weak and thus more prone to the effects of "weak" cis-acting elements. To test 
this possibility and investigate the influence of SCN8A exon 18A 5' splice site strength on 
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SCN8A exon l8A splicing, using the minigene composed ofSCN8A exons 17-19 with the 
ESS sequences deleted (SCN8N.:ffiSS EI8A), I mutated the SCN8A exon 18A 5' splice 
site in manner that brought it to match exactly the canonical mammalian 5' splice site, 
creating a new minigene, SCN8NAESS, 5'ss Mut. E18A (Fig. 22). Comparison of the two 
minigenes, SCN8NAESS El8A and SCN8NAESS, 5 ' ss Mut. E18A, shows that an 
improvement of the 5' splice site drastically increases the inclusion of SCN8A exon 18A 
with the mRNA processing of the minigene resulting in the complete inclusion of both 
mutually exclusive exon, when compared to the mRNA processing of the SCN8NAESS 
E18A. Thus, the 5' splice site of SCN8A exon l8A is inherently weak, and this 
chamcteristic is important for its incomplete inclusion and susceptibility to regulation. 
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Figure 22. The 5' ss of exon 18A is inherently weak. Left, schematic representation of the 
minigene SCN8NAESS El8A illustrating the 5'ss nucleotide sequence as well as the 
nucleotide modification performed in order to bring the 5'ss to match the canonical 
mammalian 5' splice site creating the minigene SCN8N.:ffiSS, 5' ss Mut. EI8A. Right, 
analysis of the mRNA processing of this minigene after transfection in HeLa cells where 
the effect of the introduction of a canonical 5'ss results in complete inclusion of exon 18A 
in an mRNA species composed of exons 17-18N-18A-19 as opposed to the partial 
inclusion of exon 18A in such an mRNA species observed in the presence of the wild type 
5'ss. T7 and SP6 primers are present in the 5' and 3' region, respectively, of the translated 
region in the plasmid. 
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3.6 Identification and characterization of further cis-acting 
regulatory elements in the homologous minigene SeN8A WT 
context affecting exon 18A inclusion or exclusion in the mRNA. 
The results presented in section 3.5 showed that the 5' splice site of SCN8A exon 18A is 
intrinsically weak. An exon with a weak 5' splice site would be prone to the influence of 
even "weak" cis-acting splicing regulatory sequences adding a layer of control to its 
inclusion or exclusion from the fmal mRNA other than the ESS thus far identified. This 
further layer of complexity could be in the fonn of further splicing silencers or enhancers, 
the latter who's function in Hela cells may not be active due to lack of the appropriate 
trans-acting factors in this cell line, as after all SCN8A exon 18A in non-neuronal cells 
lines is typically excluded from the final mRNA. 
3.6.1 A region in the vicinity of the 3' splice site of SeN8A exon 
18A mediates the splicing regulation of SeN8A gene. 
The fact that the deletion of the ESS resulted in a drastically reduced inclusion of the 
SCN8A exon 18A in the mRNA when I used the SCN8NAESS El8A mini gene, as 
opposed to the full inclusion observed when the ESS was deleted in the heterlogous 
minigene (pTB vector), led me to hypothesise that other cis-acting elements may be 
present in the larger homologous context. Indeed as I showed in previous paragraph, the 
seN8A exon 18A 5' splice site was inherently weak and this characteristic was one of the 
important factors contributing to the skipping of exon 18A in non neuronal cells, such as 
HeLa. 
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As has been shown previously, in the pTB minigene context (Fig. 16B, Lane 3), the 
exclusion of SeN8A exons 18A, in part, was also determined by its upstream intronic 
flanking region. To further analyze the cis-acting elements in the intronic portion between 
the two SeN8A ME SeN8A exon 18N and 18A that may be critical in determining the 
ME exon selected in the mRNA I designed six new mini gene constructs in which different 
deletions of the intronic region and/or exon 18N were made, in the presence or absence of 
the ESS thus far identified in SeN8A exon 18A (Fig. 23A). These constructs were 
transfected in HeLa cells, and analyzed by RT -peR. 
The first construct was made in order to determine whether deletion of only ex on 18N 
from the SCN8A WT minigene would have any effect on the inclusion of exon 18A. To 
this end a DNA fragment containing exons 17, 18A (with and without the ESS element) 
and 19, together with the respective intronic regions, but without exon 18N, was 
introduced in pcDNA3 expression vector (Fig. 23A, constructs I and 4). The mRNA 
produced, after transfection and RT -peR analysis continued to skip seN8A exon 18A if 
the ESS was present resulting in an mRNA species composed of exons 17 and 19 (Fig. 
23B, Lane I) and showed similar levels of exon 18A inclusion, albeit this time in an 
mRNA species obviously missing exon 18N (Fig. 23B, Lane 4). 
Subsequently, I tested the effect on the mRNA processing of the deletion of exon 18N 
together with the deletion of the intronic region between the two SeN8A ME exon, I8N 
and 18A, on inclusion of SeN8A exon 18A, again in minigenes with and without the ESS 
identified in exon 18A (Fig. 23A, constructs 2 and 5). As suspected from the previous 
results with pTB mini gene, inclusion of SeN8A exon 18A was observed (Fig. 23B, Lane 
2) even in the presence of the ESS element in SeN8A exon 18A and was more significant 
in the absence of the ESS (Fig. 23B, Lane 5) 
A further construct was made in order to try and isolate the intronic sequence responsible 
for the observed exon 18A inclusion. To this end I removed a region corresponding to the 
+ 10 bp nucleotide downstream of the S'ss of exon 18N to +227 bp in a minigenes with and 
89 
without the ESS in exon I8A (Fig. 23A, constructs 3 and 6). Unexpectedly in this scenario 
we observed that with the mini gene in which the ESS was present (Fig. 23B, Lane 3) exon 
I8N was drastically affected with the major band corresponding to mRNA composed only 
of exons 17 and 19 as opposed to the mRNA species resulting from the SCN8A WT 
minigene (Fig. 23B, Lane 1). It would therefore appear that the intronic region +10 bp to 
+227 bp between two SCN8A ME exon I8N and 18A, contains cis-acting elements that 
promote the inclusion of ex on I8N. The same +10 bp to + 227 bp deletion, in the minigene 
with the ESS in exon 18A deleted, results in three mRNA products. The principal species 
was a skipping of both ME exon, I8N and I8A. The two other species of approximately 
equal intensity were ones of exons I7-I8A-I9 and another 17-I8N-I9 (Fig. 238, Lane 6). 
This experiments start to paint an extremely complex picture of the splicing control 
provided by the intronic region between the two ME exons that I have only just began to 
comprehend and whose effect on the two ME exons are schematically represented in figure 
23C. From the data on mRNA splicing patterns observed, with construct number 2, I can 
hypothesize that the intronic region between two ME exon, I8N and I8A, contains 
elements that repress the inclusion of exon I8A. Furthermore these elements, based the 
data from construct number 3, would appear to be outside the region deleted, + 1 0 bp/+ 227 
bp, and therefore present in the intronic region located -150 bp upstream of the 3' ss of 
exon I8A. The construct number 3, on the other hand, would indicates that this region 
contains an ISE for the inclusion of SCN8A exon I8N. 
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Figure 23. Analysis of the effect of the DNA sequence upstream of exon 18A on mRNA 
processing. (A) Schematic representation of the minigenes created in order to analyze the 
effect on mRNA splicing of the DNA region upstream of exon 18A. The deletions were 
performed both in the SCN8A WT minigene (uppers section) as well as the minigene 
SCN8A1~ESS El8A (lower section). II indicates the region of endogenous DNA deleted 
from the minigene. (B) Agarose gel electrophoresis of the RT-PCR analysis of the 
constructs preformed after transfection in HeLa cells. Three forms of mRNA are observed 
as indicated on the right hand side of the gel and are composed ofexons 17-19, exons 17-
18A-19 and exons 17-18N-19. (C) Schematic representation of the deletions that were 
made in the homologous minigene context and the position of the possible cis-acting 
elements and their role they may play for the inclusion of SCN8A exon 18N and skipping 
of ex on 18A as inferred from section (B) of this figure 10. 
3.6.2 A conserved sequence in the downstream intron of exon 
18A defines an important region required for its regulation. 
Lately several trans-acting factor expressed specifically in neuronal tissues have been 
identified (section 1.3.5). The fact that the 5' splice site of SCN8A exon 18A is 
intrinsically weak means its efficient use may depend on one of these trans-acting factor, 
present possibly only in neuronal cells, where SCN8A exon 18A is included. 
To identify possible intron enhancer elements, I examined the intronic sequence around the 
SCN8A exon 18A for cis-acting elements that may function as an enhancer element. I 
observed that there are two (T)GCATG elements in the sequence downstream of SCN8A 
exon 18A, in close proximity to its 5' splice site (Fig. 24A). Interestingly, it has been 
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shown that the position and sequence context of (T)GCATG elements of SCN8A exon 
18A has been strongly conserved, from fish to humans (Minovitsky, Gee et al. 2005), 
supporting a hypothesis that this element may be a critical component of the splicing 
switch mechanism that mediates tissue-specific splicing events. The (T)GCA TG sequence 
is a previously characterized splicing enhancer element that has been shown to be 
important for the proper splicing regulation of a different genes, such as fibronectin, c-src 
and calcitonin/CGRP (Hedjran, Yeakley et al. 1997; Lim and Sharp 1998). In addition, a 
computational study demonstrated an overrepresentation of (T)GCATG hexamers in the 
downstream intron of neural and muscle-specific alternatively spliced exons (Underwood, 
Boutz et al. 2005). Thus, this element is a hallmark of many system of neuronal splicing 
regulation. The factors responsible for recognizing the hexamers were first recognized by 
Jin et al., who showed these proteins to be homologous of the Caenorhabditis elegans 
RNA binding protein feminizing on X (FOX-I). Members of Fox protein family regulate 
the splicing of many neuron and muscle specific genes. There are three mammalian family 
members, Fox-l (A2BPl), Fox-2 (RBM9) and Fox-3 (hnrbp3), each containing a nearly 
identical RNA binding domain that recognize the hexanucleotide element (U)GCAUG. 
Fox-} is expressed in neurons and muscle, Fox-3 is expressed only in neurons, while 
expression of Fox-2 shows broader range of the expression, being found in embryo, 
neurons and muscle (Kuroyanagi 2009). Brain specific Fox-l may represent a trans-acting 
factor, missing from the HeLa cells needed to enhance the recognition of the SCN8A exon 
l8A in neuronal cells. 
To investigate if brain specific Fox-l protein could indeed playa role in aiding the 
recognition of SCN8A exon 18A, I created an expression plasmid carrying the sequence 
for the expression of the brain specific isoform of Fox-l together with a tag for the Flag 
epitope. This expression plasmid was transfected into HeLa cells together with the either 
the SCN8A WT or SCN8A1.:1ESS E18A minigene. The splicing of the exon l8A was 
assayed by RT-PCR analysis (Fig. 24B). The expression of the Fox-l was monitored by 
93 
immunoblotting for the Flag epitope tag (Fig. 24C). As previously shown, the SCN8A WT 
minigene results in complete inclusion of exon 18N and skipping of exon 18A in He La 
cells (Fig. 2IA). Cotransfection of SCN8A WT minigene construct with the Fox-I 
expression plasmid did not result in a change in SCN8A exon 18A inclusion, since this 
exon was still completely skipped (Fig. 24B, Lane I). In HeLa cells the SCN8A exon 18A 
inclusion may be strongly repressed by different hnRNPs protein, binding the ESS element 
previously identified, even in the presence of Fox-I protein, thus masquerading any effect 
this latter may have. This was in accordance with the results showed by Minovitsky et aI., 
suggesting that (T)GCA TG elements alone are not sufficient to determine precise tissue 
specificity (Minovitsky, Gee et al. 2005). To examine the enhancer activity of brain 
specific Fox-I protein in the absence of ESS repression element, I used a SCN8A1aESS 
E 18A mini gene, where the ESS element was removed from the SCN8A exon 18A. 
Cotransfection with the Fox-I expression plasmid, strongly increased the SCN8A exon 
18A inclusion, resulting in an additional band corresponding to a product including both 
exons, 18N and l8A (Fig. 248, Lane 2). Identity of this band was confirmed by 
sequencing of the gel purified product. Cotransfection of the SCN8A1aESS EI8A 
minigene with an empty expression vector, CMV-4, did not have an effect on the inclusion 
of ex on 18A (Fig. 24C, Lane 3). 
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Figure 24. Effect of Fox-l protein expression on the mRNA splicing of the SCN8A WT 
and SCN8N LlliSS E 18A minigenes. (A) Schematic representation of the two (T)OCA TO 
elements in the sequence downstream of exon 18A. T7 and SP6 primers are present in the 
5' and 3' region, respectively, of the translated region in the plasmid. (B) Agarose gel 
electrophoresis of co-transcfection of the minigenes the SCN8A WT and SCN8A1LlliSS 
El8A with a brain specific Fox-l expression plasmid. When Fox-l expression plasmid was 
not transfected a empty CMV-4 plasmid was used (Lane 3). The species of mRNA 
produced are indicated on the right hand side of the gel. (C) Analysis of the expression of 
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the Fox-I proteins was monitored by immunoblotting for the Flag epitope tag and amount 
of protein loaded on the western blot controlled through western blots against the tubulin. 
3.6.3 Overexpression of Fox-1 protein aids in SCNSA exon 1SA 
inclusion in the mRNA in a (T)GCA TG dependent manner. 
As already mentioned, previous studies have shown that (T)OCA TO is an intronic splicing 
regulatory element bound with unusually high specificity by the Fox-I protein, and this 
interaction is required for efficient splicing of neural specific alternative exons 
(Underwood, Boutz et al. 2005). To test whether this observed Fox protein enhancer 
activity was dependent on the presence of (T)OCA TG in the case of SCN8A exon 18A, 
further mini genes were constructed and tested in co-transfections with the brain specific 
Fox-I expression plasmid. The minigenes were made in such a fashion as to evaluate the 
relative contribution of each intrinsic repeat individually or in combination, by mutating 
these in the SCN8A! ~SS E 18A mini gene together with co-transfection with brain 
specific Fox-I protein (Fig. 25A). 
A single mutation in the first (T)OCATO (TOCATO > TOCQTO) repeat had a drastic 
effect on SCN8A exon 18A inclusion, since the exon was almost completely skipped (Fig. 
25B, Lane 2), as can be seen by comparison with the SCN8A!~SS EISA minigene in 
which Fox-I binding sites were not mutated (Fig. 25B, Lane I). A mutation in the second 
OCATG (OCa TO> OCQTO) repeat, showed an identical effect on the reduction of exon 
18A inclusion, as was also the case when mutations were introduced in both repeats and 
the Fox-I was expressed (Fig. 25B, Lanes 3 and 4). 
Thus, splicing enhancement is strongly dependent on both (T)OCATO elements, as their 
mutation results in ineffectiveness of Fox-! to aid in the inclusion of the SCNSA exon 
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18A. Cotransfection of the minigene where both Fox binding sites were mutated, with an 
empty expression vector, CMV-4, did not have an effect on the inclusion of exon 18A 
(Fig. 25B, Lane 5). The expression of the Fox-l was monitored by immunoblotting for the 
Flag epitope tag and antibody for the tubulin was used as a loading control (Fig. 25C). 
The results obtained allow me to conclude that the deletion of a conserved element (ESS) 
is not sufficient for regulated SCN8A exon 18A inclusion in the WT mini gene construct. 
The region downstream of exon 18A, containing two (T)OCA TO repeats, defines an 
important region required for its regulation which functions through Fox-I, demonstrating 
that the Fox-l protein is an important trans-acting factor for the inclusion of the SCN8A 
ex on 18A. 
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Figure 25. Fox-} enhancer activity is dependent on the presence of the (T)GCA TG 
regulatory elements. (A) Schematic representation of the minigenes created in order to 
analyze the effect of the mutations in Fox-) binding sites, singularly or in combination. (B) 
Agarose gel electrophoresis of co-transfections of the minigenes with and without the 
mutations in Fox-} binding sites, with a brain specific Fox-l expression plasmid. Two 
forms of mRNA are observed as indicated on the right hand side of the gel. (C) Analysis of 
the expression of the Fox-l proteins was monitored by immunoblotting for the Flag 
epitope tag and amount of protein loaded on the western blot controlled through western 
blots against the tubulin. 
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3.7 Differential activities of different Fox proteins in promoting 
SeNSA exon ISA inclusion. 
In mammals, Fox-I, Fox-2 and Fox-3 are members of an extended family of proteins 
arising from multiple genes and complex alternative splicing. Previously it has been 
demonstrated that the expression of certain spliced isoform is specific to particular tissues 
and that their enhancer activities are variable (section 1.3.5). It was therefore of interest to 
compare the relative activity of individual isoform of muscle specific Fox-l and brain 
specific Fox-I, Fox-2 and Fox-3 proteins in promoting SCN8A exon 18A inclusion. This 
was performed using the SCN8A WT and SCN8A1aESS EI8A minigene constructs and 
over-expression plasmids for the specific Fox proteins created in an identical manner to 
that of the brain specific Fox-I expression plasmid. 
After the transfection in HeLa cells and RT-PCR analysis, I observed that, as before in the 
presence of the ESS in SCN8A ex on 18A (SCN8A WT minigene), Fox protein(s) over 
expression, irrespective of type or isoform, had no effect on mRNA produced (Fig. 26A, 
Lanes 1-4). On the other hand in the absence of the ESS region in SCN8A exon 18A the 
greater effect on the inclusion of SCN8A exon 18A occurred with co-transfection of the 
brain specific Fox-3 expression plasmid was observed (Fig. 26A, Lane 8). The effect on 
exon 18A inclusion after the cotransfection with brain specific Fox-2 and muscle specific 
Fox-I was the same as with the previously observed effect with the brain specific Fox-l 
protein (Fig. 26A, Lanes 7, 6 and 5 respectively). To confirm that muscle specific Fox-I 
and the brain specific Fox-I, Fox-2 and Fox-3 proteins are indeed expressed, immunoblot 
analysis was performed against the flag epitope (Fig. 26B). 
A possible explanation as to why a greater inclusion of SCN8A exon 18A is observed, 
transfecting the cells with the brain specific Fox-3 protein may lie in the efficiency of this 
protein in entering the nucleus rather than the actual function of the protein per se. Indeed 
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although all of expressed Fox proteins share an identical RNA binding domain, and are 
equally capable of binding to the (T)OCA TO element, each isoforms shows quantitative 
differences in splicing activity and nuclear distribution in transfected cells (Kim, Adelstein 
et al. 2009). 
However, more interestingly is the outcome that the presence of Fox proteins, and not in 
particular of specific isoform, is necessary but not sufficient to get complete inclusion of 
SCN8A exon 18A in neuronal cells, but rather the amount of other trans-acting factors 
together with the Fox protein expression is what dictate the inclusion of SCN8A 18A exon. 
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Figure 26. Analysis of different Fox-I proteins and isoforrns promoting SCN8A exon 18A 
inclusion. (A) The effect of individual isoforms of brain (br) and muscle (m) Fox-I, brFox-
2 and brFox-3 proteins in promoting SCN8A exon l8A inclusion was analyzed by RT-
PCR after co-transfection of overexpression plasm ids for these proteins with SCN8A WT 
and SCN8NAESS E18A minigene constructs. The mRNA species produced are indicated 
on the right hand side of the gel. (B) Immunoblot analysis of Fox-I, Fox-2 and Fox-3 
proteins overexpression. 
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3.S Different cell lines tested in search for the SeNSA exon ISA 
inclusion. 
In order to ascertain the role played by Fox protein in SCN8A exon I8A inclusion in the 
mRNA as well as any possible effect it may have on the ME splicing mechanism it was 
important to find a cell line in which the ME nature of these exons was respected and 
SCN8A ex on I8A included in the mRNA rather than SCN8A exon I8N. 
Neuronal clonal cell lines have often been used to study the differentiated features of 
authentic neurons. It can often be demonstrated that a particular neuronal property is 
retained in a neuroblastoma cell line with characteristics that are apparently identical to 
authentic neuronal tissue. Thus, I decided to test some of the neuroblastoma cell lines. To 
this end, I used two neuroblastoma SK-N-BE (ATCC Number: CRL-227ITM) and SH-SY-
5Y (ATCC Number: CRL-2266 TM) cell lines. Unfortunately, in both cell lines tested, two 
products after the transfection and the RT-PCR analysis, of the SCN8A WT mini gene, 
were observed, with a major band corresponding to a product including exon I8N and a 
minor band corresponding to a skipping of both ME exon (Fig. 27 A, Lanes 1 and 2). In 
these two cell lines, SCN8A transcript was also endogenously present with a similar 
pattern of inclusion than the minigene, that is only SCN8A exon 18N inclusion or skipping 
of both ME exon (Fig. 27B). I also tested the Fll cell line (provided by Prof. E. Wanke, 
Universita degli studi di Milano-Bicocca) that is hybrid cell line derived from a mouse 
N18TG2 neuroblastoma and rat ORG sensory neuron, and the rat pheochromocytoma cell 
line, PC-I2 (ATCCNumber: CRL-I72ITM). 
Fll cell, morphologically in culture showed characteristics of neuronal cells. As a 
mini gene for a transfection experiment, I used a SCN8A WT minigene, and after the RT-
PCR analysis, the same pattern as in neuroblastoma cell lines was observed (Fig. 27 A, 
Lane 3). 
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Previously, it has been shown that clonal cell lines may be grown under different culture 
conditions in which they exhibit altered morphologies (Nelson, Christian et al. 1976; 
Nirenberg, Wilson et al. 1983). These alterations may be associated with changes in the 
expression of various functions. Such changes may provide insights into the factors and 
mechanisms underlying the regulation and expression of neuronal characteristics during 
normal differentiation. A classic example of this is the use of the PC12 pheochromocytoma 
cell line for study of the mechanism of action of nerve growth factor (NGF) (Race and 
Wagner 1985). I therefore decided to investigate if these cells could provide a suitable 
substrate in which to further ascertain for the role Fox-1 had on SCN8A exon 18A splicing 
regulation in vivo. In order to induce differentiation, PC-12 cells were cultured in DMEM 
containing 1 % serum and 50ng/mL NGF as described in material and methods (section 
6.19). After 10 days oftreatrnent with NGF, RNA and protein were extracted from PC-12 
cells at several different time points. Expression of Fox-l protein was observed to be 
induced in PC-12 cells treated with NGF from day 7, steadily increasing till day 10 (Fig. 
27D). Surprisingly however RT -PCR analysis using primers that flanked exons 17 and 19 
of the endogenous rat SCN8A gene resulted in mRNA species only including SCN8A exon 
18N (Fig. 27C), even if the Fox-l protein expression increased after the treatment with 
NGF. Thus, even ifin some of these cells, such as PC-12, Fox-1 protein was expressed, the 
cellular environment was not appropriate for the inclusion of SCN8A exon 18A. This may 
be due to the presence or the amount of hnRNPs that bind to the silencer element being 
such that, the repression of SCN8A exon 18A inclusion via the ESS is overpowered, or 
maybe there are some other factors that somehow aid the inclusion of SCN8A exon 18N, 
factors that are in direct competition with tissue specific factor, such as Fox-I. What is 
certain is that, amounts of different, ubiquitously expressed proteins, such as hnRNPs or 
SRs, and/or the presence of some tissue specific factors and their interactions, all together 
are the part of the complex cellular environment, that dictate the splicing pattern of the 
genes, such as SCN8A transcript. 
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Figure 27. Analysis of endogenous and exogenous SCN8A exon 18A inclusion in 
neuronal cell lines_ (A) RT-PCR analysis of the transfection of SCN8A wild type minigene 
in neuroblastoma SK-N-BE, SH-SY-5Y and Fll cell lines. The mRNA species produced 
are indicated on the right hand side of the gel. (B) RT-PCR analysis of the endogenous 
SCN8A gene in neuroblastoma SK-N-BE and SH-SY-5Y cells using primers in exons 17 
and 19. The mRNAs species produced are indicated on the right hand side of the gel. (C) 
RT-PCR analysis using primers that flanked exons 17 and 19 of the endogenous rat 
SCN8A gene in PC-12 cells cultured in DMEM containing I % serum and treated for 10 
days with 50nglmL of NGF. Inclusion of SCN8A exon 18N was consistently detected 
irrespective of the time point. (D) Fox-I protein expression analysis at different time points 
of differentiation, of the PC-12 cells. The treatment with NGF as can be observed in the 
western blot analysis causes Fox-l to appear and steadily increase from day 7. The 
antibody against the tubuJin was used as a loading control (the lower panel). 
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Finally I decided to examine the splicing pattern of endogenous SCN8A transcript in the 
primary culture of rat trigeminal ganglion neurons. To this end, the primary culture of a rat 
TG neurons was prepared as described in material and methods (section 6.20). To 
demonstrate that the SCN8A channel transcript is indeed expressed in these cells, and that 
the ME exon included is the exon 18A, I performed a simple RT-PCR analysis, using 
primers in rat SCNSA exons 17 and 19 on RNA isolated from these neurons, and after the 
agarose gel electrophoresis I observed three amplicons, one major and two very minor 
(Fig. 2S). Sequencing of the gel-purified cDNA fragments showed that the major amplicon 
product consisted of SCN8A exon 17 -18A -19. The band in the middle corresponded to the 
inclusion of exon 17 -lSN -19, while the lowest band corresponded to the skipping of both 
seN8A ME exons I8N and 18A. 
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Figure 28. Endogenous SCN8A transcript in the primary culture of the rat trigeminal 
ganglion (TO) neurons. RT-PCR analysis, using primers in rat SCN8A exons 17 and 19 
and agarose gel electrophoresis. On the right hand side of the gel the species of mRNA 
produced are indicated. 
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3.9 Endogenous Fox-I protein in the primary culture of the 
trigeminal ganglion (TG) neurons regulates ME splicing pattern 
of endogenous SeN8A exon I8N and I8A. 
The primary culture of rat trigeminal ganglion neurons fulfilled the criteria of the cell type 
I was searching for in order to further analyse the role played by Fox-I in the ME control 
of SCN8A exons I8N and I8A, namely the inclusion of SCN8A exon I8A rather than I8N 
in themRNA. 
I therefore sought to determine the effect knockdown of Fox-l protein would have in these 
cells. To be sure that the Fox-l protein would be silenced and uncertain which of the six 
protein isoforms of Fox-I mayor may not be present in this cell type I designed an si-RNA 
to target all six isoforms of Fox-I protein. As a control, for si-experiment I used a si-RNA 
against a luciferase gene. The knockdown of Fox-I was performed as described in 
materials and methods section 6.25. Briefly two subsequent si-RNA transfections were 
carried out distanced 24 hours apart and after a further 24 hours the cells were harvested 
and total RNA was isolated for RT-PCR analysis using primers that correspond to 
sequences in the rat SCN8A exons 17 and 19. Analysis of alternative splicing of 
endogenous SCN8A ME I8A and I8N, in these cells demonstrated that Fox-I is indeed a 
key player in the mechanism of ME splicing as from an almost exclusive cDNA consisting 
of SCN8A exon I7-I8A-I9, I now observe three cDNA species. The principal band is 
composed of SCN8A I7-I8N-I9 and two minor bands of approximately the same intensity 
corresponding to SCN8A 17-18A-19 and SCN8A 17-19 reveled changes in splicing 
pattern, with an increase of exon I8N and decrease of exon 18A inclusion (Fig. 29A). 
Unfortunately, the amount of trigeminal ganglion neurons in culture after 2 days of 
treatments with SI for the Fox-l protein, was not sufficient to get enough of material for 
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the Western blot analysis, as can be seen in Fig. 29B. Indeed an antibody against the 
tubulin resulted in a signal that was barely detectable (Fig. 29B). Notwithstanding the fact 
that the si-RNA experiments were repeated three times and resulted in the same result in 
regards to the splicing patterns of the two ME exons, I was never able to obtain enough 
material for a good western blot signal. The animals utilized were a generous gift from 
Prof. Giacca's laboratory. In order to have enough cells in a p35 to perform the si-RNA 
experiment, one rat needs to be sacrificed per well. To be able to increase this number, 
with the aim of been able to extract enough material for RT -peR experiments as well as 
western blots, I have now set up my own breeding program and hope to be able to 
complete the experiments in the near future. 
However, as a partially indication that the SI against Fox-l can indeed knockdown this 
protein, comes from previous experiments where I initially tested the SI efficiency for the 
Fox-l protein in He La cell, transfected with brain specific Fox-l overexpression plasmid 
with the flag epitope. 
Overexpressed Fox-l protein was observed to be greatly decreased, after the SI 
experiments as can be seen in the western blot analysis using an antibody against Fox-l 
(Fig. 29C). 
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Figure 29. Analysis of the endogenous Fox-l protein on the regulation of the ME splicing 
of SCN8A exon 18N and 18A endogenously present in rat TG neurons. (A) RT-PCR 
analysis of the endogenous SCN8A gene after SI experiment against Fox-l and luciferase 
proteins. The mRNA species produced are indicated on the right hand side of the gel. (B) 
Immunoblot analysis of tubulin protein in TG neurons after the knockdown of Fox-I. 
(C) In the upper panel, immunoblot analysis of Fox-l protein overexpression before and 
after the SI of Fox-I and luciferase protein in HeLa cells (black arrow), and unspecific 
bands (white arrow). NE; nuclear extract. Lower panel: the antibody against the tubulin 
was used as a loading control. (D) The knock down was also correlated to the functional 
effect in the RT-PCR analysis using SCN8NdE:SS El8A minigene construct. 
4. Investigation into the cis-acting elements controlling the 
inclusion of exon I8N in non neuronal cell line. 
Till now I have being investigating into the molecular mechanisms principally responsible 
for SCN8A exon 18A exclusion in the mRNA. However, it is obvious that the ME splicing 
will also depend on strict regulation of SCN8A 18N via auxiliary cis-acting splicing 
elements. We have observed in section 3.6.1 that, in part, there appears to exist some ME 
control for SCN8A exon 18N through elements in the intronic sequence between the two 
ME exons. 
Furthermore, we have already observed that in trigeminal ganglion when we constrain the 
inclusion of SCN8A exon 18A in the endogenous transcript via si-RNA of Fox-l protein 
the mRNA species goes from nearly a 100% pure inclusion of 17-18A-19 to a dominant 
mRNA species containing 18N as well as two other mRNA species, one carrying the 18A 
exon and also complete skipping of the two ME exons (Fig. 29A). This data would indicate 
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that the trans-acting factors responsible for I8A inclusion are still to some extent present in 
the trigeminal ganglion 
4.1 An exonic enhancer element (ESE) necessary for SeN8A 
exon 18N inclusion in non-neuronal cells is present within this 
exon. 
Alternatively spliced exons often contain ESEs for binding of splicing regulators that 
determine their inclusion. Different amounts of the trans-acting factors in different cells 
types can then subsequently determine their inclusion or exclusion in specific cells or 
under specific circumstances. Previous studies have indeed shown that SR proteins, the 
family of proteins principally shown to exert their effect through ESE's, are differentially 
expressed in different tissues including neuronal (Hanamura, Caceres et a1. 1998). 
As SCN8A exon 18N was always observed to be included in the mRNA when the 
minigenes were transfected in HeLa cells, I decided to initiate the investigation of the 
splicing control mechanisms underlying SCN8A exon 18N by determining if any ESE 
could be identified within this exon necessary for its inclusion in mRNA in Hela cells. 
A first approach using ESE finder ver3.0, a bioinformatic program that searches for some 
of the more common ESE sequences was undertaken. The ESE finder program identified 
mUltiple putative SR protein responsive elements in SCN8A exon 18N (Fig. 30A). In order 
to see if these putative ESE's had a functional role in the inclusion ofSCN8A exon 18N I 
created a series of constructs with sequential and overlapping deletions in the minigene 
SCN8A WT: minigenes SCN8NE18N AI, A2, AJ, A4, AS and A6 (Fig. 30B). 
After RT-PCR analysis I observed that the SCN8A1E18N A2, AJ, A4 and A5 minigenes 
resulted in complete skipping of SCN8A exon 18N (Fig. 30C, Lanes 3-6), while SCN8A 
E 18N A 1 and A6 minigenes had no consequences on the inclusion of seN8A exon I8N in 
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the mRNA (Fig. 30e, Lanes 2 and 7). The SeN8A E18N A2 minigene construct overlaps 
with SCN8A EI8N A3 which also overlaps with SCN8A EI8N ~4 and ~5, all of these 
deletions cause exon 18N to be skipped. As SeN8A E 18N ~6 minigene construct, that 
does not have an negative effect on the inclusion of exon 18N, partially overlaps with A2, I 
therefore concluded that the segment A3, that I shall now refer to as the ESE element, is 
likely to cover the region containing most of the ESE activity and decided to use this 
minigene to further investigate the ESE element responsible for inclusion of seN8A exon 
18N. 
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Figure 30. Identification of an exoruc splicing enhancer element (ESE) in the SCN8A 
exon 18N. (A) The score matrix of SC35 and ASF/SF2 SR proteins predicted to bind 
SCN8A exon I8N, as predicted by ESE fmder ver3.0. (B) Schematic representation of the 
SCN8A1E18N minigene carrying deletions AI, A2, A3, A4, AS and A6. (C) Results of the 
RT-PCR analysis of these minigenes in agarose gel electrophoresis. On the right hand side 
of the gel are the forms ofmRNA observed. 
112 
4.2 Identification of the trans-acting factors binding to the ESE 
element identified in SeNSA exon ISN. 
In order to identify the trans-acting factors binding the ESE element identified in the 
SCN8A exon 18N, I performed a pull down experiment, in a identical manner as to that 
described in section 3.3. Therefore, pTB E18N (with the ESE identified present) and pTB 
E18N A3 minigenes (without the ESE element) were used as a template for the synthesis in 
vitro of the corresponding RNAs (Fig. 31A). These RNA's were then covalently linked to 
adipic acidic beads, incubated with nuclear extract prepared from HeLa cells, precipitated 
and washed. RNA-associated proteins were then eluted with SDS sample buffer and 
separated by SDS-P AGE. The proteins from the gel were immediately transferred to the 
nitrocellulose membrane, and after the transfer of the proteins, specific antibodies against 
some of the more common trans-acting factors binding to ESE were used for the detection 
of the proteins. 
As a first approach we probed the pulldowns with the an IH4 antibody which in theory is 
recommended for detection of SR RNA processing factors, including SRp7S, SRpSS, 
SRp40. I was only able to observe a signal against SRp55 protein that was however visible 
irrespective of the presence or not of the RNA sequence containing the ESE element (Fig 
31B). As the binding SC3S and ASF/SF2 highlighted in the bioinformatics analysis would 
be disrupted by deletion of region 3, I probed the pull down assay with antibodies for 
SC3S and ASF/SF2. From the western blot shown in figure 31 B, I can see that the signal 
for these proteins was observed exclusively in the pull down experiment using the RNA 
with the ESE element (Fig. 31 B). 
In order to test the functional significance of this differential binding to the RNA with or 
without the presence of the region ESE, I decided to perform an si-RNA experiment, 
depleting these two proteins, singularly or in combination, in HeLa cells. Both si-RNA 
treatments were effective at reducing the protein levels of the target protein as can be 
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observed from their reduction in Western blot analysis (Fig. 31 C). The effect the knock 
down of these proteins had on the mRNA processing of seNSA exon ISN was analysed 
by transfecting the WT SeNSA minigene in these backgrounds, where both these proteins 
had being knocked down. Unfortunately, we could not detect any change in the levels of 
SeNSA exon lSN inclusion, depleting these proteins (Fig. 31 C). These results may mean 
that these proteins do not have a functional role in the inclusion of seNSA exon lSN. 
However it is much more likely, as has being shown in previous studies, where it was 
observed that different members of SR proteins are generally interchangeable in their 
ability to fulfill a wide range of activities in the splicing reaction (Tacke and Manley 1999) 
since the binding sites for a SR protein members can be fairly degenerate (Black 2003), 
that a redundancy in the occupation of the ESE by the SR proteins is occurring upon 
depletion of SC35 and ASF/SF2 proteins. 
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Figure 31. Identification of trans-acting factors binding to the exonic splicing enhancer 
identified in the SeN8A exon I8N. (A) DNA sequences used in T7 in vitro transcription 
for the production of WT RNA and mutant Ll3 RNA. (B) Western blot analysis for SRp55 
(left panel), SC35 and ASF/SF2 proteins (right panel), performed on a pull down of the 
WT RNA (with the ESE) and Ll3 RNA (without the ESE). NE; HeLa nuclear extract (C) 
Left panel: agarose gel electrophoresis analysis of the RT-PCRs analyzing the effect of the 
knockdown experiments on the skipping of SCN8A exon I8N in the mRNA using the 
SCN8A WT minigene. Right panel: the western blot analysis of si-RNA experiments, 
depleting the SC35 and ASF/SF2. An antibody against actin protein was used as a loading 
control. 
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4.3 Overexpression of SC35, ASF/SF2 and Fox-! proteins in 
HeLa cells. 
To further analyse the possible role played by SC35 and ASF/SF2 in the ME splicing of 
SCN8A exon 18N through overexpression of these two trans-acting factors ideally we 
would want a mini gene system in which this exon is not completely recognized. In Hela 
cells this is partially provided by the mini gene SCN8NdESS El8A with over expression 
of Fox-l protein. In these case, exon 18N inclusion is not excluded, as two mRNA species 
composed of SCN8A exons 17-18N-18A-19 and 17-18N-19 (Fig. 24B, Lane 2) can be 
observed, however it is incorrectly proceeded in that the mRNA species 17-18N-18A-19 
containing the two mutually exons does not occur in vivo. I therefore decided to determine 
the effects of elevated levels of the SR proteins, ASF/SF2 and SC35, on the splicing of 
SCN8N~ESS El8A mini gene in HeLa cells co-transfected with Fox-l expression 
plasmid. The RT-PCR analyses showed that overexpression of ASF/SF2, SC35 and Fox-l 
decreased the relative intensity of the band corresponding to the mRNA product including 
both the SCN8A 18N and I8A exons, relative to that containing SCN8A exon I8N (Fig. 
32). Thus, it would appear that elevated levels of both ASF/SF2 and SC35 enhance correct 
processing of exon 18N inclusion of the SCN8A transcript in HeLa cells via binding to 
enhancer elements within the exon, indicating that these proteins aid the correct ME 
processing of the mRNA overpowering the effects exerted by the deletion of the ESS 
element in SCN8A exon 18A and Fox-lover expression and pushing the splicing 
processing towards exclusive inclusion of SCN8A exon I8N. 
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Figure 32. Effect of SC35, ASF/SF2 and Fox-lover expression on the mRNA splicing of 
the SCN8A! ~ESS E 18A minigene in HeLa cells_ Agarose gel electrophoresis analysis of 
the RT -PCR analyzing the effect of SC35, ASF/SF2 and Fox-lover expression 
experiments_ On the right hand side of the gel are the forms of mRNA observed_ 
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5. Mutually exclusive splicing regulation of SCN9 A exons 5N 
and SA sodium channel gene. 
In order to see if the control mechanism that I have begun to elucidate for the SCN8A 
exons 18A and I8N ME splicing could represent a more general mechanism, I also 
investigated the ME splicing regulation of SCN9A exons SN and SA. 
Exons SN and SA of the SCN9A sodium channel gene are mutually exclusive, and their 
selection is regulated during development in a tissue specific manner (Raymond, Castle et 
al. 2004). The SCN9A exon SN is preferentially expressed in the peripheral (PNS) and 
central (CNS) nervous system of adult tissues and significant usage of SCN9A exon SA 
was found only in dorsal root ganglion (DRG). The alternative SCN9A exons SN and SA 
encode part of segment S3 and all of S4 of domain I in the a subunits of SCN9A sodium 
channel gene. The two splice variants differ by one amino acid substitution, residue 7 is 
aspartic acid (Asp) in SA and serine (Ser) in SN. The functional consequences of this 
change is thought to be significant, for two principal reasons. Firstly, the alternative 
splicing to generate N and A isoforms is developmentally regulated, thus representing a 
substantial investment by the organism in maintaining this differential expression (Sarao, 
Gupta et al. 1991). This suggests that channels with a neutral charged residue (SCN9A 
with exon SN) are advantageous in the neonate when cells are migrating and differentiating 
whereas channels with a negatively charged residue (SCN9A with exon SA) are preferable 
in the mature cells of the adult (Onkal and Djamgoz 2008). Secondly, the same alternative 
splicing module, (exons SN and SA), has been preserved in distinct sodium channel genes 
(SCN2A, SCN3A, SCNSA and SCN8A) provides further support to the idea that the single 
amino acid difference has substantial functional significance that may be related to the 
different perception of pain believe existing between adults and neonates. 
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S.1 Splicing regulation of SCN9A ME exons SN and SA in 
heterologous mini gene systems. 
As with SCN8A gene, in order to be able to better map the individual elements that control 
exon inclusion/exclusion of SCN9A exon 5N and 5A I decided to clone the individual 
exons together with flanking intronic upstream and downstream sequence in the pTB 
minigene system. Creating pTB wt 5N and pTB wt 5A mini gene, the splicing assay was 
performed by transfecting each mini gene plasmid into HeLa cells. Using the pTB wt 5A 
minigene I observed a unique PCR product identified as inclusion of exon SA in the 
mature transcript (Fig. 33, Lane 1). This result was unexpected as SCN9A exon 5A 
inclusion, from the literature is only documented in DRG cells. This result therefore 
demonstrate that the cis-acting regulatory elements that dictate the exclusion of SCN9A 
exon 5A are missing from the DNA fragment inserted in the pTB minigene, or HeLa cells 
may be expressing important trans-acting factors positively regulating SCN9A exon SA 
inclusion. To determine if this latter option was the case I attempted to amplify the 
endogenous transcript in this cells line. In order to ascertain the identify of the 
amplification, as SCN9A exons 5N and 5A are of identical size, the RT-PCR product was 
digested with restriction enzyme, Nde I, specific for only one alternatively spliced isoform, 
specifically 4-SA-6. In figure 33C we can observe that HeLa cells express the SCN9A 
gene, with inclusion of SCN9A exon 5N making the fonner assumption as to why the 
SCN9A exon SA was present in the cDNA the more likely explanation. 
The pTB wt E5N minigene, resulted in a cDNA product corresponding to the use of 
cryptic exon with the exclusion of the SCN9A exon 5N (Fig. 33A, Lane 2), using as a 3' 
splice site an ag in the intron of pTB mini gene and as the 5'splice site the gt in the intronic 
region upstream of exon 5N (Fig. 33B). The use of the cryptic splice site could just be a 
fortuitous occurrence. To establish if the context of pTB minigene system was responsible 
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for aberrant splicing of exon 5N we cloned this exon together with the flanking intronic 
sequence in another minigene system, called p Y7, described in materials and methods. 
After transfection and RT -peR skipping of exon 5N was observed (Fig. 33D). However it 
is also important to note that the p Y7 alpha-tropomyosin exons 2 and 3 splice sites are very 
well defined therefore that this pair is preferred over those we inserted could be expected. 
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Figure 33. Analysis of minigene splicing assay performed with pTB wt E5A and pTB wt 
E5N minigenes. (A) In the uppper panel a schematic representation of the pTB wt E5A and 
pTB wt E5N mini genes. Lower panel: analysis of expression of the constructs in HeLa 
cells. The mRNA produced was analyzed through RT-PCR using oligonucleotides ALFA 
and BRA (black arrows) and agarose gel electrophoresis. On the right hand side of the gel 
is a illustration indicating what each amplification corresponds to. (B) Schematic 
representation of the pTB wt E5N mini gene together with the position of the cryptic splice 
sites used. (e) RT-PCR analysis of the endogenous SCN9A gene in HeLa cells using 
primers in exons 4 and 6. (D) In the upper panel a schematic representation of the pY7 
E5N minigene. Lower panel: The mRNA produced was analyzed through RT-PCR using 
oligonucleotides T7 and SP6 (black arrows) and agarose gel electrophoresis. On the right 
hand side of the gel is a illustration indicating what each amplification corresponds to. 
5.2 SCN9 A ME exons SN and SA splicing in homolgous 
minigene system. 
The results obtained for both SCN9A exons 5N and 5A in heterlogous context highlighted 
the fact that the splicing control of these ME exons would appear to be dependent on a lot 
more than the "core" cis elements that are generally used to defme an exon and depend on 
splicing cis-acting regulatory elements that I failed to include in the minigenes constructs 
thus far made. Therefore to verify this possibility I subcloned a genomic DNA fragment 
from ex on 4 through to exon 6, encompassing both mutually exclusive SCN9A exon 5N 
and 5A (Fig. 34A). Transient transfection experiments with WT SCN9A minigene in HeLa 
cells and subsequent RT-PCR analysis showed that the processing of RNA of the minigene 
in this case was very similar to the endogenous processing of SCN9A previously observed 
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(Fig. 33C). Infact three products are seen on agarose gel electrophoresis, with the lowest 
band representing a cDNA product lacking exons 5N and 5A, the middle and major band 
by far representing a cDNA product including either exon 5N or 5A and the upper band 
representing a eDNA product including exon 5N and 5A. The identify of the major band 
was analysed as before through digestion with Nde I enzyme, showing that although this 
corresponding principally to cDNA product composed of SCN9A exons 4-SN-6 a small 
amount of cDNA compossed of SCN9A exons 4-5A-6 was also present (Fig. 34B, Lane 2). 
Notwithstanding this faet and that normally for genes with mutually exclusive exon pairs, 
no cellular mRNAs have yet been detected that incorporate both exons, despite the fact that 
the introns between them contain functional 5' and 3' splice sites, I deemed this type of 
splicing outcome acceptable to begin to study the mechanisms behind the ME splicing of 
the two exons. 
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Figure 34. Analysis of the alternative splicing of SCN9A exon 5N and 5A in a 
homologous minigene system_ (A) Schematic representation of the minigene SCN9A WT 
that spans SCN9A exons 4 through to 6_ Transfection in HeLa cells followed by RT-PCR 
analysis and agarose gel electrophoresis. On the right hand side of the gel are indicated the 
species of mRNA produced. T7 and SP6 primers are present in the 5' and 3' region, 
respectively, of the translated region in the plasmid. (B) Agarose gel electrophoresis 
analysis of the RT -PCRs, analyzing the effect of the digestion with Nde I enzyme with the 
species of mRNA produced that are indicated on the right hand side of the gel. 
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S.3 TDP43 protein, as a potential trans-acting factor that binds 
the (TG)n repeats in the intron between SCN9A ME exons SN 
and SA. 
Previous research in our laboratory have been identified a TDP43 protein as a trans·acting 
factor binding to the (TG)n repeat region near the 3' splice site of human CFTR exon 9 and 
inducing exon skipping (Buratti, Brindisi et a1. 2004). The intronic sequence between the 
SCN9A ME exons 5N and 5A was observed to be rich in (TG) repeats. It was therefore of 
interest to test if TDP43 is also acting here in an analogous fashion. In order to investigate 
ifTDP43 has a role in SCN9A exons 5N and 5A ME splicing, I tested the RNA processing 
of WT SCN9A minigene in the absence of TDP43 (Fig. 35A). Specifically a double 
transfection distanced 48h from each other of the si·RNA were performed for an effective 
reduction of the endogenous protein as can be observed in HeLa celllysates collected and 
analysed for TDP43 endogenous protein by western blot assay after the double transfection 
(Fig. 35B and C). Following successful knock down of TDP43 in HeLa cells through si· 
RNA, I transfected WT SCN9A minigene construct. The processing of the mini genes was 
then analyzed through RT ·PCR analysis (Fig. 35D) were I observed that knockdown of 
TDP43 had no effect on the previously observed splicing patterns. To differentiate weather 
the principle amplification was composed of the cDNA SCN9A exons 4·5N·6 or 4·5A·6 
this time I performed radioactive labeled hybridisation analysis (Fig. 35E). Briefly three 
probes were used that were specific for exon 4 (common to both eDNA species), exon 5A 
and 5N with the probe being in a region where the nucleotide sequence is different from 
each other (5'-CTCAGCATTGAGAACA·3' on exon 5N, and 5'· 
TICAGCTCTICGAACT·3' on exon 5A). 
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Figure 35. Analysis by si-RNA of the functional role played by TDP-43 protein in a ME 
splicing regulation of SCN9A gene. (A) Schematic representation of the rninigene SCN9A 
WT that spans SCN9A exons 4 through to 6 together with the transfections in HeLa cells, 
before and after the SI experiment. T7 and SP6 primers are present in the 5' and 3' region, 
respectively, of the translated region in the plasmid. (B) The western blot analysis of si-
RNA experiment, depleting the TDP-43 protein. (C) The SI treatment was effective at 
reducing the protein level of the target protein as can be observed comparing the western 
blot signal and that of tubulin used as a control. (D) Agarose gel electrophoresis analysis of 
the RT-PCR analyzing the effect of the knock down experiment using the SCN9A WT 
minigene. On the right hand side of the gel are indicated the species of mRNA produced. 
(E) Southern blot analysis performed on PCR amplicons using radioactive labeled probes 
specific for exon 5A, 4 and 5N. 
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5.4 The Fox-1 protein plays a critical role in mediating splicing 
switches in SCN9 A sodium channel gene. 
Another obvious starting point considering the results obtained with SCN8A exons 18N 
and 18A was to investigate the possible role Fox-l may play in the control of the ME 
splicing of SCN9A exons SN and SA. Inspection of the intron's sequence downstream of 
exon SA, revealed four (T)GCA TG sequences (Fig. 36A), all of them conserved during the 
evolution, further emphasizing potential regulation by Fox-l protein. Furthermore, one 
(T)GCATG motif is also present upstream of of SCN9A exon SN. Several studies have 
indicated that the position of a Fox protein binding site relative to a target ex on will 
determine whether the protein will enhance or repress splicing. Upstream binding sites are 
repressive, but downstream Fox sites generally act as enhancers (LIorian, Schwartz et al.; 
Licatalosi, Mele et al. 2008; Zhang, Zhang et al. 2008; Yeo, Coufal et al. 2009). To 
investigate if Fox-l is also playing a critical role in the ME splicing regulation of the of 
SCN9A sodium channel, I co-tranfected the WT SCN9A minigene with the brain specfic 
Fox-l overexpression plasmid previously described (paragraph 3.6.2). The RT-PCR 
products were than digested with Nde I restriction enzyme, specific only for exon 4-SA-6 
transcript. From the restriction enzyme digestions expression of brain specific Fox-l 
protein in He La cells resulted in almost completely inclusion of SCN9A exon SA in the 
mature transcript (Fig. 36B, compare lines 1 and 2). Simultaneously, the inclusion of exon 
5N was strongly inhibited. Curiously over expression of Fox -1 also reduces the cDNA 
species in which both ME are skipped, SCN9A 4-6 (Fig. 36). 
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Figure 36. Effect of Fox-l protein expression on the mrna splicing of the SCN9A WT 
mini gene. (A) Schematic representation indicating the positions of the (T)GCATG motifs 
in the minigene. The circles are for Fox-l binding sites. T7 and SP6 primers are present in 
the 5' and 3' region, respectively, of the translated region in the plasmid. (B) Agarose gel 
electrophoresis analysis of the RT-PCRs digested with Nde I enzyme of the cotransfections 
experiments with SCN9A WT and Fox-l expression plasmid. The species of mRNA 
produced are indicated on the right hand side of the gel. (C) Analysis of the expression of 
Fox-l protein was monitored by immunoblotting for the Flag epitope tag and amount of 
the protein loaded on the western blot controlled through western blot against tubulin. 
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5.5 Mutational analysis of individual (T)GCA TG repeats in the 
downstream intronic region of exon 5A. 
To detennine which Fox binding sites are most important for the effect observed on the 
splicing of the SCN9A WT minigene, each of the putative Fox binding elements 
downstream of exon 5A was mutated either singly or in combination with the other 
elements by changing one nucleotide in the motifs, in particular TGC8 TG to TGCGAG. 
These mutant minigenes were cotransfected with the Fox-l expression plasmid or with an 
empty vector (CMV-4) as a control. The splicing pattern was assayed by RT-PCR analysis, 
and Fox-l protein expression was assayed by western blot analysis. A complete panel of 
mutant constructs is shown in figure 37A (constructs 1-5). 
The resultant RT-PCRs of the transient transfection experiments using the WT SCN9A and 
four mutant SCN9A minigenes, together with Fox-l expression plasmid were digested 
using Nde I restriction enzyme in order to be able to distinguish between the cDNA species 
exon 4-5N-6 and 4-5N-6. As can be observed in figure 37B the increased inclusion of 
exon 5A in the WT SCN9A minigene was reduced significantly irrespective of which 
motif was mutated notwithstanding the fact that overall some increased inclusion of 
SCN9A exon 5A was still observed and in order to eliminate any effect of Fox-Ion 
splicing all four motifs had to be disrupted. Interestingly it was only when all four motifs 
had being disrupted did an equivalent amount of the cDNA species 4-5 return to the 
amounts observed when the wildtype construct was transfected on its own without the Fox 
expression plasmid. 
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Figure 37. Fox-l enhancer activity is dependent on four (T)GCATG repeats present in the 
intronic region downstream of exon SA. (A) Schematic representation of a complete panel 
of Fox-I binding sites mutants in the SCN9A WT minigene. The circles are for Fox-I 
binding sites. T7 and SP6 primers are present in the 5' and 3' region, respectively, of the 
translated region in the plasmid. (B) RT-PCRs analysis of the transfections of mutant 
constructs (MI, M1I2, M2/3, MI,2,3, Ml,2,3,4) and the SCN9A WT minigenes in HeLa 
cells, without and with overexpression of the brain Fox-l protein, digested with Nde I 
enzyme. The species of mRNA produced are indicated on the right hand side of the gel. 
(C) Quantification of the percentage of exon 5N or SA inclusion and skipping of both was 
performed using ImageJ 1.38 software. Standard deviation values from three independent 
experiments are shown. 
(D) Analysis of the expression of Fox-l protein was monitored by immunoblotting for the 
Flag epitope tag and amount of the protein loaded on the western blot controlled through 
western blot against tubulin. 
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4. Discussion 
Many eucaryotic genes employ alternative splicing as a means of generating protein 
diversity. The differential incorporation of the exons into the mature RNA is often under 
developmental and/or tissue specific control and enables the cell to tailor the protein to suit 
its own particular requirements. The mechanisms that determine which splice sites are used 
and how this process is regulated in different cell types or developmental stages have still 
not be precisely defined. However, much progress has been made in identifying the cis-
acting elements involved in alternative splicing some of which are responsible for setting 
the default competition between splicing events, while others are necessary for the cell 
specific switch to a regulated splicing pattern. Less is known about the trans-acting factors 
involved in regulation of tissue specific splicing. Such factors may be tissue specific 
regulators of splicing or alternatively, tissue specific splicing may be regulated by 
alterations in the concentrations or activities of general splicing factors. 
The work performed in this thesis has begun to unravel the mechanisms behind the ME 
splicing ofSCN8A exons I8A and I8N and SCN9A exons SA and SN. The choice by the 
splicing machinery of ME exons I8A and 18N of the SCN8A gene appears to be 
dependent on at least four distinct cis-acting sequences present in a 620 nucleotide stretch 
of DNA and the trans-acting factors through which these exert their role on the splicing 
outcome. In section 3.2 through deletion mapping I identified an ESS in SCN8A exon 18A 
present between nucleotides +51+26 of the exon that represses the inclusion of this exon in 
mRNA in Hela cells by making the spliceosome A complex less stable. In fact deleting this 
sequence from this exon in a minigene causes the SCN8A exon 18A to be efficiently 
included in the mRNA. Further proof of this elements ability to act as a ESS comes from 
the fact that when placed in a heterlogous exon it was also observed to repress this exon 
inclusion in the final mRNA transcript (Fig. 8C). 
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Through pull down analysis I identified the trans-acting factors that bind to this ESS 
element. Four proteins emerged from this study and they were formally identified by mass 
spectrometry and western blot analyses as hnRNP At, hnRNP JKTBP and PTB/nPTB. I 
also demonstrated that down regulation of these splicing repressors hnRNP A I, PTB/nPTB 
and JKTBP in HeLa cells partially relieves repression of SCN8A exon 18A inclusion in a 
heterologous minigene context. hnRNP At is a splicing repressor protein that, typically, 
but not always recognize splicing silencer elements, and once bound to these elements it 
can interfere with the binding of spliceosomal components or activator proteins. PTB is 
also an abundant RNA binding protein that may binds to the ESS element and it can 
regulate alternative splicing by creating zone of silencing. Till now, there is no evidence of 
the involvement of hnRNP JKTBP protein in splicing, but an VAG present in these 
consensus bindig site that was found in the JKTBP high-affinity binding sites, suggest a 
possible role in alternative splice site switching (Akagi, Kamei et a1. 2000). It is of interest 
to note that the expression patterns for these proteins tie in well with the observed 
inclusion of SCN8A exon t8A neuronal tissue. It is known for example that levels of 
hnRNP Al are high in non neuronal tissues, while there is less of this protein in neuronal 
tissues, such as brain (Clower, Chatterjee et a1.). The presence of a tissue restricted 
counterpart of the ubiquitously expressed PTB was initially detected in rat brain extracts. 
Two independent studies latter identified and cloned nPTB confirming that is a tissue 
restricted paralog of PTB, expressed only in neuronal cells. Data from in vitro analysis 
showed that nPTB can act either neutrally or as a repressor weaker than PTB in preventing 
exon inclusion. The mRNA levels of PTB were also found to decrease rapidly during 
differentiation (Shinozaki, Arahata et a1. t999). There is also an evidence that Fox-112 
strongly activate inclusion of the nPTB exon, presumably by interacting with the two 
downstream hexamer sequences (T)GCATG, in contrast, the effect of Fox-112 on the 
paralogous PTB exon is more subtle (Zhang, Zhang et a1. 2008). The JKTBP protein that 
we identified in a pull down experiments is a 38kDa protein ubiquitously expressed, while 
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in neuronal tissue the major form of JKTBP is a 54kDa protein isofonn witch may have 
different function or less repressive effect than 38kDa JKTBP isoform (Akagi, Kamei et al. 
2000). Thus the fact that the level of expression of the inhibitor factors in neuronal tissue is 
lower than in other tissues or completely absent would mean that this ESS would be less 
functional in this scenario. 
Deletion of the ESS element from SCN8A exon 18A in a homologous minigene context 
containig both ME exon 18N and 18A together with the constitutive exons 17 and 19, 
however resulted in only a minor rescue of SCN8A exon 18A inclusion and furthennore 
the inclusion occurred in concert with that of SCN8A exon 18N. This indicated a much 
more complex ME control mechanism behind the switch of SCN8A exons 18A and 18N 
observed between neuronal and non neuronal cells respectively and clearly of a much more 
intricate control behind the inclusion of SCN8A exon 18A in the mRNA transcript. This 
difference between the heterologous and homologous mini genes was likely due to the fact 
that in the latter multiple cis-acting splicing regulatory signals exist whose cumulative 
effect result in the desired splicing outcome. Indeed, I showed that the 5'ss of SCN8A 
exon 18A is intrinsically weak and therefore easily subjective to the influence of weak cis-
acting splicing elements. Furthennore, the trans-acting factors binding these elements may 
or may not be present in Hela cells. In this regard it had been shown that a (T)GCATG 
motif association with regulated exon 18A has been highly conserved in evolution 
particularly in the downstream proximal intron of vertebrates from fish to humans 
(Underwood, Boutz et al. 2005). This observation supports the hypothesis that this element 
may be a critical component of the splicing switch mechanism that mediates tissue-specific 
splicing events. The (T)GCATG motif has been identified as a binding site for the family 
of Fox proteins (Minovitsky, Gee et a1. 2005). There are three mammalian family 
members, Fox-I, Fox-2 and Fox-3, together with different isofonns of each of them, 
expressed predominantly in neuronal and striated muscle tissues and was therefore feasible 
that these protein played a role in the inclusion ofSCN8A exon 18A in neuronal tissues. 
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This motif revealed itself to be the second cis-acting regulatory element involved in the 
regulation of SCN8A exon 18A. Over expression of different members of the Fox family 
as well as different isoforms (sections 3.6.2 and 3.7 and figures 11 and l3) were all capable 
of increasing the inclusion of the SCN8A exon 18A in the minigene with the ESS deleted 
(SCN8A1~SS EI8A). The increased inclusion due to the brain specific Fox-lover 
expressed was linked to the presence of both (T)GCA TG motifs downstream of SCN8A 
exon 18A (section 3.6.3 figure 12). The fact that no SCN8A exon 18A inclusion was 
observed upon over expression of these proteins in the presence of the ESS enhancer 
(SCN8A WT minigene section 3.6.2 and figure 11) indicated that in the hierarchy of 
splicing regulation of SCN8A exon 18A the hnRNPs binding to the ESS were dominant 
over the presence of Fox protein. It is interesting to note that the over expression of Fox-3 
had a more pronounced effect on SCN8A exon 18A inclusion, but this may be because the 
more efficient entry of this protein into the HeLa cell nucleus. In a recent paper it has been 
shown that all Fox-l and Fox-2 isoforms were diffusely distributed in both the nuclei and 
cytoplasm or predominantly localized to the cytoplasm when they were exogenously 
expressed in cultured cells. In contrast, exogenously expressed Fox-3 isoforms localize 
almost exclusively to nuclei in cultured cells (Kim, Adelstein et al. 2009). I have being 
unable as yet to ascertain the identity of the member of the Fox-l family of proteins 
responsible for the inclusion of exon 18A in its endogenous context as this family of 
proteins share an identical RNA binding domain, all of them binds to the (T)GCA TG 
hexamer in an identical manner and transfecting each of them singularly with the 
SCN8A1~ESS El8A mini gene, I observed that all three Fox proteins are capable of 
activating exon 18A inclusion when they are over-expressed in cultured cells (Section 3.7, 
figure l3). However, some hypothesis as to which is the more likely candidate can be 
made based on the literature. SCN8A exon 18A is included in neurons of CNS and PNS, 
where all three Fox proteins are expressed, but this exon seems to be also included in 
Purkinje cells, in which expression of Fox-3 was not observed (Kim, Kim et al.), thus we 
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can exclude this protein as a specific trans-acting factor necessary for the inclusion of exon 
18A in its endogenous context. This leaves the two other candidates, Fox-l and Fox-2. 
Fox-2 however, is known to have a broader tissue expression, being mainly found in 
neurons and striated muscles, but also in embryo (Kuroyanagi 2009). If we consider the 
fact that SCN8A exon 18N, instead of exon 18A, is included in embryo (Plummer, 
McBurney et al. 1997), this leaves us with Fox-l as the potential candidate behind the 
increased inclusion of SCN8A exon 18A in neuronal cells. I reiterate that this is a 
hypothesis as there may be other or different players in different neuronal tissues. 
A third cis-acting regulatory element, this time responsible for the inclusion of SCN8A 
exon 18N in Hela cells, was mapped between nucleotides +41 and +61 of this exon. 
Deletion of this region in the SCN8A WT minigene gave rise to the minigene 
SCN8A1E18N ~ (section 4.1 and figure 17) whose transfection in cells produced an 
mRNA species that skipped both SCN8A exons 18A and I8N. This ESE was observed to 
bind the SR proteins SC35 and ASF/SF2. Notwithstanding that the removal of these 
proteins through siRNA knock down differed from the deletion of this region with the 
SCN8A exon 18A still being included in the mRNA the fact that we are in the presence of 
an ESE is indisputable. ESE's are known to act in the vast majority of cases through 
members of the SR protein family as discussed in sections 1.3.1. These proteins 
furthermore have being often shown to be able to substitute one another, providing an 
explanation as to the discrepancies between the effect on the splicing outcome between 
deletion of the ESE and the knockdown of the trans acting factors observed to bind to it 
(Caceres, Screaton et al. 1998; Hanamura, Caceres et al. 1998; Tacke and Manley 1999; 
Rooke, Markovtsov et al. 2003; Long and Caceres 2009). 
Finally, a fourth element or rather a fourth region containing two cis-acting regulatory 
elements is present in the intronic region between the two ME exons. In particular, an ISE 
for SCN8A exon 18N is present within the intronic region +10/+227 downstream of the 
SCN8A exon 18N and an ISS for SCN8A exon 18A would appear to be present within the 
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first 150 bp of intronic sequence upstream of the SCN8A exon 18A (section 3.6.1 figure 
10). However these assumptions are based on preliminary data and further experimentation 
is needed in order to refme the area of these cis-acting elements as well as the trans acting 
factors involved. 
The over expression experiments of Fox proteins in Hela cells with the minigene the 
SCN8A1~SS EI8A resulted in a mRNA processing that does not occur in vivo, namely 
the inclusion of both SCN8A exons 18N and 18A in the same transcript. This as mentioned 
previously is most likely due to other cis-acting splicing regulatory signals or indeed lack 
of trans acting factors in Hela cells that play an important role in the determination of the 
splicing event. In order to obtain a clear idea of the role of the Fox protein in the ME of 
SCN8A exons 18A and 18N I turned to a cell line (primary rat trigeminal neurons) in 
which SCN8A exon 18A was included in the transcript rather than 18N. The effect of the 
depletion of neuron specific Fox-I protein on the inclusion of SCN8A exon 18A was 
impressive, as we observed a decrease in the exon 18A inclusion, together with the 
appearance of the transcripts containing exon 18N and skipping of both ME exons (section 
3.9 and figure 16). Unfortunately a formal proof of these results needs further experiments 
mainly to complete the controls, see section 3.9. Although all the direct and circumstantial 
evidence are extremely clear and support the tentative model for the regulation of ME 
splicing of SCN8A exon 18A and I8N presented in figure 25A that takes into account all 
the experimental evidence collected in this thesis. 
The expression of certain SRs, such as ASF/SF2, is highly regulated during development, 
such that, for example, in neurons, at an early stage the amount of ASF/SF2 protein is 
high, but progression during development versus adult organism, shows a decrease in its 
level of expression (Shinozaki, Arahata et al. 1999). From the previous research it appears 
that ASF/SF2 and other members of the SR protein family regulate alternative splicing, 
usually by promoting the use of the proximal 5' splice sites (Caceres and Komblihtt 2002). 
This activity of SR proteins is often counteracted by hnRNP A 1 and related proteins, 
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which generally favor the use of the distal 5' splice sites. Therefore, the antagonistic 
activities of SR proteins and hnRNP AI-like proteins are important determinants of 
alternative 5' splice site selection in vitro and in vivo. The hypothetical mechanism of this 
alternative splicing regulation requires that the relative abundances or activities of these 
antagonistic factors, SRs and hnRNPs, vary under conditions in which the transcript 
undergo differential splicing in different cell types and during development. The 
expression of specific trans-acting factor and the relative levels of SRs and hnRNPs, rather 
than their absolute amounts, together with the myriad of cis-acting elements present in and 
around the SCN8A exons 18A and 18N determine the selection of alternative SCN8A ME 
exons 18A and 18N. 
This type of control in part appears to be what I am beginning to observe behind the 
regulation of SCN9A ME splicing of ME exons 5A and 5N. Although still at the initial 
stages I have been able to determine that one of the principal factors in the switch between 
the two ME exons is the Fox protein. Indeed over expression of Fox-I protein in HeLa 
cells, together with the SCN9A WT minigene resulted in inclusion of SCN9A exon 5A in 
the mature transcript and again was associated with the presence of the (T)GCA TG motifs 
downstream of the exon (section 5.4, figure 23). In this case however the inclusion of 
SCN9A exon 5N was strongly inhibited. The fact that over expression of the Fox protein 
even in Hela cells results in the ME switch unlike the scenario observed with SeN8A ME 
of exons 18A and 18N is indicates that the hierarchy of cis-acting elements in this case 
may be dependent on Fox family of proteins. 
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Figure 38. Model for the Mechanism of SCN8A ME exon 18N and 18A Cell-Type-
Specific Splicing. (A) Schematic representation of all cis and trans acting factors identified 
controlling the inclusion or exclusion of SCN8A ME exons 18N and 18A. An ISE for 
SCN8A exon 18N and and an ISS for SCN8A exon 18A exist in the intronic region 
between the two ME exons however as the trans acting factors through which these 
function have yet to be identified they are denoted X and Y respectively. (B) In tissues 
where SCN8A exon 18N is included such as non neuronal cells, hnRNPs, among which 
hnRNPAl, JKTBP and PTB, bind to the ESS in SCN8A exon 18A repressing its inclusion 
in the mRNA. SR proteins, among which ASF/SF2 and SC35, bind to the ESE in SCN8A 
exon 18N stimulating its inclusion in the mRNA. (C) In tissues where SCN8A exon 18A is 
included, such as neuronal cells, a decrease in the quantity of SR proteins binding the ESE 
in SCN8A exon 18N in combination with a decrease or absence of hnRNPs binding to the 
ESS in SCN8A exon 18A and the increased defmition of the SeN8A exon 18A provided 
by the presence of Fox-l protein occurs. Thickness and fullness of arrows indicate relative 
amount of the trans acting factors. 
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s. Conclusion 
The molecular mechanisms behind the ME splicing of SCN8A exons 18A and 18N have 
been investigated and my analysis is consistent with the model depicted in figure 25, Band 
C in which exon 18A exclusion in non-neuronal tissue is regulated primarily by the 
presence in the cell types of several hnRNPs proteins (hnRNP AI, hnRNP JKTBP and 
PTB) that function through an exonic splicing silencer (ESS) mapped in this exon together 
with the absence of neuron specific Fox-l protein. In neuronal cells the reduction of these 
hnRNPs together with the presence of Fox-l allow the exon to be included. The seN8A 
exon 18N is included in non neuronal cells due to SR proteins that function through an 
exonic splicing enhancer (ESE) mapped in this exon. In neuronal cells the lower levels of 
these SR proteins together with the enhanced recognition of SeN8A exon 18A, due to the 
presence of Fox-l and lower levels of the hnRNPs that bind to the ESS element in SeN8A 
ex on 18A, causes the exon 18N to be skipped and the SeN8A exon 18A to be included. 
It is tempting to hypothesize that considering the results obtained thus far from the study of 
SCN9 A ME splicing of exons 5A an 5N this type of control of mutually exclusive splicing 
through the proteome make-up of a cell type could be influential in the temporal and tissue 
specific splicing of other members of voltage gated sodium channels representing a more 
general mechanism. 
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6. Materials and Methods 
6.1 Chemical reagents 
General chemicals were purchased from Sigma Chemical Co., Merck, Gibco BRL, 
Boehringer Mannheim, Carlo Erba and Serva. 
6.1.1 Standard solutions 
All the solutions are identified in the text when used apart from the following: 
a) TE: 10 mM Tris-HCI (PH 7.4), 1 mM EDTA (PH 7.4) 
b) PBS: 137 mM NaCI, 2.7 mM KCI, 10 mM Na HP04, 1.8 mM KH P04, pH 7.4 
2 2 
c) lOX TBE: 108 gil Tris, 55 gil Boric acid, 9.5 gil EDTA 
d) 6X DNA sample buffer: 0.25 % w/v bromophenol blue, 0.25 % w/v xylene 
cyanol FF, 30 % v/v glycerol in H O. 
2 
e) lOX protein sample buffer: 20 % w/v SDS, 1 M DTT, 0.63 M Tris-HCI (pH 7), 
0.2% w/v bromophenol blue, 20 % v/v glycerol, 10 mM EDTA (PH 7). 
6.2 Enzymes 
Restriction enzymes were from New England Biolabs, Inc. DNA modifying enzymes such 
as Taq Polymerase, DNaseI RNase free, and T4 DNA ligase were obtained from Roche 
Diagnostic. Klenow fragment of E. coli DNA polymerase I and T4 polynucleotide Kinase 
were from New England Biolabs, Inc. RNase A was purchased from Sigma Chemicals Ltd. 
A 10 mg/ml solution of RNase A was prepared in sterile water and boiled for 10 minutes to 
destroy trace amounts of DNase activity. All enzymes were used following manufacturer's 
instructions. 
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6.3 Synthetic oligonucleotides 
Synthetic DNA oligonucleotydes were purchased from Sigma-Genosy and IDT and 
Integrated DNA Biotechnologies. 
6.4 Radioactive isotopes 
32 32 
Radioactive [(l- P]dCTP and [(l- P]UTP were supplied by Amersham U.K. Ltd. 
6.S Bacterial culture 
The E. Coli K12 strain DHS(l was transformed with the plasm ids described in this study 
and used for their amplification. Plasm ids were maintained in the short term as single 
colonies on agar plates at 4 °C but for long term storage they were kept on glycerol stocks 
made by adding sterile glycerol to a final 30% vlv concentration to liquid bacterial 
cultures. Glycerol stocks were stored at -80°C. When necessary, from the glycerol stocks 
an overnight culture of bacteria was grown in Luria-Bertani medium [LB medium: per 
litre: 10 g Difco Bactotryptone, 5 g Oxoid yeast extract, 10 g NaCI, (pH 7.5)]. Bacterial 
growth media were sterilized before use by autoc1aving. When appropriate, ampicillin was 
added to the media at a fmal concentration of 200 J,lg 1m!. 
6.6 Cell culture 
The cell line used for transfection and cotransfection experiments were: 
a) HeLa cells, an immortal cell line derived from cervical cancer cells. 
b) SK-N-BE (ATCC Number: CRL-2271TM), neuroblastoma cell line. 
c) SH-SY-5Y (ATCC Number: CRL-2266 TM), neuroblastoma cell line. 
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d) FII (provided by Prof. E. Wanke, Universita degli studi di Milano-Bicocca), a 
hybrid cell line derived from a mouse NI8TG2 neuroblastoma and rat DRG 
sensory neuron. 
e) PC-12 (ATCC Number: CRL-I721TM), the rat pheochromocytoma cell line. 
f) Primary rat trigeminal neuronal culture. 
6.7 DNA preparation 
6.7.1 Small scale preparation of plasmid DNA from bacterial cultures 
The alkaline lysis of recombinant bacteria was performed by resuspending the bacterial 
pellet in 200 J.tl of ddH20; 150 JlI of solution II (0.2 M NaOH, 1 % w/v SDS) were then 
added and the contents mixed by inversion. 250JlI of solution III (3 M potassium acetate 
pH 5.2) were then added and the contents mixed by inversion. The bacterial lysate was 
then centrifuged in an Eppendorf microcentrifuge at maximum speed and the supernatant 
transferred to a new tube. An equal volume of I: I v/v phenol:chloroform solution was 
added to the supernatant. The tube was then vortexed and centrifuged as above. The 
aqueous phase containing the DNA was transferred to a new tube. An equal volume of 
chloroform was added to the supernatant. The tube was then vortexed and centrifuged as 
above. The aqueous phase containing the DNA was then recovered and the DNA pelleted 
by ethanol precipitation. The fmal pellet was resuspended in 50 J.tl of ddH20 and 5 Jll of 
such preparation were routinely taken for analysis by restriction enzyme digests. 
6.7.2 Large scale preparations of plasmid DNA from bacterial cultures 
For large-scale preparations of plasmid DNA that was necessary for the transfection 
experiments, JetStar purification kit (Genomed) wa s used according to the manufacturer's 
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instructions. In order to get a good amount of plasmid, an inoculation in 50 ml of TB 
medium is grown overnight at 37°C. 
6.S RNA preparation from cultured cells 
Cultured cells were washed with PBS and RNA extracted using RNA Trizol, (Invitrogen 
inc) according to the manufactures instructions. Briefly, 750ul of Trizol was added/p6 well 
and allowed to incubate for 5 minutes. The solution was subsequently moved to a l.5ml 
eppendoff tube and 200ul of ,chloroform was added. After centrifugation at 10000rpm the 
supernatant was collected and the RNA precipitated with 0.75 vol. of isopropanol. The 
pellet was resuspended in 100 J.lI of ddH20 and digested with 1 U of DNase RNase free by 
incubateion at 37°C for 30 minutes, and then the RNA was purified by acid phenol 
extraction. The final pellet was resuspended in 35 J.lI of ddH20 and frozen at -80°C. The 
RNA quality was checked by electrophoresis on 1 % agarose gels. 
6. 9 Estimation of nucleic acid concentration 
An optical density of 1.0 at 260 nm is usually taken to be equivalent to a concentration of 
50 J.lg/ml for double stranded DNA, 40 Ilg/ml for single stranded DNA and RNA, and 
approximately 20 Ilg/ml for single-stranded oligonucleotides samples. The ratio of values 
for optical densities measured at 260 nm and 280 nm is considered as 1.8 for pure sample 
of DNA and 2 for RNA and these are reduced by protein contaminants (Sambrook et al., 
1989). Therefore, these values were used to determinate not only the concentration but also 
the purity of the samples. 
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6.10 Enzymatic modification of DNA 
6.10.1 Restriction enzymes 
Restriction endonucleases were used in the construction and analysis of recombinant 
plasmids. Each restriction enzyme functions optimally in a buffer of specific ionic 
strength. All buffers were supplied by the same company that supplied the enzymes and 
were used according to the manufacturer's instructions. 
For analytical digests 100-500 ng of DNA were digested in a volume of 20 III containing 5 
U of the appropriate restriction enzyme. The reaction was incubated for 2-3 hours at 37°C. 
Preparative digestion was made of 5-10 Ilg DNA using the above conditions and 5 U of 
restriction enzyme for Ilg of DNA in 200 J1l reaction volume. 
6.10.2 Large fragment of E. coli Polymerase I and T4 Polynucleotide 
Kinase 
These enzymes were used to treat PCR products for blunt-end ligation during construction 
of recombinant plasmids. The large fragment of DNA Polymerase I (Klenow) is a 
proteolytic product of E. coli DNA Polymerase I. It retains polymerization and 3'->5' 
exonuclease activity, but has lost 5'->3' exonuclease activity. This was useful for digesting 
specific residues added by Taq DNA polymerase at the 3' terminus to create compatible 
ends for ligation. T4 Polynucleotide Kinase catalyses the transfer of phosphate from ATP 
to the 5' hydroxyl terminus of DNA. It was used for example in the addition of 5'-
phosphate to PCR products to allow subsequent ligation. Klenow fragment (2.5 U) was 
added to 23 J1l of PCR product in 5 mM MgCI buffer. The mixture was incubated at room 
2 
temperature for 10 minutes. EDrA to a final concentration of 0.2 mM, ATP to a fmal 
concentration of 1 mM, 10 U of T4 Polynucleotide Kinase and the proper quantity of 
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Kinase buffer were added to the above mixture and incubated at 37°C for 30 min. The 
enzymes were inactivated by incubation at SO °C for 20 min. 
6.10.3 T4 DNA ligase 
T4 DNA ligase catalyses the formation of a phosphodiester bond between adjacent 3' 
hydroxyl and 5' phosphoryl termini in DNA, requiring ATP as a cofactor in this reaction. 
This enzyme was used to join double stranded DNA fragments with compatible sticky or 
blunt ends, during generation of recombinant plasmid DNAs. 
20 ng of linearized vector were ligated with a 5-10 fold molar excess of insert in a total 
volume of 20 III containing IX ligase buffer and I U of T4 DNA ligase. Reaction was 
carried out at room temperature for 6-12 hours. 
In some reactions synthetic oligonucleotide were included in the reaction. In these cases, 
the amounts added to each reaction to obtain inclusion of oligonucleotides in the resulting 
plasmid were about 100 fold molar excess over the DNA vector. 
6.11 Agarose gel electrophoresis of DNA 
DNA samples were size fractionated by electrophoresis in agarose gels ranging m 
concentrations from O.S % wlv (large fragments) to 2 % wlv (small fragments). The gels 
contained ethidium bromide (0.5 Ilg Iml) and IX TBE. Horizontal gels were routinely used 
for fast analysis of DNA restriction enzyme digests, estimation of DNA concentration, or 
DNA fragment separation prior to elution from the gel. Samples of 20 JlI containing IX 
DNA loading buffer were loaded into submerged wells. The gels were electrophoresed at 
50-SO rnA in IX TBE running buffer for a time depending on the fragment length expected 
and gel concentration. DNA was visualized by UV trans illumination and the result 
recorded by digital photography. 
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6.12 Elution and purification of DNA fragments from agarose gels 
This protocol was used to purify small amounts (less than 1 Jig) of DNA for sub-cloning. 
The DNA samples were electrophoresed onto an agarose gel as described previously. The 
DNA was visualized with UV light and the required DNA fragment band was excised from 
the gel. This slab was cut into pieces, and the JETquick Spin Column Technique 
(Genomed) was used according to the manufacturer's instructions. Briefly, 600 Jil of gel 
solubilisation solution L1 (NaCIO , Na acetate and TBE) were added for each 100 mg of 
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the gel slice pieces and incubated at 55°C for 15 min vortexing every 5 min. The mixture 
was loaded into a prepared JETquick column and it was centrifuged at maximum speed for 
1 min. The flowthrough was discarded. 700 Jil of washing and reconstituted solution L2 
(ethanol, NaCI, EDTA and Tris-HCI) were added into the spin column and after 5 min, the 
column was centrifuged in the same conditions twice. The flowthrough was again 
discarded both times. To elute the bound DNA, 30-50 Jil of pre-warmed sterile water were 
added onto the centre of the silica matrix of the spin column and the system was 
centrifuged for 2 min. The amount of DNA recovered was approximately calculated by 
UV fluorescence of intercalated ethidium bromide in an agarose gel electrophoresis. 
6.13 Preparation of bacterial competent cells 
Bacterial competent cells, E. Coli strains, were grown overnight in 3 ml of LB at 37°C. 
The following day, 300 ml of fresh LB were added and the cells were grown at room 
temperature for 4-5 h until the OD 600 was 0.3-0.4. The cells were then put in ice and 
centrifuged at 4 °C and 1000g for 15 min. The pellet was resuspended in 30 ml of cold 
TSS solution (10% w/v PEG, 5% v/v DMSO, 35mM Mg C12, pH 6.5 in LB medium). The 
cells were aliquoted, rapidly frozen in liquid nitrogen and stored at -80°C. Competence 
was determined by transformation with 0.1 ng of pUC19 and was deemed satisfactory if 
this procedure resulted in more than 100 colonies. 
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6.14 Transformation of bacteria 
Transfonnations of ligation reactions were perfonned using 112 of the reaction volume. 
Transfonnation of clones was carried out using 20 ng of the plasmid DNA. The DNA was 
incubated with 60 JlI of competent cells for 20 min on ice and at 4rC for 1.5 minutes. At 
this point 60 JlI of LB were added and the bacteria allowed to recover for 10 min at 37°C. 
The cells were then spread onto agarose plates containing the appropriate antibiotic. The 
plates were then incubated for 12-15 hours. When DNA inserts were cloned into p-
galactosidase-based virgin plasmids, 25 JllofIPTG 100 mM and 25 JlI of X-Gal (4 % w/v 
in dimethylfonnamide) were spread onto the surface of the agarose before plating to 
facilitate screening of positive clones (white colonies) through identification of p-
galactosidase activity (blue colonies). 
6.15 Amplification of selected DNA fragments 
The polymerase chain reaction was perfonned on genomic or plasmid DNA following the 
basic protocols of the Roche Diagnostic Taq DNA Polymerases. The volume of the 
reaction was 50 J.Ll. The reaction buffer was: IX Taq buffer, dNTP mix 200 J.1M each, 
oligonucleotide primers 1 nM each, Taq DNA Polymerase 2.5 U. As DNA template, 0.1 ng 
of plasmid or 100-500 ng of genomic DNA were used for amplification. When a DNA 
fragment longer than 2000bp was amplified, DMSO 3% was also added to the mixture. 
The amplification conditions are described for each particular PCR. The amplifications 
were perfonned on a Cetus DNA Thennal Cycler (Perkin Elmer) or on a Gene Amp PCR 
System (Applied Biosystems). 
6.16 Sequence analysis for cloning purpose 
Sequence analysis of plasmid DNA was perfonned using the CEQ 2000 sequencer 
(Beckman Coulter) or sequencing service (BMR Genomics). The plasmid DNA of interest 
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(approximately 100 ng) was purified through a MicroSpin S-400 HR Column (Amersham 
Phannacia Biotech). The DNA was then amplified using fluorescent labeled dideoxy 
nucleotide tenninators according to the manufacturer's instructions. The samples were 
analized by loading them into the automatic sequencer. 
6.17 Minigene systems 
In this study, the splicing pattern of several exons has been investigated through the use of 
two mini gene backbones. 
The PTB mini gene is a hybrid construct containing exons from a-globin and fibronectin, 
under the control of the a-globin promoter. The intronic region between the two 
fibronectin exons contains a unique Nde I site in which the exon along with its flanking 
regions with and without the nucleotide substitution under study can be inserted. In fact 
this system allows us to insert a single exon with its intronic flanking regions, which could 
contain splicing regulatory elements, and analyze its splicing outcome. 
In this study, the splicing pattern of one exon has been investigated by using pY7 
minigenes/splicing-construct which contains the alpha-tropomyosin exons 2 and 3 
separated by a lil-nucleotides synthetic intron sequence with a 5'ss partially derived from 
the human beta-globin gene. The SP6 promoter controls the expression of this reporter 
minigene inserted into the pBMN vector backbone. 
6.17.1 Generation of minigenes 
In this thesis several mini genes have been created and this has been done through PCR 
amplification of the exon under study with its intronic flanking regions, treatment with 
Klenow-Kinase enzymes as described previously (section 6.10.2), purification from 
agarose gel (section 6.12) and cloning in pUC19 vector (Fennentas) using the enzyme 
restriction site Sma I and through sequencing using oligonucleotides Universal For and 
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Rev the absence of any other nucleotide variation in the entire amplified fragments was 
checked. Following sequencing in order to check the nucleotide sequence to be correct, the 
subcloning in pTB or pY7 minigenes is performed using the enzyme restriction site Nde I. 
The orientation of the inserted fragment in the pTB minigene was checked through colony 
PCR using, respectively, specific oligonucleotides forward and pTB1950 antisense (as) 
that recognized respectively the inserted fragment and the pTB plasmid; thus the 
amplification of the product could have been possible only in presence of a fragment with 
the correct orientation. Subsequent positive clones were further controlled through 
sequencing using oligonucleotide pTB1698 sense (s). 
In addition, in this work one construct was created by inserting the fragment of interest in 
the pY7 minigene system using an Nde I restriction site present in this minigene, together 
with the two alpha-tropomyosin exons. The DNA fragment containing the fragment of 
interest together with flankng alpha-tropomyosin exons was now amplified by PCR 
reaction using the two external oligos in the pY7 minigene, pY7-KpnI-sense and pY7-
Xbal-antisense. Finally, the obtained DNA inserts was digested with the Kpnl and XbaI 
enzymes (New England Biolabs), gel extracted (EuroClone) and ligated with T4 DNA 
ligase (New England Biolabs) into the pcDNA3 plasmid using the KpnI and Xbal 
restriction sites, which carries the CMV promoter suitable for in vitro coupled 
transcription-splicing and in cell culture experiments. When it was possible to make a 
minigene consisting of at least two exons three introns I preferred to make a homologous 
mini gene by cloning of the appropriate fragment in pcDNA3 vector, using specific primers 
containg BamH I and Xho I restriction sites, via PCR method. The splicing assay was 
performed by transfecting each mini gene into HeLa cells. 
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Universal forward 
5'GT AAAACGACGGCCAGT3' 
Universal reverse 
5'GAAACAGCTATGACCAT3 ' 
pTB1689s 
5'CTAAAACAGTTTTGGAA TA3' 
pTB1950as 
5'CGAAGAGGCTTAAGTTGCCAC3 ' 
pY7-KpnI-s 
5' GGGGTACCGAATACAAGCTTGTCGAG3' 
pY7-Xba I-as 
Rev: 5'GCTCTAGAGTCGGACCTG3' 
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SV40 fibronectin fibronectin poly(A) 
. ~__ I axon 3-3' axon 3-5' signal 
·· .. ·-L-LJ--I::=II }-I -~----.. --[III =:J~ ..... 
alpha-globin alpha-globin 
axon 1 axon 2 Ndal 
I 
BstEil 
I 
alpha-globin 
axon 3 
BstEil 
.... J:[L_J----r--.-,,---t_--ll ..... 
alpha-tropomyosin 
axon 2 Ndel 
alpha-tropomyosin 
exon 3 
I 
8amHI 
Figure 39. Schematic representation of the reporter minigenes used in this study. 
Upper panel: pTB minigene. Lower panel: p Y7 minigene. 
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6.17.2 PCR amplifications and Quick Change Mutagenesis PCR method 
External primers that contained an restriction site were used for the PCR amplifications of 
the fragments that were subsequently cloned, as described previously, in the pTB mini gene 
system or pcDNA3 vector (for the primers that were used see section 6.17.3). 
Two steps PCR technique has been used for generating the hybrid mutants using different 
minigenes as a templates. A first set of PCR reactions was perfonned using a combination 
of primers: forward external primer and reverse internal primer and forward internal and 
reverse external primer. The DNA fragments were gel extracted and used as templates for 
a second PCR reaction using both external primers. The DNA insert obtained was then 
cloned into pTB vector using the Ndel restriction site or pcDNA3 vector using BamH I and 
Xho I restriction site (for the primers that were used see section 6.17.3). 
Mutagenesis and deletions were also at times perfonned using the QuikChange site-
directed methodology. Briefly, oligonucleotide primers, each complementary to opposite 
strands of the area of interest and carrying the mutant nuc1eotides are designed and utilized 
during temperature cycling by PfuTurbo DNA polymerase. Incorporation of the 
oligonucleotide primers generates a mutated plasmid containing staggered nicks. 
Following temperature cycling, the product is treated with Dpn I. The Dpn I endonuclease 
(target sequence: 5'-Gm6ATC-3') is specific for methylated and hemimethylated DNA 
and is used to digest the parental DNA template and to select fO,r mutation-containing 
synthesized DNA. DNA isolated from aImost all E. coli strains is dam methylated and 
therefore susceptible to Dpn I digestion. The nicked vector DNA containing the desired 
mutations is then transfonned into competent cells. The small amount of starting DNA 
template required to perfonn this method, the high fidelity of the PfuTurbo DNA 
polymerase, and the low number of thennal cycles all contribute to the high mutation 
efficiency and decreased potential for generating random mutations during the reaction (for 
the primers that were used see section 6.17.3). 
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Briefly, two separate primer extension reactions were set up (one for each forward and 
reverse primer) containing: 
5 microliters lOX Pfu Buffer (supplied with enzyme) 
1 microliter 10 micromolar primer (0.13 microgram 4S-mer) 
0.1 - 0.2 microgram plasmid template 
1 microliter 10 mM dNTP mix 
H20 to a final volume of SO microliters 
1 microliter Pfu turbo polymerase (Stratagene) 
PCR reaction was done using standard conditions: 
1. 94 deg, 30 sec 
2.95 deg, 30 sec 
3.55 deg, 1 min 
4.68 deg, 2 min/kb up to 10 KB plasmid 
Digestion of amplification product was done by adding into a PCR reaction 10 units of 
Dpn I enzyme, mixed well and incubated at 37 deg for at least one hour. 1 microliter of the 
reaction was used to transform DHSa competent cells. 60 microliters of cells on separate 
plates were plated. 
IS5 
6.17.3 A complete list of the primers used in the section 3 in this thesis. 
The amplifications for the generation of the fragments to clone in the mini gene were 
perfonned through using the following oligonucleotides. 
The results section 3.1.1. 
External primers that contained an Nde I restriction site were used for the PCR 
amplifications of the fragments that were subsequently cloned as described previously in 
the pTB minigene system using as a template SCN8A WT minigene (see bellow). 
Name of the minigene: pTB SCN8A El8N 
For: 5'GGAATTCCATATGGAAATAGCACTGAGATCTTCATATATG 3' 
Rev: 5'TTCCATATGGAATTCCGGGAAGAGAAAATCGAGAAGGC 3' 
Name of the minigene: pTB SCN8A El8A 
For: 5'GGAA TTCCATATGGAAAATCTGTGTCTGCAGTGCTAG 3' 
Rev: 5'TTCCATATGGAA TTCCGCTGCATCACAGAATTCGTGTTTG3' 
The results section 3.1.2 
Quickchange site directed mutagenesis PCR technique has been used for generating the 
hybrid mutant pTB SCN8A E 18A ACE I using pTB SCN8A E 18A mini gene as a template 
using two primers: 
Name of the minigene: pTB SCN8A El8A ACEI 
For: 5'CTTT A TTCT AACAGAGAGGAATGGCTGTTTTCTTTCTTTT3' 
Rev: 5'GAAAGAAAACAGCCA TTCCTCTCTGTT AGAA T AAAGCCCCTAGCAC3' 
Two steps PCR technique has been used for generating the hybrid mutants using both pTB 
SCN8A E18N and pTB SCN8A El8A as a templates. A first set of PCR reactions was 
perfonned using a combination of primers: forward external primer and reverse internal 
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primer and forward internal and reverse external primer. The DNA fragments were gel 
extracted and used as templates for a second PCR reaction using both external primers. 
The DNA insert obtained was then cloned into pTB vector using the NdeI restriction site. 
Name of the minigene: pTB El8A Int.up. E18N 
For External: 5'GGAA TTCCATATGGAAA TAGCACTGAGATCTTCATA T ATG 3' 
Rev Internal: 3' ATCTGTA TTCTTTTCCATAGGTCTCTTT AGTCAGC5' 
For Internal: 5'TCCATAGGTCTCTTTAGTCAGCCTT A3' 
Rev External: 5'GGAA TTCCATATGGAAA TAGCACTGAGATCTTCATATATG 3' 
Name of the minigene: pTB El8A Int. up and down. exon E18N 
For External: 5'GGAA TTCCATATGGAAA TAGCACTGAGATCTTCATATATG 3' 
Rev Internal: 3 'CACGA TTTGAAGGGATGAGGGT AAGGCTCT5' 
For Internal: 5'GAAGGGATGAGGGT AAGGCTCTTGTCGTCTGTTC3' 
Rev External: 5'TTCCATATGGAA TTCCGGGAAGAGAAAA TCGAGAAGGC 3' 
Name of the minigene: pTB E 18N Int. down. exon E 18A 
For External: 5'GGAA TTCCATATGGAAA TAGCACTGAGATCTTCA TATATG 3' 
Rev Internal: 3' AGACTGT AAAGGGCGAGGGT AAGATACTA5' 
For Internal: 5' AAGGGCGAGGGT AAGAT ACTAAGAGCAG3' 
Rev External: 5'TTCCATATGGAA TTCCGCTGCATCACAGAA TTCGTGTTTG3' 
Name of the minigene: pTB El8N Int. up and down. exon EISA 
For External: 5'GGAA TTCCATATGGAAAA TCTGTGTCTGCAGTGCTAG 3' 
Rev Internal: 3 'CTCTTCTGTTTCTGTGTAGGTACCA IT AM T5' 
For Internal: 5'CTGTGTAGGTACCA IT AAA TITGTC3' 
Rev External: 5'TTCCATATGGAA ITCCGCTGCATCACAGAA TTCGTGTTTG3' 
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The results section 3.2 
Quickchange site directed mutagenesis PCR technique has been used for generating the 
hybrid mutant mini genes using pTB SCN8A El8A minigene as a template. 
Name of the minigene: pTB SCN8A El8A 
6-27.1 
For: 5'TCTGTGTAGGTCTCTGCCCTGGGCTACTCGGAACT3' 
Rev: 3 'TCTCTTCTGTTTCTGTGTAGGTCTCTGCCCTGGGC5' 
27-43.1 
For: 5'T ATAGCT AAACTAGGTGCCAT AAAGTCCCT3' 
Rev: 3'CTTT AGTCAGCCTT ATAGCT AAACTAGGTGCCA5' 
43-69.1 
For: 5'CTACTCGGACTT AGGACCCT AAGAGCTTTG3' 
Rev: 3'T AGCT AA TGCCCTGGGCTACTCGGACTT AGGACCCT5' 
The results section 3.2.1 and 3.3 
For the in vitro transcription analysis the RNA was transcribed from PCR templates 
amplified from the pTB SCN8A El8A and pTB SCN8A El8A 6-27 .1. A T7 promoter 
sequence was added towards the 5' end of the templates using forward primer carrying T7 
sequence and the primer. 
Name of the minigene: Ex. 18A WT and Ex. 18N.1ESS 
For: S'T ACGT AA TACGACTCACTATAGGGTGCT AGGGGCTTTA TTCT AACAC3' 
Rev: 3 'GAAACTGTTT AAGCA TGCTAGAACTGATS' 
Name of the minigene: pTB SCN8A WT El8A T7 promoter 
For: S'T ACGT AA TACGACTCACTATAGGAGGTCTCTTT AGTCAGCCTT AT3' 
Rev: 3 'TCCCTT AGGACCCT AAGAGCTTTGAGACCCTT AAGS' 
Name of the minigene: pTB SCN8N.1ESS El8A T7 promoter 
For: S'T ACGTAA TACGACTCACTATAGGAGGTCTCTGCCCTGGGCTACTCGG3' 
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Rev: 3 'TCCCTT AGGACCCT AAGAGCTTTGAGACCCTT AAG5' 
The results section 3.4 
Human SCN8A WT minigene was amplified from genomic DNA using fOIWard primer 
containing BamH I restriction site and reverse with the Xho I restriction site. Amplification 
of this fragment was perfonned by PCR analysis. 
Name of the minigene: SCN8A WT 
For: 5'CGGGATCCCGATGCCTTCGAGGACATCTACA TT3' 
Rev: 5'GGCGAGCTCGCCCTATACTTGAAGAAGGGCCAGGT3' 
Quickchange site directed mutagenesis PCR technique has been used for generating the 
hybrid mutant minigenes using SCN8A WT minigene as a template. 
Name of the minigene: SCN8A1~SS El8A 
For: 5'GTCTCTGCCCTGGGCTACTCGGAACTAGGTG3' 
Rev: 5'CTCTTCTGTTTCTGTGTAGCGTCTCTTGCCCTGGG3' 
Name of the minigene: SCN8A1+ESS E18N 
For: 5'TAGGTACCTTTAGTCAGCCTT ATAGCTAATTAATGGGGACTTCTGGGA3' 
Rev:3 'GTA TTCTTTTCCATAGGTACCTTTAGTCAGCCTT ATAGCTAA TT AA TGGG 
G5' 
The results section 3.5 
Quickchange site directed mutagenesis PCR technique has been used for generating the 
hybrid mutant minigenes using SCN8A1~SS El8A mini gene as a template. 
Name of the minigene: SCN8A1~SS EI8A, 5'ss Mut. El8A 
For: 5'GAAGGGATGAAGGT AAGTT ACTAAGAGCAGCTGATC3' 
Rev: 5' AGCTGCTCTT AGT AACTT ACCTTCATCCCTTCAAA TCGTGAT AAGGC3' 
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The results section 3.6.1 
Two steps PCR technique has been used for generating the hybrid mutants using both 
SCN8A WT and SCN8A1.:1ESS El8A as a templates. A ftrst set of PCR reactions was 
perfonned using a combination of primers: forward external primer and reverse internal 
primer and forward internal and reverse external primer. The DNA fragments were gel 
extracted and used as templates for a second PCR reaction using both external primers. 
The DNA insert obtained was then cloned into pcDNA3 vector using the BamH I and Xho 
I restriction sites. 
Name of the minigene: .:1 E18N 
For External: 5'CGGGATCCCGATGCCTTCGAGGACATCTACA TT3' 
Rev Internal: 3' A TIT ATCTGTA TTCTTITCCATAGGTAAGGC5' 
For Internal: 5'TA TTCTrTTCCATAGGTAAGGCTCTTGTCGTCTGTTC3' 
Rev External: 5'GGCGAGCTCGCCCTATACTTGAAGAAGGGCCAGGT3' 
Name of the minigene: .:1 EI8N/.:1 Int. El8NlE18A 
For External: S'CGGGATCCCGATGCCTTCGAGGACATCTACA TT3' 
Rev Internal: 3' A TIT ATCTGTA TTCTTITCCATAGGTCTCTTT AS' 
For Internal: 5' A TTCTTTTCCATAGGTCTCTTT AGTCAGCCTTAT3' 
Rev External: S'GGCGAGCTCGCCCTA TACTTGAAGAAGGGCCAGGT3' 
Name of the minigene: .:1 Int. E18NlE18A +10/+227 bp 
For External: S'CGGGATCCCGATGCCTTCGAGGACATCTACA TT3' 
Rev Internal: 
S'TAGCACTGGAAGAGAAAATCGAGAAGGCGGTAGAACATACAC3' 
For Internal: S'GA TTTTCTCTTCCAGTGCTAGGGGCTIT A TTCT AAC3' 
Rev External: S'GGCGAGCTCGCCCTATACTTGAAGAAGGGCCAGGT3' 
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The results section 3.6.3 and 4.1 
Quickchange site directed mutagenesis PCR technique has been used for generating the 
hybrid mutant minigenes using SCN8A! ~SS E 18A minigene as a template. 
Name of the minigene: Fox b.site Ml SCN8A!~SS/tgcatg > tgcgtg 
For: S'CAGCTGATCCITCTGCGTGCCAGTGGAAACTGTIT AAGC3' 
Rev: 3 'CT AAGAGCAGCTGATCCITCTGCGTGCCAGTGGAS' 
Name of the minigene: Fox b.site M2 SCN8A!~SS/gcatg > gcgtg 
For: S'CTGTTT AAGCGTGCTAGAACTGA TCACATG3' 
Rev: 3 'CCAGTGGAAACTGTIT AAGCGTGCTAGAS' 
Name of the minigene: SCN8NE18N .1.1 
For: S'TCCATAGGTACCTT AATGGGGACITCTGGGA3' 
Rev: 3 'CTGT A ITCTTITCCATAGGTACCIT AATGGGGAS' 
Name of the minigene: SCN8NE18N A2 
For: 5'TCTGGCITAATGCAGAGACTGTAAAGGGC3' 
Rev: 3 'CCA IT AAA TITGTCTGGCIT AA TGCAGAGACTS' 
Name of the minigene: SCN8NE18N A3 
For: 5'TGGGGACTTCTAGGGCGAGGGT AAGGCTCTTG3' 
Rev: 3 'CIT AA TIT AA TGGGGACTTCTAGGGCGAGS' 
Name of the minigene: SCN8NE 18N .1.4 
For: 5'TGGGGACTTCTAGAGACTGT AAAGGGCGA3' 
Rev: 3 'CIT AA ITT AA TGGGGACTTCTAGAGACTGTAS' 
Name of the minigene: SCN8NE18N AS 
For: S' ACITCTGGGACCTAGGGCGAGGGT AAGGCTCT3' 
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Rev: 3'T AA TIT AA TGGGGACTTCTGGGACCTAGGGCGAGGS' 
Name of the minigene: SCN8A1E18N d6 
For: 5'TCTGGCTT AAGGGACCTGCAGAGACTGT AAAG3' 
Rev: 3'T AAA ITTGTCTGGCIT AAGGGACCTGC5' 
The results section 4.2 
For the in vitro transcription analysis the RNA was transcribed from PCR templates 
amplified from the pTB SCN8A E18N and pTB SCN8A E18N AJ. A T7 promoter 
sequence was added towards the 5' end of the templates using forward primer carrying T7 
sequence and the primer. 
Name of the minigene: pTB SCN8A E18N andpTB SCN8A E18N d3 
For: 
5'TACGT AA TACGACTCACTATAGGAAGGTACCA IT AAA TTTGTCTGGCTTA3' 
Rev: 3' AGGGCGAGGTGAAGGCTCITGTCGTC5' 
The results section 5.2 
Human SCN9A WT minigene was amplified from genomic DNA using forward primer 
containing BamH I restriction site and reverse with the Xho I restriction site. Amplification 
of this fragment was performed by PCR analysis. 
Name of the minigene: SCN9A WT (For BamH IIRev Xho I) 
For: 5'CGGGATCCCGA IT ACACITIT ACTGGAA TATATAC3' 
Rev: 3 'GAGTGAAGAAGAAGACTTT AGAA TAGGGCGAGCTCGCCS' 
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The results section 5.1 
External primers that contained an Nde I restriction site were used for the PCR 
amplifications of the fragments that were susequently cloned as decribed previously in the 
pTB mini gene system using as a template SCN9A WT mini gene (see bellow). 
Name of the minigene: pTB wt ESA 
For. S'GGAA TTCCATATGGAA TA TTTGGGAGTTGTTCTTTGTTCG3' 
Rev: S'TTCCATATGGAA TTCCAGCCAAGTAGTCATCCTCATC3' 
Name of the minigene: pTB wt ESN 
For. S'GGAATTCCATATGGAACTTGCAGAACTATACATTTAAAAT3' 
Rev: S'TTCCATATGGAA TTCCAAACGAACAAAGAACAACTCCCAA3' 
The results section 5.5. 
Quickchange site directed mutagenesis PCR technique has been used for generating the 
hybrid mutant mini genes using SCN9A WT minigene as a template. 
Name of the minigene: SCN9A Fox b.site Ml 
For: S'GTTT AATCAA TTGCGTGGGTCTTTAGGATGAGGATGACT3' 
Rev: 3 'CTTTGAGTTT AA TCAA TTGCGTGGGTCTTT AGS' 
Name of the minigene: SCN9A Fox b.site M2/M3 
For: S'T AAA TA TCAGCGTGGGGA TA TTGCGTGACATTGTTTTTT ATTTTTTC3' 
Rev: 3' AGAGA TCATAAA TATCAGCGTGGGGATA TTGCGTGACATTG3' 
Name of the minigene: SCN9A Fox b.site M4 
For: S'TGA TAT AA TGCGTGACTTTCT AGGAAAGCTTG3' 
Rev: 3 'TCA TTGA TTTGATAT AA TGCGTGACTTTCTAGS' 
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6.18 Maintenance and analysis of cells in culture 
HeLa, SK-N-BE, SH-SY-5Y, FII and cell lines was grown in Dulbecco's Mem with 
Glutamax I (Gibco) (Oulbecco's modified Eagle's medium with glutamine, sodium 
pyruvate, pyridoxine and 4.5 gil glucose) supplemented with 10% fetal calf serum (Euro 
Clone) and Antibiotic Antimycotic (Sigma) according to the manufacturer's instructions. 
Plates containing a confluent monolayer of cells were treated with 0.1 % w/v trypsin as 
follows. Cells washed with PBS solution, were incubated at 37°C with 1-2 ml of 
PBSIEOTAItrypsin solution (PBS containing 0.04% w/v EDTA and 0.1% w/v trypsin) for 
2 minutes or until cells were dislodged. After adding 10 ml of media, cells were pelleted 
by centrifugation and resuspended in 5 ml pre-warmed medium. 1-2 ml of this cell 
suspension was added to 10 ml medium in a fresh plate and was gently mixed before 
incubation. 
6.19 Maintenance and differentiation of the PC-12 cell line in culture 
Rat pheochromocytoma (PC-12) cells were grown in Dulbecco's Minimal Eagle Media 
(OM EM; CellGro, Manassas, VA) supplemented with 10% heat-inactivated horse serum 
(HS, Sigma-Aldrich), 5% fetal bovine serum (FBS, Hyclone) and 1% 
antibiotic/antimycotic mixture (Gibco). Cells were plated in 35-mm collagen-coated dishes 
(10 Jlglml, Sigma). Cultures were mantained at 37°C in a humidified atmosphere 
containinf 5% C02 until reaching the desired confluence (- 50% or -90%). To differentiate 
PC-12 cells (dPC-12), DMEM containing 1% FBS and 1 % antibiotic/antimycotic mixture, 
was supplemented with 50 ng/ml of Nerve Growth Factor 7S (Sigma) for 10 days. 
6.20 Trigeminal neuron cells preparation 
P9-P12 rats were anesthetized by diethyl ether and decapitated. Trigeminal ganglion (TG) 
were rapidly excised and placed in F12 medium (Sigma) without serum and cleaned from 
meningeal residues. For each animal (2TGs) enzymatic dissociation was carried in 500 
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microliters of F12 medium containing 0.25mg/ml trypsin, 1 mg/ml collagenase and 0.2 
mg/ml DNAse at 37°C in agitation for 25 min. The digestion was stopped by adding 50 
microliters of FBS. The cells were dissociated mechanically through pipetting. After 
centrifugation of the suspension for 3 min at 1000 rpm, the supernatant was removed and 
cells were resuspended in F12 +10% FBS (500 microliters). Cells were plated on 
collagene-coated (10 J.lg/mL) 12-well treated Petri dishes with 500 microliters of the F12 
medium with 10% fetal calf serum and left at 37°C 5% C02. 
Enzimatic Solution used for 50ml F12 + PIS (without serum) 
ENZYME CON CENTRA TION UNITS COMPANY + 
COD 
trypsin 0.5 mg/mt 6000BAEE Sigma T -1005 
units/mg 
collagenase 1 mg/ml 300 units/mg Sigma c-o 130 
DNAse 0.2 mg/ml 2,580 kunits/mg Sigma D-5025 
solid 
6.21 Transfections 
The DNA used for transfections was prepared with JetStar purification kit (Genomed) as 
previously described. Liposome-mediated transfections of 3xlO(5) HeLa cells were 
perfonned using Effectene reagent (Qiagen). 0.5 ~g of construct DNA was mixed with 4 ~l 
of Enhancer for each transfection and the mixture was incubated at room temperature for 5 
minutes to allow the condensation of the DNA. Then, 5 ~l of Effectene were added to the 
mixture and an incubation of 10 minutes has been perfonned. After the addition of 500 ~l 
of complete culture medium the mixture was added to the cells in 3 ml of the same 
medium and incubated at 37°C. After 6 h the medium was replaced with fresh medium and 
12 h later, the cells were harvested. RNA isolation followed as described. 
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6.22 Contruction of the expression plasmids. 
Muscle specific Fox-l and brain specific Fox-I, Fox-2 and Fox-3 were synthetically made, 
the cDNA sequence of whoms NCBI Reference Sequence is: NM_145891.2, 
NM_001l42334.1, NP _001026865.1 and NP _001076044.1 respectively. The synthetic 
cDNA was delivered in GenScript's standard vector pUC57 (GenScript). Defined cDNA 
fragments encoding various Fox proteins were generated by digestion with appropriate sets 
of enzymes, Hind III and Kpn I for muscle specific Fox-I, brain specific Fox-l and Fox-3, 
Hind III and Xba I for brain specific Fox-2, and cloned in the CMV-4 vector, using the 
same restriction sites that were used for digestion, which contained a flag epitope tag. 
6.23 Cotransfections 
In cotransfection experiments, cells were transfected with 0.5 J.lg of mini gene and 0.5 J.lg of 
muscle specific Fox-I, brain specific Fox-I, Fox-2 and Fox-3 separately or ASF/SF2 and 
SC35 expression plasm ids provided by Javier F. Caceres. 
6.24 mRNA analysis by Polymerase Chain Reaction 
6.24.1 cDNA synthesis 
In order to synthesize cDNA, the 3 J.lg of total RNA extracted from cells were mixed with 
random primers (Pharmacia) in a final volume of 20 J.ll. After denaturation at 70°C the 
RNA and the primer were incubated for 1 hour at 37°C in the following solution: IX First 
Strand Buffer (Gibco), 10 mM Drr, 1 mM dNTPs, RNase inhibitor 20 U (Ambion) and 
Moloney murine leukemia virus reverse transcriptase 100 U (Gibco). IJ.lI of the eDNA 
reaction mix was used for the PCR analysis. 
166 
6.24.2 eDNA analysis 
PCR analysis of cDNA was carried out for 35 cycles (94°C 30 sec, 58°C 30 sec, 72 °c 1 
min) in 50 J.lI reaction volumes using the following oligonucleotides which recognize 
specific regions of the pTB mini gene or pcDNA3 expression vector. 
Oligonucleotide name pTB minigene Sequence ofthe oligonucleotide (5'-3') 
ALFA CAACTTCAACTCCTAAGCCACTGC 
BRA GTCACCAGGAAGTTGGTTAAATCA 
Oligonucleotide name pcDNA3 vector Sequence of the oligonucleotide (5'-3') 
T7 AATACGACTCACTATAG 
SP6 ATTTAGGTGACACTATAGAATA 
6.25 Small interfering RNA (si-RNA) transfections 
Si-RNA transfections were perfonned in cells using Oligofectamine Reagent (Invitrogen) 
according to the manufactures instructions. Briefly, 40-50% confluent 35 mm well plates 
were prepared. 25 J.1.M of si-RNA were mixed with 175J.lI of Opti-MEM medium and, 
separately, 5 J.lI Oligofectamine with 15 J.1.l of Opti-MEM medium. 
The si-RNA sequence used for depletion were: 
HumanlRat Fox-l 5' -CCGUUUUGCUCCAUACUAAUU-3' (Sigma); 
Human hnRNP At 5'-CAGCUGAGGAAGCUCUUCA-3' (Sigma); 
Human JKTBP 5' - GUUGUAGACUGCACAAUUA-3' (Sigma); 
Human PTB 
HumannPTB 
5'-GCCUCUUUAUUCUCUUCGG-3'; (provided by C.W.J. Smith) 
5'-GAGAGGAUCUGACGAACUA-3' (provided by C.W.J. Smith) 
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Luciferase 5'- GCCAUUCUAUCCUCUAGAGGAUG-3' (Dharmacon). 
Small interfering RNA oligonucleotide specific for TDP-43 is a Y. M. Ayala personal 
communication. The samples were incubated for 7 min at room temperature. Then the 
Oligofectamine mix was added to precomplexed siRNA mix and incubated for 20 min at 
room temperature. Finally, the mix was dropped onto the cells maintained in 800J.lI of 
Opti-MEM without antibiotics and FBS. After 24h, a second siRNA transfection was 
performed as described above, followed by the trasfection with the different minigenes. 
The following day, cells were harvested for RNA extractions, RT-PCR analyses and 
Western blots. Particularly, western blot was performed in order to check the depletion of 
each protein. 
6.26 Denaturing polyacrylamide gel electrophoresis (SDS·PAGE) 
, 
Whole-protein extracts were obtained by cell sonication in lysis buffer (IX PBS and IX 
Protease inhibitor cocktail). Upon quantification with Bradford assay, proteins from each 
sample were mixed with lOX protein loading buffer (20% w/v SDS, 1M DTT, 0.63M Tris-
HCI pH 7, 0.2% w/v bromophenol blue, 20% v/v glycerol, lOmM EDTA pH 7). 
Conventional slab gel SDS PAGE (Laemmli, 1970) was performed in vertical gels with the 
required percentage of polyacrylamide (37,5:1 acrylamide:bis-acrylamide, ProtoGel, 
National Diagnostics), depending on each case. The gels were run at 40 rnA in IX SDS-
PAGE running buffer (50 mM Tris, 0.38 M glycine, 0.1 % w/v SOS). After running, gels 
were either stained with coomassie Blue R250 in methanol-water-acetic acid 45:45:10 
(v/v/v) or Western blot analysis was performed. 
6.27 Western blots and antibodies 
SDS-P AGE gels were blotted on standard nitrocellulose membrane and incubated in 
blocking solution (PBS IX, 0.2% Tween, 2% milk) over night. Primary antibodies were 
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incubated with the membrane in the same buffer for 2 hours. Afterwards, the membrane 
was then washed three times in washing solution (PBS IX, 2%Tween), incubated with the 
proper HRP-secondary antibodies (anti-mouse/rabbit, Dako) for 1 hour, washed twice and 
stained with ECL reagent (Thermo Scientific). Finally, an autoradiography was taken on 
Kodak Biomax XAR films. 
The following primary antibodies were used in this study: 
Fox-I: N-14 (sc-135476, Lot#1709, Santa Cruz Biotechnology) 
hnRNP A I: donated by Emanuele Buratti 
PTB/nPTB: donated by C. W.J Smith 
hnRNP JKTBP: (Product number: A V 40585, Sigma-Aldrich) 
DAZAPI: donated by Natasa Skoko 
ASF/SF2, SC35 and IH4 (against SRp 75, 55, 40): Zymed Laboratories Inc. 
Tubulin: (I :5000, Sigma T5168) 
Actin: (I: 1000, Sigma-Aldrich) 
Anti-flag epitope: (1:2000) (Sigma F1804) 
TDP-43: donated by Emanuele Buratti. 
6.28 RNA preparation for pull down and band-shift analysis 
RNA templates were obtained by amplifying the respective exonlintron sequences using a 
forward primer carrying a T7 polymerase target sequence (5'-
T ACgT AA TACgACTCACT ATAg-3 ') with complementary to the specific exon and a 
reverse primer carrying of the target sequence. The amplified products were then purified 
and -2 Jlg of ON A was transcribed using T7 RNA Polymerase (Stratagene) in the presence 
of transcription buffer (350 mM HEPES, pH 7.5, 30 mM MgCI2, 2 roM spermidine, and 
40 mM dithiothreitol), 40 units of RNasin, 7 mM each of the four NTPs, and 60 units of T7 
polymerase (1.5 unitslJlg). Following incubation for 2 h at 37 °c, the RNA was purified 
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using NICK Columns (Amersham Biosciences), precipitated and resuspended in RNAse-
free water. 
6.29 Pull down analysis 
One nanomole of cold RNAs was placed in a 400 J.ll reaction mixture containing fresh 0.1 
M NaOAc, pH 5.0, and 5 mM sodium m-periodate (Sigma). Reaction mixtures were 
incubated for 1 h in the dark at room temperature. The RNA was ethanol-precipitated and 
resuspended in 500 III of 0.1 M NaOAc, pH 5.0. Then, 400 III of adipic acid dehydrazide-
agarose bead 50% slurry (Sigma) was washed four times in 10 ml of 0.1 M NaOAc, pH 
5.0, and pelleted after each wash at 3000 rpm for 3 min in an Eppendorf minifuge. After 
the final wash, 300 III of 0.1 M NaOAc, pH 5.0, was added to the beads. The slurry was 
then divided into equal aliquots that were mixed with each periodate-treated RNA sample 
and incubated for 12 h at 4 °C on a rotator. The beads with the bound RNA were then 
pelleted and washed three times in 2 ml of 2 M NaCI and three times in 3 ml of RNA 
washing buffer (52 mM HEPES-KOH, pH 7.5, 10 mM MgC12, 8 mM Mg(acetate), 5.2 
mM dithiothreitol, 38% v/v glycerol). They were incubated in IX RNA binding buffer (i.e. 
RNA washing buffer added with 7.5 mM ATP, 10 mM GTP, and 5 mg/ml heparin) with 
0.3 mg of HeLa cell nuclear extract for 20 min at 30°C in a 500 J.ll final volume, pelleted 
by centrifugation at 1000 rpm for 3 min, and washed five times with 5 ml of RNA washing 
buffer. After the final centrifugation 60 III of SOS-PAGE sample buffer were added to the 
beads and heated for 5 min at 90°C before loading onto a 10% SOS-PAGE gel. Internal 
sequence analysis from the Coomassie Blue-stained bands excised from the SOS-PAGE 
gel was performed using an electrospray ionization mass spectrometer (LCQ OECA XP, 
ThermoFinnigam). The bands were digested by trypsin, and the resulting peptides were 
extracted with water and 60% acetonitrile/1 % trifluoroacetic acid. The fragments were 
then analyzed by mass spectrometry by the Protein Networks Group at ICGEB. 
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Alternatively, a western blot analysis can be perfonned using the specific antibody against 
the protein we want to check the presence. 
6.30 Spliceosomal assembly analysis 
Spliceosome complexes were assembled as described earlier (Behzadnia, Hartmuth et a1. 
2006). Briefly, 10 Nm of (32)P-labelled RNA was incubated with 40% (v/v) of HeLa 
nuclear extract under splicing condition. Aliquots were collected at 5 and 30 minutes time 
points and reaction was stopped by addition of 2.5111 of 5X spliceosome gel loading buffer 
(IX TBE, 30% v/v glycerol, O.SgIl Heparin, 0.1% w/v bromophenol blue). The splicing 
complexes were separated through electrophoresis using a 4% polyacrylamide native gel 
run at 300V for 3 hours. Finally, gels were dried and visualized by phosphor imager 
(Molecular Dynamics). 
6.31 Southern blot analysis 
Briefly, RT-PCR amplicons were checked in an agarose gel. The resulting fragments were 
separated according to size by electrophoresis through a 0.6% (w/v) agarose gel (120V). 
The gel was photographed under UV light and washed twice (for 10 minutes each) with 
O.2N HCI for depurination of DNA, then twice (10 minutes each) with Denaturation 
Solution (1.5 M NaCI; 0.5 M NaOH). The DNA was transferred from the gel to the nylon 
membrane (Z-Probe, BioRad) by upwardcapillary transfer using Denaturation solution 
(overnight). The day after the blotting was removed. To checked blotting efficiency the 
membrane was observed under UV light, whereas the agarose gel was stained with a 
solution containing ethidium bromide. After the membrane was neutralized twice (10 
minutes each) with Neutralizing Solution (1 M Tris-CI; 1.5 M NaCI) and dried at room 
temperature on a Whatman 3 MM filter paper. The DNA was bound to the membrane by 
UV cross-linking (2X, 0.25 J). Then, the membrane was prehybridised for at least Ih at 
65°C in 20 ml of Pre-hybridization solution (6X sec, 5X Denhardt's reagent, 0.5% (w/v) 
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SDS, 100 Jlg/ml salmon spenn DNA) and hybridized overnight at 6SoC to the 
radio labelled probe, in 10 ml of a pre-hybridisation solution. The day after the 
hybridization solution was removed and the membrane was washed with several washing 
solutions at 6SOC: 4X SSC, 0.1 % SOS (w/v) to remove the excess of the hybridisation 
probe; 2X SSC, 0.1 % SDS (w/v) and O.SX SSC, 0.2% SDS (w/v) with more stringent 
conditions to eliminate non specific hybridisation. After each wash the membrane was 
checked for radioactive signal using a geiger (Canberra Packard SRL) to evaluate if 
continue or suspend the washing. Finally, the membrane was immediately covered with 
plastic wrap mounted on Whitman 3 MM filter paper and exposed overnight using Cyclone 
screen (Cyclone, Storage Phosphor System, Canberra Packard SAL). 
6.31.1 Hybridization probes preparation 
The different DNA fragment used as Southern blot hybridisation probes were 
oligonucleotides for SCN9A exon 4, SN and SA; 5'CTTCTGTGTAGGAGAATTC3', 
S 'CTCAGCA TTGAGAACA3' and S 'TTCAGCTCTTCGAACT3' respectively (lOT 
Integrated DNA Technologies). Radioactive probes were generated from 50 ng of DNA by 
the Rediprime II Random Prime Labelling System (Amersham Bioscience) using [a_32p] 
dCTP (Amersham Bioscience) and were then purified from unincorporated nucleotides by 
Nick columns (Amersham bioscience). Both the labelling and the probe purification were 
carried out according to the manufacturers' instructions. 
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